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 AďstƌaĐt 
 
The splanchnic region (abdominal gastrointestinal organs) is sometimes known as the 
͞ĐaŶaƌǇ of the ďodǇ͟ foƌ its susĐeptiďilitǇ to deǀelop hǇpoǆia at aŶ eaƌlieƌ stage, 
analogue to the old times practice in coal mining. When the neuroendocrine response 
is activated, it exhibits regulation of blood flow and extraction of oxygen, facilitating 
redistribution of blood to vital organs. This can ultimately lead to systemic inflammatory 
response and multiple organ failure. The vital need to monitor the perfusion of the 
splanchnic region in critically ill patients has not yet been met by existing techniques. 
The goal of this research was to evaluate the feasibility of using the technique of 
photoplethysmography intraluminally in the duodenum in order to measure the 
haemodynamic changes occurring in the splanchnic circulation in a minimally invasive 
fashion. A bespoke processing system and data acquisition virtual instrument were 
designed and developed to allow continuous and simultaneous monitoring of two 
probes: an existing miniaturised PPG probe intended for intraluminal use and optically-
identical finger PPG probe. Nine anaesthetised patients undergoing elective open 
laparotomy surgery were recruited and consented for the clinical trial at The Royal 
London Hospital. Due to the great proximity to the surgical site, monitoring of duodenal 
pulse oximetry signals could not be done in a continuous way. Also, the presence of 
moderate respiratory modulation in otherwise good quality, high amplitude signals 
seemed to result in an underestimation of arterial blood saturation of 2%. A frequency 
domain algorithm was thus applied to the data with results in agreement with both the 
finger PPG probe and commercial pulse oximeter. Blood oxygen saturation estimation 
at respiratory frequency yielded values within the physiological range expected for 
venous blood. For three of the patients, PPG signals were also acquired from the 
stomach, with results showing a similar pattern to the ones obtained from the 
duodenum. During the clinical trials, two patients experienced hypotension. PPG signals 
obtained before, during and after showed a great decrease in estimated blood oxygen 
saturations, which remained low even when monitored haemodynamical variables were 
back to normal values. Finger PPG probe estimations and commercial pulse oximetry 
values did not demonstrate this change. This suggests the possibility of 
photoplethysmography identifying changes in tissue oxygenation and blood volume in 
the splanchnic circulation resulting from external and/or internal regulatory 
mechanisms. This clinical trial thus show the great promise of pulse oximetry as 
complementary monitoring for patients at risk of developing splanchnic ischaemia. 
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Chapteƌ 
1 
 
 
 
INTRODUCTION 
In the past few decades there has been an increased understanding of the role 
of the splanchnic circulation (blood flow to abdominal gastrointestinal organs) in the 
development of sepsis and multiple organ failure in critically ill patients and 
consequently an increased interest in monitoring this region [1], [2]. In the face of 
circulatory distress, the splanchnic region exhibits auto regulation of blood flow and 
extraction of oxygen, facilitating redistribution of blood to vital organs, such as the heart 
and brain. Before central circulation is affected, hypoxia ensues within the splanchnic 
circulation. Unnoticed, this results in mucosal barrier dysfunction, ultimately inducing 
septic shock and multiple organ failure [3], [4]. The splanchnic region is therefore known 
as the ͞ĐaŶaƌǇ of the ďodǇ͟ [4], analogue to the old times practice in coal mining, and 
similarly vital to monitor for early detection of inadequate oxygenation.  
Existing techniques for monitoring perfusion of the splanchnic region from within 
the gastrointestinal tract rely on either invasive procedures [5] or are based on indirect 
parameters, like blood flow for laser Doppler flowmetry and magnetic resonance 
angiography or mucosal carbon dioxide tension for gastric tonometry [6]. These 
techniques, considering the metabolic mechanisms of increased oxygen extraction in 
the splanchnic circulation [7], may not suffice in giving a true representation. Therefore, 
there is a need for a simple, continuous and non-invasive method for monitoring oxygen 
saturation in this region. 
18 
Pulse oximetry has become a standard of care present in most operating 
theatres, intensive care units and during transport of critically ill patients [8]. It provides 
non-invasive continuous monitoring of arterial blood oxygen saturation (SpO2) and heart 
rate. Pulse oximetry estimates the percentage of oxygen bound to haemoglobin by 
measuring the ratio of light absorbance of vascular tissue at two different wavelengths, 
red and infrared, at the finger or ear lobe. The time dependant photoplethysmographic 
(PPG) signals received at the photodetector of the pulse oximeter are assumed to be 
caused exclusively by changes in the arterial blood volume associated with the cardiac 
cycle [9]. More recent studies have suggested the possibly of measuring venous blood 
oxygen saturation by isolating the respiratory modulation of the PPG signals [10], [11]. 
This project hypothesises that photoplethysmographic signals obtained from the 
lumen of the duodenum may provide a window into the perfusion of splanchnic 
circulation and enable the early detection of hypoxia. A bespoke processing system and 
data acquisition virtual instrument were designed and developed to accept an existing 
miniaturised PPG probe intended for intraluminal use and optically-identical finger PPG 
probe. This will enable simultaneous monitoring and comparison of signals from the 
lumen of the duodenum and the traditional pulse oximetry site during clinical trials on 
nine patients undergoing open laparotomy. 
Chapter 2 illustrates the importance of oxygen in cell metabolism and describes 
the process by which it is made available to the cells through coordination of the 
respiratory and cardiovascular system, giving particular focus on the oxygen carrying 
molecule haemoglobin. 
Chapter 3 covers the basic anatomy and blood circulation, both arterial supply 
and venous drainage, of the stomach and duodenum. It also explains the processes of 
blood flow and oxygenation regulation that occur in this area, discussing some of the 
pathologies that arise due to inadequate perfusion. 
Chapter 4 gives a review on the techniques used and/or under research for 
estimating perfusion of the splanchnic circulation, focusing on those used intraluminally. 
It details the physiological principle in which they are based, the technology used for the 
measurement and an account of their use in both animal and human studies. 
19 
Chapter 5 introduces the principles of photoplethysmography (PPG) and pulse 
oximetry that are the base to the technology used in this study. It begins with Beer-
Laŵďeƌt͛s laǁ foƌ the aďsoƌptioŶ of light, ďefoƌe highlightiŶg the optiĐal pƌopeƌties of 
blood, more specifically of oxyhaemoglobin and deoxyhaemoglobin. It explains the 
technique of PPG and the PPG waveform used in pulse oximetry to develop the 
equations needed for calibration and estimation of arterial blood saturation. It also 
describes the opto-electronic components and configurations used for pulse oximeter 
probes. A brief overview of the limitations of pulse oximetry is also given. Following this, 
it gives an overview on the research done on monitoring venous blood oxygen 
saturation using the techniques of photoplethysmography and pulse oximetry. 
Chapter 6 gives a description and evaluation of the dual wavelength processing 
system used to drive the optics of the intraluminal and finger PPG probes, used in the 
clinical study, and process the acquired signals. A 3-lead ECG channel and an air pressure 
sensing channel were also incorporated in the hardware system. 
Chapter 7 details the virtual instrument developed in LabVIEW for acquisition 
and display of the photoplethysmographic signals. 
Chapter 8 describes the clinical trials performed on nine anaesthetised patients 
undergoing routine open laparotomy surgery. The intraluminal probe was positioned in 
the duodenum and PPG signals were obtained in both stable and hypotensive 
conditions. For three of the patients, PPG signals were also acquired from the stomach. 
Data and statistical analysis of all acquired PPG signals is undertaken, presented and 
discussed. 
Chapter 9 presents the conclusions along with suggestions for further work. 
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OXYGEN DELIVERY AND ROLE IN THE CELL 
Oxygen plays a vital role in the human body. It is the most electronegative 
element available to the cells and thus the strongest acceptor of electrons within the 
chain of chemical reactions that convert glucose into adenosine triphosphate (ATP). ATP 
is the energy currency for the metabolic processes of cells, which include maintenance 
of membrane integrity, ionic pumps and other specialized functions [12]. 
In the absence of oxygen, hypoxia ensues and the cell has to resort to 
energetically inefficient processes for ATP production. Ultimately this situation will lead 
to irreversible cell damage and cell death. 
The oxygen present in the atmosphere is made available to cells through the 
coordinated actions of the respiratory and cardiovascular systems. “iŶĐe gases aƌeŶ͛t 
particularly soluble in the plasma of the blood, a specialized molecule present in red 
blood cells, haemoglobin, facilitates transport and release of oxygen to every cell in the 
human body to meet their metabolic needs. 
This chapter will expand on oxygen transport, delivery to cells via haemoglobin 
in red blood cells and what happens in the cell and tissues when it is insufficient to 
support metabolism. 
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2.1 Respiration 
Respiration occurs in three phases (Figure 2.1): 
 Pulmonary ventilation: exchange of air between the atmosphere and the lungs 
through inspiration and expiration.  External respiration: exchange of gases between the alveoli of the lungs and the 
blood in pulmonary capillaries.  Internal respiration: exchange of gases between blood in systemic capillaries and 
tissue cells. 
 
Figure 2.1: The three stages of respiration: 1 - pulmonary ventilation, 2 - external respiration,  
3 – internal respiration (adapted from: 
http://www.vnacne.org/body.cfm?id=103&chunkiid=197587) 
 
2.1.1 Pulmonary ventilation 
The act of breathing is mostly an involuntary process controlled by neuron 
clusters located in the medulla oblongata and pons of the brain stem [13]. The excitation 
of these neurons is transmitted to motor neurons in the spinal cord that cause 
contraction of the diaphragm, pectoral muscles and intercostal muscles, lifting the ribs 
and pulling them outward during inspiration. The expansion of the thoracic cavity causes 
the tiny air sacs in the lungs, called alveoli, to enlarge. As the air inside the alveoli 
eǆpaŶds, ďǇ BoǇle͛s laǁ its paƌtial pƌessuƌe dƌops. This creates a negative pressure 
gradient about of 3 mmHg between the lungs and the atmosphere [14], drawing air in 
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through the nose or mouth and into the body. The inspired air passes through the 
pharynx and trachea, into the left and right bronchi. Inside the lungs, each bronchus 
divides into even narrower bronchioles before the air reaches the alveoli. This is where 
external respiration takes place. 
Cyclically, the respiratory centre in the brain becomes inactive and the nerve 
impulses cease. With no impulses arriving, the inspiratory muscles relax. Expiration 
results from the natural elastic recoil of the lungs to its original volume and, according 
to BoǇle͛s laǁ, ĐoŶseƋueŶt iŶĐƌease iŶ pƌessuƌe to a value that is about 3 mmHg above 
atmospheric pressure [13]. The pressure gradient is now reversed and the air is forced 
out of the lungs into the atmosphere, until the two pressures are equalized. 
The neurons of the respiratory centre of the brain control both rhythm and depth 
of respiration. Normal quiet respiration rate averages 12 breaths per minute [13] but 
this can be modified voluntarily, by emotional stimuli (i.e. during crying or laughing), by 
chemical stimuli (increased carbon dioxide, decreased oxygen or decrease pH in blood) 
or by other factors including temperature, pain, blood pressure or irritation of airways.  
2.1.1.1 Mechanical ventilation 
Mechanical ventilators are used to deliver additional oxygen or breathing 
support to a patient who has either severe respiratory problems or is undergoing 
general anaesthesia during a surgical procedure. The first workable mechanical 
ventilators, developed in the 1920s, were negative pressure ventilators, known as iron 
lungs [15]. This type of ventilator works by applying negative pressure around the 
thoracic cavity. However, valuable in allowing a patient to remain connected for years 
at a time, it greatly limits access to the patient for medical staff. 
Positive pressure ventilators, on the other hand, force air into the alveoli by 
creating a positive pressure gradient: gas at a higher pressure is applied to the airways 
through an endotracheal tube, a tracheostomy tube or via a tight fitting face mask. 
Exhalation occurs passively due to the elastic recoil of the lungs when the delivered air 
pressure drops. These ventilators can be operated in either volume control or pressure 
control modes and even in assist mode, helping with ventilation after the patient 
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initiates the breathing cycle. The addition of PEEP (positive end expiratory pressure) 
minimizes the collapse of the airways and alveoli by maintaining the air pressure above 
atmospheric pressure at the end of expiration. 
However, the additional increase in intrathoracic pressure has a reflection on the 
cardiovascular system leading to decrease in venous return, right ventricular output,  
pulmonary blood flow and associated consequences [16]. 
2.1.2 External respiration 
External respiration is the term used for the gas exchange between the inspired 
air and blood occurring at the level of the alveoli through the process of diffusion. 
Oxygen diffuses from the alveolar air, where its partial pressure is higher at 105 mmHg 
[13], into the lower partial pressure environment of the blood in the pulmonary 
capillaries. Under resting conditions, the partial pressure of oxygen (PO2) in the blood 
that reaches the lungs to be re-oxygenated is around 40mmHg, but in exercise this value 
can be even lower. Diffusion will continue until the pressures are equalized. Carbon 
dioxide (CO2) is also subjected to a partial pressure gradient but in the opposite 
direction: CO2 will move across the gas/blood barrier to the alveolar air by diffusion and 
be expelled from the body during expiration. 
The alǀeoli aƌe ideallǇ suited foƌ the pƌoĐess of diffusioŶ. AĐĐoƌdiŶg to FiĐk͛s laǁ, 
the rate of diffusion of a gas across a membrane is not only dependent on the partial 
pressure difference but also on properties of the membrane itself. An adult human has 
approximately 600 million alveoli, totalling a 70 m2 of gas exchange surface area [13]. In 
addition, a dense network of capillaries surrounds each alveolus and as much as 900 mL 
[13] of blood is able to participate in gas exchange at any instant. Furthermore, the 
membrane of the alveoli is approximately 0.3 µm thick [17] which, coupled with one cell 
thick walled capillaries, decreases the diffusion distance. 
2.1.3 Internal respiration 
The purpose of respiration is to deliver oxygen to cells throughout the body for 
cellular respiration. Oxygen is consumed in the breakdown of glucose into adenosine 
triphosphate (ATP) [13]. ATP is the principal source of energy used in various metabolic 
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ƌeaĐtioŶs iŶ the Đell aŶd it ŵust ďe ĐoŶtiŶuouslǇ sǇŶthesised as the ďodǇ͛s ƌeseƌǀes ǁill 
last no longer than a few minutes [12]. 
In the absence of oxygen or when there is a temporary increase in demand, the 
cell is able to synthesise ATP through anaerobic processes, meaning they occur in the 
absence of oxygen. In the first stage of glucose oxidation, denominated glycolysis, two 
pyruvic acid molecules are produced with a net gain of two molecules of ATP. The 
pyruvic acid is then removed from the cell through fermentation. The waste products of 
this process will be lactic acid and carbon dioxide. 
However, if enough oxygen is available to the cell, the pyruvic acid will enter the 
mitochondria and undergo further oxidation with liberation of CO2 and production of 
the energy containing molecules ATP, NADH+H+ and FADH2. These molecules are the 
source of high energy electrons that are moved through the electron transport chain. As 
electrons are passed to the protein complexes of the electron transport chain, protons 
are pumped across the mitochondrial inner membrane, resulting in an electrochemical 
gradient. In the fifth and last protein complex, the energy derived from the protons 
flowing back into the matrix and subsequent collapse of pH gradient will be utilized to 
form ATP. The strongest acceptor of electrons in this chain is the molecular oxygen. Each 
atom of oxygen will accept two electrons transferred from the electron transport chain, 
becoming negatively charged. It then picks up two hydrogen protons (H+) from the acidic 
surrounding medium forming one water molecule. Even though this aerobic process, 
known as oxidative phosphorylation, will take longer than the anaerobic option, it yields 
a larger energy gain: 36 or 38 molecules of ATP can be generated from one molecule of 
glucose [13]. 
Oxygenated blood in the systemic capillaries has a greater oxygen partial 
pressure than the tissues it bathes, and exchange of gases will occur through diffusion 
as well. Oxygen will diffuse into the interstitial fluid surrounding the cells before entering 
the nearest cells, within a distance of about 1 mm. The waste product carbon dioxide 
will diffuse from the cells into the blood. 
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2.2 Transport of oxygen 
2.2.1 Cardiovascular system 
 In order to maintain homeostasis, the human body can consume over 1023 
molecules of oxygen per second [9]. This amount of oxygen is made available to cells 
through coordination between the cardiovascular and respiratory systems. 
2.2.1.1 The heart 
The heart is the primary pumping mechanism for maintaining a constant 
circulation of blood throughout the body. It has four chambers: the atria that receive 
blood, and the ventricles, that pump blood away from the heart to the systemic and 
pulmonary circulations. The septum divides the left and right sides, separating 
oxygenated and deoxygenated blood. 
The contraction of the heart is initiated by the electrical activity generated by the 
pacemaker cells in the sinoatrial node (SA). The action potential then propagates 
through the conduction system to the atrioventricular (AV) node, causing polarization 
and depolarization of the muscle fibres of the heart. This inherent electrical activity 
ensures a rhythmical and alternating contraction of the atria and the ventricles [13]. The 
heart rate and strength of heartbeat is controlled and regulated by the cardiovascular 
centre of the autonomic nervous system located in the medulla oblongata of the brain 
and by chemoreceptors that detect hormonal changes in the blood and baroreceptors 
that detect changes in blood pressure. A healthy heart rate is between 50 to 70 beats 
per minute but it may reach 200 beats per minute in a healthy young adult with maximal 
nervous stimulation [13]. 
The action potential from the SA node spreads through the contractile fibres in 
both atria to the AV node, causing atrial systole (contraction). As the pressure rises 
inside the atria, the blood within is forced through the mitral (or bicuspid) valve in the 
left side of the heart and through the tricuspid valve in the right side at the same time. 
The end of atrial systole marks the end of ventricular diastole (relaxation). Rapid 
ventricular depolarization causes ventricular systole, as the action potential spreads 
through the ventricular contractile fibres. Pressure rises inside the chambers and pushes 
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blood up against the semilunar cups of the aortic valve in the left side of the heart and 
the pulmonary valve in the right side, forcing them shut. Continued contraction causes 
pressure inside the ventricles to rise sharply. When the pressure in the left ventricle 
reaches about 80 mmHg the valve opens and the blood is pushed into the aorta to the 
systemic circulation. The pressure inside the ventricle will continue to rise until 
approximately 120 mmHg. In a resting adult, the volume of blood that is ejected from 
the left ventricle each minute, called the cardiac output, is about 5 L, close to the total 
blood volume [13]. In the right ventricle, the pressure will climb to 20 mmHg when the 
pulmonary valve opens to the pulmonary trunk and the blood is pumped to the 
pulmonary circulation. The pressure in the right ventricular will continue to rise to about 
25 to 30 mmHg [13]. After contraction, ventricular repolarization causes ventricular 
diastole (relaxation).  
The different phases of the cardiac cycle can be observed in Figure 2.2. 
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Figure 2.2: The phases of the cardiac cycle (blue colouring represents muscle contraction and 
green represents valve opening) (in: 
http://academic.kellogg.edu/herbrandsonc/bio201_mckinley/cardiovascular%20system.htm) 
2.2.1.1.1 ECG 
The electrocardiogram (ECG) is the recording of the electrical activity initiated by 
the SA node by suitable electrodes at the surface of the body. Its trace represents the 
temporal and spatial summation of the action potential of all the heart muscle fibres 
throughout the cardiac cycle. 
The first wave of the ECG trace is the P wave, which represents atrial 
depolarization. The second recognizable feature, called the QRS complex, corresponds 
to the rapid ventricular depolarization while the third wave, the T wave represents 
ventricular repolarization just as the ventricles start to relax. The ECG trace is then flat 
during the plateau period of depolarization [13] before the cardiac cycle starts gain with 
atrial depolarization. Figure 2.3 provides a visualization of this process. 
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Figure 2.3: Action potentials throughout the cardiac cycle and normal ECG trace. (in: 
http://basic-clinical-
pharmacology.net/chapter%2014_%20agents%20used%20in%20cardiac%20arrhythmias.htm) 
2.2.1.2 Pulmonary circulation 
During inspiration, air flows into the lungs and, as explained previously, gas 
exchange occurs at the level of the alveoli. Oxygen is diffused into the dense network of 
capillaries that surrounds each alveolus. As this oxygen rich blood leaves the lungs, it is 
drained through larger vessels, known as venules and eventually into the pulmonary 
veins. Two left and two right pulmonary veins enter the left atrium of the heart. 
From the right ventricle, the blood depleted of oxygen originating from the 
systemic circulation, is pumped through the pulmonary valve into the pulmonary artery. 
It is then carried by two branches, the right and left pulmonary arteries, to the alveoli in 
the lungs for external respiration. 
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2.2.1.3 Systemic circulation 
The systemic circulation carries the oxygenated blood that leaves the aortic valve 
to supply nourishment and remove waste products from all the cells of the body, 
excluding the alveoli. 
The aorta is the largest artery of the body and all the major arteries that supply 
all the major organs in the body branch off it. Arteries have a thick muscular elastic wall 
with high compliance, allowing them to expand easily with the periodical pressure 
variations of the blood inside. Vasoconstriction and vasodilation is also possible by 
sympathetic and parasympathetic innervations of the smooth muscle fibres on their 
tunica media [13]. 
These arteries will give rise to smaller diameter arterioles, which continue to 
branch out into finer capillaries. An extensive network of thin walled capillaries 
facilitates the exchange of gases and other nutrients to tissue. Oxygen is delivered to 
the cells for internal respiration and carbon dioxide and waste products are picked up. 
When it leaves the systemic capillaries, the level of oxygen in the blood has dropped 
from 95-99% to 60-80% (or around 40% during exercise) [18]. This is commonly known 
as deoǆǇgeŶated ďlood, eǀeŶ though it isŶ͛t ĐoŵpletelǇ desatuƌated of oǆǇgeŶ. The 
capillaries will drain into a systemic venule, which will merge into systemic veins and 
ultimately the superior and inferior vena cava. Veins, in contrast to arteries, have thinner 
walls with larger lumens and, as a result, the venous pressure is lower than the arterial 
pressure: the normal range for central venous pressure (CVP) is 0 to 6 mmHg [19].  Some 
veins contain valves that prevent backflow of blood. 
 The blood returns to the right atrium of the heart, right ventricle and pulmonary 
circulation to be re-oxygenated. 
2.2.2 Haemoglobin 
Gases are not particularly soluble in water and, oďeǇiŶg HeŶƌǇ͛s laǁ, at a paƌtial 
pressure of 100 mmHg, 100 ml of plasma contains 0.3 ml of oxygen, corresponding to 
about 1.5% of the total oxygen transported [20]. The vast majority is bound to 
haemoglobin in red blood cells (RBC), also called erythrocytes. RBCs are highly 
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specialized for the transport and delivery of O2: their surface area for diffusion of gas 
molecules is increased by their biconcave disc shape and a strong plasma membrane 
concedes them the flexibility and strength to deform without rupturing as they squeeze 
through narrow capillaries. Being devoid of a nucleus and mitochondria, RBCs generate 
ATP aŶaeƌoďiĐallǇ aŶd doŶ͛t ĐoŶsuŵe aŶǇ of the oǆǇgeŶ theǇ tƌaŶspoƌt. A healthy adult 
has approximately 5 million of RBCs per microliter of blood and each cell contains about 
280 million molecules of oxygen-carrying haemoglobin [13]. 
The molecule of haemoglobin consists of a protein globin, composed of two 
alpha and two beta polypeptide subunits, and a haem group bound to each globin chain. 
Each haem group contains one iron atom each that can form a reversible covalent bond 
with an oxygen molecule, totalling 4 oxygen bonds for every haemoglobin molecule 
(Figure 2.4). 
 
Figure 2.4: Haemoglobin is the main functional constituent of the red blood cell (in: 
http://science.cabot.ac.uk/?p=2357) 
When oxygen binds to one of the haem groups, the structure of the haemoglobin 
molecule changes slightly, enhancing the attraction to oxygen by the remaining groups. 
The loading of the first oxygen results in the rapid loading of the next three, forming 
oxyhaemoglobin. Conversely, when one haem group unloads its oxygen, the others will 
also unload rapidly [21]. This property of haemoglobin is called cooperative binding. 
When the haemoglobin molecule is not fully saturated with oxygen it is known 
as deoxyhaemoglobin. Together with oxyhaemoglobin, they are called functional 
haemoglobins. The presence of carbon monoxide, for example, which has a higher 
affinity to haemoglobin and so competes with oxygen for the binding position, leaves 
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the haemoglobin molecule unable to reconnect to oxygen. Carboxyhaemoglobin is then 
called a dysfunctional haemoglobin species, along with methaemoglobin, an oxidised 
haemoglobin molecule. 
2.2.2.1 Oxyhaemoglobin dissociation curve 
The success of cellular respiration is dependent on the ease of dissociation of 
oxygen from haemoglobin. A useful tool to understand this relationship is the oxygen 
dissociation curve (Figure 2.5). This is graphical representation of the amount of oxygen 
chemically bounded to haemoglobin in blood as a function of oxygen partial pressure 
(PO2). 
PO2 is the most important factor that influences the affinity of haemoglobin to 
oxygen. As can be seen in Figure 2.5, haemoglobin is close to 100% saturated at about 
105 mmHg, the partial pressure of oxygen in the alveolar air at inspiration. It is also 
important to notice that haemoglobin is still over 90% saturated with O2 at a PO2 of 
60 mmHg and a nearly full load of oxygen can still be picked up from the lungs. On the 
other hand, in active tissues, where PO2 can fall below 40 mmHg, large amounts of 
oxygen dissociate from haemoglobin in response to small decreases in partial pressure 
[13]. This characteristic sigmoid shape is a result of the cooperative binding of oxygen 
to the haem groups. 
 
Figure 2.5: Oxygen-haemoglobin dissociation curve showing the relationship between 
haemoglobin saturation and PO2 at normal body temperature (in: 
http://www.frca.co.uk/article.aspx?articleid=100345) 
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Other factors that influence the affinity of haemoglobin for oxygen include the 
acidity of the cell environment, temperature and carbon dioxide: 
 An increase in acidity shifts the oxygen dissociation curve to the right and will 
enhance the unloading of oxygen from haemoglobin. An example of this is the presence 
of lactic acid during anaerobic cell respiration. 
 An increase in temperature will also cause a curve shift to the right. Heat is a 
byproduct of metabolic activity and active cells require more oxygen. Fever produces a 
similar result.  
 Carbon dioxide can also bind to haemoglobin and, similarly to hydrogen ions (H+) 
when acidity increases, it shifts the dissociation curve to the right [13]. The attachment 
of carbon dioxide to the amino groups of the globin molecule is known as 
ĐaƌďaŵiŶohaeŵogloďiŶ ďut doesŶ͛t Đoŵpete ǁith oǆǇgeŶ foƌ the iƌoŶ ďiŶdiŶg positioŶs 
[21]. Hoǁeǀeƌ, this isŶ͛t the ŵost effiĐieŶt ǁaǇ of tƌaŶspoƌt aŶd ŵost of CO2 is carried 
by plasma in the form of carbonates. 
 
2.3 Oxygen deficiency in the cell 
The oxygen transport system operates to maintain a balance of oxygen 
consumption and delivery to cells. Under resting conditions, the tissue cells will receive 
more than adequate oxygen to meet their requirements and ensure aerobic 
metabolism. Higher metabolic activity, i.e. during exercise, will lead to higher 
requirements and cells extract more oxygen from haemoglobin and the saturation of 
mixed venous blood falls below 70% [22]. 
Failure of oxygen supply to meet the demands of cells will lead to hypoxia 
ensuing. Firstly, as the oxygen level decreases, the cell is able to adapt, going into a state 
of hibernation [23]. As mitochondrial activity diminishes and enzymes adjust their 
metabolism, ATP production is maintained at a sufficient level. 
The next threshold of hypoxia, as defined by Connett et al [12], happens when 
the cell has to resort to anaerobic metabolism for production of ATP to match the 
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energetic demand. Besides being energetically inefficient, the anaerobic metabolic 
pathway produces lactic acid. Clearance by conversion to glucose is an ATP requiring 
process and so lactic acid rapidly builds up in the cell. This has the effect of lowering the 
pH of blood causing a shift to the right in the oxyhaemoglobin dissociation curve. 
The third threshold of hypoxia is crossed when anaerobic metabolism becomes 
insufficient to produce enough ATP to maintain cellular function. If oxygen deprivation 
continues, cellular membrane disruption will follow resulting in electrolyte (potassium, 
sodium and calcium) disturbance and ultimately irreversible cell damage and death by 
necrosis or activated apoptosis (genetically encoded cell death) [24]. 
There are four types of hypoxia determined by the pathophysiological cause of 
oxygen deprivation: 
 Ischaemic hypoxia: also known as stagnant hypoxia is the result of an inadequate 
circulating volume, reduced cardiac output or arteriolar obstruction or vasoconstriction; 
it can also be caused by intravascular blood stagnation due to impairment of venous 
outflow or decreased arterial flow. It can be brought on by a variety of conditions 
including cardiac arrest, pulmonary embolism or stroke [25]. 
 Anaemic hypoxia: also known as hypemic hypoxia is seen when there is a 
reduction in oxygen carrying capacity, whilst arterial partial pressure of oxygen remains 
normal. It is attributable to a low total haemoglobin concentration in blood or low 
functional haemoglobin concentration. Possible causes include anaemia, haemorrhage, 
carbon monoxide poisoning and respiratory failure [25]. 
 Hypoxic hypoxia: it is a state of oxygen deficiency in which the arterial partial 
pressure of oxygen is low. It can be caused by a decrease in oxygen concentration of 
inspired air, decreased pulmonary ventilation, the inability to diffuse the oxygen across 
the alveoli membrane or a right to left shunt in the heart [25]. 
 Histotoxic hypoxia: occurs when the cells are unable to use the oxygen 
effectively, despite an adequate oxygen supply. Possible causes include sepsis, cyanide 
poisoning and cellular metabolic disorders [25]. 
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The fundamental physiological response to hypoxia is local vasodilation. Cells 
release vasodilators that promote dilation of arterioles and relaxation of precapillary 
sphincters [13] in order to increase blood flow and maybe restore normal oxygen levels. 
However, this may have the adverse effect of decreasing systemic vascular resistance 
and consequently lower the blood pressure. 
The neuroendocrine response (fight-or-flight response) is also activated by the 
release by the cell of numerous substances into the bloodstream to protect the body 
from the effects of hypoxic injury. This leads to an increase in heart rate and cardiac 
output as well as selective vasoconstriction and vasodilation in specific vascular beds to 
redistribute circulating volume to vital organs, such as the heart and brain [24]. Lactic 
acidosis in the circulation also stimulates chemoreceptors [26] that help maintain 
arterial pressure and increase respiratory rate to eliminate the excess acid. These 
compensatory mechanisms can however have harmful effects when activation is 
continued for a longer time, with reduction of wound healing, cardiac function and 
immune response to infection [27]. 
 
2.4 Conclusion 
Hypoxia is a consequence of the interrupted supply of ATP available for cellular 
work and the extent of the consequences of hypoxic injury will depend on the degree of 
oxygen deprivation and the metabolic needs of the tissue. It is essential to promptly 
detect and correct it in order to avoid progressive tissue dysfunction that can lead to 
organ failure [28]. Medical interventions include providing supplemental oxygen and 
fluid replacement, but must be directed to treating the underlying cause of hypoxia [23]. 
It was noted previously that when the neuroendocrine response is activated 
some vascular beds are affected by selective vasoconstriction in order to redistribute 
circulating volume to vital organs, such as the heart and brain. Splanchnic perfusion 
exhibits vasoconstriction in the face of circulatory distress, leaving it susceptible to 
hypoxia. In critically ill patients, this will contribute to the development of ischaemia, 
sepsis, multiple organ failure and increased mortality. These pathologies will be 
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discussed further, along with the anatomy and arterial and venous vasculature of part 
of the upper GI tract. The duodenum, which receives supply from the splanchnic 
circulation, will be presented as an option for monitoring the splanchnic circulation for 
the detection of hypoxia. 
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UPPER GASTROINTESTINAL ANATOMY AND BLOOD SUPPLY 
The gastrointestinal tract is used in the clinical setting as a site of minimally 
invasive monitoring and diagnosis, and procedures like the TOE (trans-oesophageal 
echocardiography) have become standard. Furthermore, the splanchnic region 
(abdominal gastrointestinal organs, including stomach, liver, spleen, pancreas, small 
intestine and large intestine) is kŶoǁŶ as the ͞ĐaŶaƌǇ of the ďodǇ͟ foƌ ďeiŶg ŵoƌe 
susceptible to changes in the arterial supply [3] and, so, monitoring this region can yield 
further information. 
 
Figure 3.1: Upper GI tract, depicting the location of the stomach and the duodenum (in: 
https://igehrprodisis.med3000.com/patiented/html/14878.html) 
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This chapter aims to take a closer look at the anatomy and blood supply of this 
region and its mechanisms of circulatory control, focusing on the stomach and 
duodenum. 
 
3.1 Anatomy of the stomach and duodenum 
3.1.1 The stomach 
The stomach is the most dilated part of the digestive tract and is situated 
between the oesophagus and the duodenum (Figure 3.1), just below the diaphragm in 
the mid upper abdomen. In the stomach, food is subjected to grinding and mixing with 
strongly acidic gastric juices that aids in the digestion of starch, proteins and 
triglycerides, to form the chyme that then is slowly delivered to the intestines. The 
sphincter that connects to the duodenum is called the pylorus. 
For convenience, the stomach is divided into different areas based on the 
structure and cells of their mucosal layer [29]. The cardia is the area adjacent to the 
gastroesophageal junction. The fundus is left lateral and superior to the cardia and lies 
above the horizontal imaginary line drawn at the level of the gastroesophageal junction. 
Inferior to the fundus is the larger central portion of the stomach, the corpus. The corpus 
is the area with the largest number of acid secreting parietal cells. It follows the greater 
curvature of the stomach until the incisura angularis. The antrum begins where the 
corpus ends and extends to the pylorus. The right curved border of the stomach, 
extending from the cardia to the pylorus, is called the lesser curvature. The greater 
curvature is up to 5 times longer than the lesser curvature as it arches to the left and 
upwards from the gastroesophageal junction, up to the level of the 5th left intercostal 
space [30], before sweeping downwards towards the pylorus. The stomach is related to 
the liver and biliary tree to the right, the spleen to the left, and the pancreas and 
transverse colon posteriorly. 
3.1.2 The duodenum 
The duodenum (Figure 3.1) is the first part of the small intestine and acts as a 
reservoir for evacuated gastric chyme. It also plays a part in gastric emptying through 
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release of hormones, in neutralising acidity from the stomach and promoting the 
digestion of fats, carbohydrates and proteins by mixing the chyme with enzymatic 
secretions and bile [31]. The digestion and absorption process continues in the jejunum 
portion of the small intestine before later expulsion of the faeces from the body through 
the anus. 
The name duodenum, meaning two plus ten in Latin, originated because it is 
roughly as long as the width of 12 fingers, 25 to 30 cm [32]. It is curved in an incomplete 
circle, enclosing the head of the pancreas and terminates at the duodenojejunal flexure. 
The duodenum is divisible into four parts for convenience of description: superior, 
descending, inferior and ascending. The first part of the duodenum is located at the level 
of the first lumbar vertebra, posteriorly to the liver and gallbladder and anteriorly to the 
gastroduodenal artery, the portal vein and the inferior vena cava. Its first 2 cm, known 
as the ampulla, for its bulb shape, are the most mobile and resemble the stomach in 
that are covered by peritoneum [33]. The rest of the duodenum is retroperitoneal, has 
no mesentery and is immobile. 
The second part of the duodenum runs inferiorly parallel to inferior vena cava, 
curving around the head of the pancreas [34]. The pancreatic duct from the pancreas 
and the common bile duct from the liver and gall bladder pierce the duodenum to 
deliver enzymatic secretions and bile. The third part of the duodenum runs transversally 
to the left passing over the inferior vena cava, aorta and third lumbar vertebra. It is 
crossed by the superior mesenteric artery and vein and the root of the mesentery of the 
jejunum and ileum [34]. The ascending part of the duodenum runs superiorly and along 
the aorta as far as the second lumbar vertebra, where it joins the jejunum at the 
duodenojejunal flexure. 
3.1.3 Mucosa 
The mucosal wall is composed of three basic layers throughout the whole 
gastrointestinal tract. Below the surface of the mucosa, lies the lamina propria, 
composed of connective tissue rich in capillary blood vessels, lymphatic vessels, elastic 
fibres, and a muscularis mucosa, a thin layer of smooth muscle [35], [36]. 
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Below the mucosa lies the submucosa, a layer of dense connective tissue of 
collagen and elastin fibres containing arterioles and venules, lymphatic vessels and 
nerve plexus. Overlying the submucosa lays the muscularis externa, allowing for 
differing contractile movements, and a thin connective tissue layer, either called serosa 
covering peritoneal organs or adventitia covering retroperitoneal organs [35], [36]. 
The luminal surface of the stomach is smooth, blood-filled red colour with thick 
longitudinal folds, known as rugae. The gastric mucosa surface is composed by a layer 
of tightly packed simple columnar epithelial cells which extend down to the lamina 
propria where they form secretory glands which open into narrow channels, the gastric 
pits [13]. The nature of the epithelial cells that line the gastric glands differs from region 
to region of the stomach, from acid-secreting in the body and fundus to gastrin-
producing in the pylorus [35].  
In the pylorus, this mucosal configuration of glands and pits changes to villi lined 
with absorptive cells, endocrine cells and surrounded by cripts of Lieberkühn [35]. 
Characteristic of the jejunum, these villi become progressively taller and thinner from 
the proximal to the distal duodenum [36]. Besides the ampulla which is smooth and 
featureless, the luminal surface forms numerous circular folds, called plicae circulares. 
The submucosa of the duodenum is easily identifiable from the rest of the GI tract by 
the pƌeseŶĐe of BƌuŶŶeƌ͛s glaŶds, seĐƌetiŶg alkali ŵuĐous. The ŵusĐulaƌis ŵuĐosa of the 
duodenum is composed by a layer of inner circular muscle fibres surrounded by a layer 
of longitudinally arranged fibres. 
 
3.2 Blood supply to the upper gastrointestinal tract 
3.2.1 Arterial blood supply 
The arterial blood supply of the gastrointestinal tract is one the most variable in 
the human body. A description of the most commonly found arterial pattern follows. 
The celiac trunk forms the great majority of the blood supply to the stomach, 
duodenum and the rest of the supramesocolonic organs [37]. The celiac trunk arises 
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from the aorta between the twelfth thoracic and first lumbar vertebrae. It gives rise to 
the left gastric, hepatic and splenic arteries. The left gastric artery sends branches to the 
cardia, as well as the lower oesophagus, to the fundus and to the lesser curvature. It 
then descends towards the antrum and pylorus where it anastomoses with the right 
gastric artery, a branch of the hepatic artery. The hepatic artery also gives rise to the 
gastroduodenal artery that supplies the duodenum and pancreas and terminates at right 
epiploic artery which courses along the greater curvature. The left epiploic artery, a 
branch off the splenic artery, anastomoses with the right epiploic artery and both bathe 
the anterior and posterior walls of the corpus of the stomach. The anterior and posterior 
walls at the region of the fundus receive branches from the short gastric arteries, which 
also originates from the splenic artery [38]. 
 
Figure 3.2: Blood supply of the stomach (in: 
http://musom.marshall.edu/graphicdesign/ibooks/Gastrointestinal%20Normal.html) 
The arterial supply of the duodenum is determined by embryonic development. 
The first part of the duodenum and the second part, up to the bile duct opening, is 
supplied by branches of the celiac trunk that feeds the foregut organs – stomach and 
oesophagus. From the celiac trunk arises the gastroduodenal artery, branching into the 
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superior pancreaticoduodenal artery which gives anterior and posterior branches to the 
duodenum [35]. 
The rest of the duodenum receives blood from branches of the superior 
mesenteric artery that also bathes the midgut – small intestine and pancreas. The 
inferior pancreaoduodenal artery, a branch of the superior mesenteric artery, gives 
anterior and posterior branches to the duodenum, anastomosing with the analogous 
branches deriving from the superior pancreaticoduodenal artery [35]. 
 
Figure 3.3: Blood supply of the duodenum (adapted from: http://web.uni-
plovdiv.bg/stu1104541018/docs/res/skandalakis%27%20surgical%20anatomy%20-
%202004/Chapter%2016_%20Small%20Intestine.htm) 
3.2.2 Venous blood drainage 
In the stomach, the capillary network in the lumen drains into mucosal venules 
at the level of the lamina propria and into the submucosal venous plexus. The stomach 
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is then drained by 5 veins – the right and left gastric, the right and left gastroepiploic 
and the short gastric veins – into the portal vein, like the lower oesophagus. 
In the duodenum, submucosal and intramural veins give rise to 
pancreaticoduodenal veins, which drain into the portal vein either directly or through 
the superior mesenteric or splenic veins [34]. 
 
3.3 Regulation of blood supply 
The arterial tree that supplies the splanchnic region is known to be innervated 
by fibres of the sympathetic division of the autonomic nervous system [36], [39]. In the 
gut, sympathetic activation of the alpha adrenergic receptors results in constriction of 
the smooth muscle that encircles the blood vessels reducing local arterial blood flow. 
The systemic nervous system favours physiological changes that support 
vigorous physical activity and rapid production of ATP [13]. In situations of physical or 
emotional stress, the hypothalamus sends nerve impulses that activate the entire 
systemic nervous system producing the neuroendocrine response. It promotes 
physiological changes including an increase in heart rate and cardiac output, increase in 
breathing rate and bronchial dilation, dilation of pupils, release of glucose from liver and 
dilation of blood vessels to the heart and skeletal muscles, organs involved in fighting a 
foe or fleeing a predator. Functions that favour storage of energy are reduced and the 
fight-or-flight response results in vasoconstriction of the cutaneous, renal and 
gastrointestinal vascular beds. This allows redistribution of the cardiac output to cope 
with the metabolic demands of vital organs, such as the heart and brain. The adrenal 
medulla, also stimulated by the hypothalamus, releases cathecolamine hormones 
(epinephrine, norepinephrine and dopamine) into the bloodstream, supplementing and 
prolonging the fight-or-flight response. Adrenergic receptors also bind to both 
epinephrine and norepinephrine [13]. The reduction in blood flow to the kidneys 
promotes the release of renin which enters the renin-angiotensin-aldosterone pathway 
to convert angiotensin I to angiotensin II. Angiotensin II is a strong peptide 
vasoconstrictor and affects the splanchnic circulation more consistently than other 
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vascular beds [39]. Another important peptide hormone in the stress response is 
vasopressin. It is synthetized in the hypothalamus but stored in the pituitary gland to be 
released in response to hypovolaemia. It acts to constrict vascular smooth muscle and 
increase its responsiveness to cathecolamines [40].  
The splanchnic organs, except the spleen, exhibit some moment to moment auto 
regulation in the face of changes in the supplying systemic system [41]. Two regulatory 
mechanisms, the myogenic and the metabolic, have been proposed to explain the 
intrinsic ability of the gastrointestinal tract to regulate its vasculature tone. The 
myogenic response is based on the Young-Laplace equation for wall tension that relates 
internal pressure to the radius of the vessel [7]. A sudden increase in vessel diameter 
due to an increase in supplying arterial pressure would lead to contraction of vascular 
smooth muscle (vasoconstriction), and vice versa, in order to keep blood flow relatively 
unchanged [42]. The metabolic mechanism, on the other hand, is based on the 
experimental evidence of a vasodilator by-product of cell metabolism in result of an 
imbalance in oxygen demand/supply, as mentioned in section 2.3 [36]. The subsequent 
increases in blood flow and capillary surface area would tend to increase oxygen supply 
to tissue, restoring O2 homeostasis. 
The ƌegioŶ͛s laƌge ĐapaĐitǇ to adapt ŵaǇ steŵ fƌoŵ its iŵpoƌtaŶt ƌole iŶ the 
regulation of circulating blood volume [43]. When faced with a reduction in blood flow, 
splanchnic oxygen extraction can increase up to 90% so as to ŵaiŶtaiŶ the Đells͛ Ŷoƌŵal 
metabolic processes, even though the gut may be may already be hypoxic when 
extraction approaches 70% [43]. 
However, it has been shown that this ability to regulate both blood flow and 
oxygen extraction is overpowered by sympathetic nervous activity [44], leaving the gut 
vulnerable to developing hypoxia in the face of circulatory complications at an earlier 
stage than the rest of the body. It is also one of the last vascular beds to regain adequate 
flow [45]. 
3.3.1 Inadequate perfusion of the splanchnic region 
At very low rates of blood flow, the diffusion rate of oxygen to the cells reaches 
a critical low level at which point mitochondrial O2 uptake is compromised [7], [36]. This 
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condition is known as ischaemia and is characterized by flow dependant oxygen 
consumption, oxygen deficit and anaerobic metabolism with its resulting fall in cellular 
pH, lactic acidosis and changes in AtP/ADP [39]. The severe hypoxia that ensues has 
adverse effects on the secretory, absorptive and motor activity of the gastrointestinal 
tract [7], ultimately contributing to a dysfunctional mucosal barrier. Injury of the luminal 
mucosa starts within minutes of the onset of ischaemia and within 30 minutes can lead 
to the translocation of viable bacteria and toxins into the surrounding sterile tissues [3], 
[4], [39]. In addition to becoming a potential source of infection and activating the 
immune response, this may also trigger the inflammatory response. 
Migration of toxins and macrophages to distant sites such as the heart, lungs and 
kidneys results in tissue injury and distant organ dysfunction. Along with systemic sepsis, 
these are all components of the multiple organ failure (MOF) syndrome [39]. Evidence 
of gut ischaemia is found in 80% of the patients with MOF [39], which has a mortality 
rate of 60% [46]. 
In terms of the circumstances that cause oxygen delivery to fall below the 
metabolic needs of tissue, the most common types of ischaemia seen in critically ill 
patients are known as the non-occlusive and relative ischaemia. The third type, the 
occlusive type, is mostly the result of an embolus or thrombosis. 
Relative ischaemia is caused by an increase in the metabolic need for oxygen 
beyond that being delivered [39] and it can be seen in sepsis. Sepsis is the systemic 
inflammatory response syndrome (SIRS) in the presence of an infection, mainly 
bacterial, but can also be of fungal or viral origin [39]. It is thought that the inflammatory 
response leads to a change in plasma which induces mitochondrial dysfunction, 
oxidative stress and apoptosis [47]. Since the mitochondria are responsible for 
synthesizing ATP, its impairment will eventually lead to cell damage and tissue injury in 
septic patients. Sepsis is accompanied by abnormal temperature and white blood cell 
count and characterized by hypotension, decreased vascular resistance, high cardiac 
output and altered blood coagulation [48]. Ischemia occurs despite the supranormal 
delivery of oxygen. As the infection becomes more severe, the release of harmful toxins 
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from ischemic tissues causes further deterioration of the circulatory system and acute 
organ dysfunction [48].  
Non-occlusive ischaemia is caused by low blood flow and is seen in patients in 
shock. Shock is a life threatening medical condition characterized by hypotension. The 
delivery of oxygen and nutrients to tissue becomes inadequate resulting in reduced 
metabolism and cell damage, eventually leading to tissue ischaemia. Sympathetic 
activity and other factors compensate for the deterioration of the circulation. The 
intense vasoconstriction of the splanchnic bed results in an increase of the effective 
circulating volume and increase in systemic blood pressure, in what is known as 
͞autotƌaŶsfusioŶ͟ [39]. 
The most common causes of shock are sepsis (septic shock), low pump function 
of the heart (cardiogenic shock) and low circulating volume (hypovolaemic shock). In 
sepsis the release of inflammatory mediators from damaged cells causes vasodilation 
and blood pooling [49]. Shock will become established if, in addition to the lowered 
systemic vascular resistance, there is a fall in venous return and cardiac output, even 
within the normal range. The consequent fall in blood pressure is the primary 
physiological marker of the haemodynamic component of shock and, along with 
inhomogeneous redistribution of blood flow, contributes to inadequate oxygen delivery 
to some tissue beds. The splanchnic vascular bed is selectively underperfused in shock 
and may have a pivotal role in the development of MOF. 
Cardiogenic shock results from impaired cardiac function. Cell hypoxia and 
hypoglycemia become increasingly more severe eventually leading to cardiac arrest. 
Hypovolaemic shock is seen in trauma or massive gastrointestinal haemorrhage. 
The decrease in intravascular volume causes the venous return to the heart to become 
inadequate. Endogeneous cathecolamines are released in an attempt to compensate for 
the lowered cardiac output, and up to 25% of volume reduction can be compensated for 
[46]. However sympathetic stimulation is unable to maintain mean arterial pressure 
when the loss of intravascular volume is prolonged or severe. Shock ensues with a 
significant systemic inflammatory component initiated by the release of inflammatory 
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mediators by an ischaemic gut, resembling the effect of septic shock. This response can 
be minimized by rapid and adequate resuscitation [46]. 
 The hormonal, metabolic and inflammatory response in critically ill patients is 
proportional to the magnitude and duration of the stress of trauma, surgery or severe 
medical illness [50]. In patients, whose cardiorespiratory function is compromised, the 
delivery of oxygen and nutrients is unable to meet the increased requirements [48] and 
tissue is more susceptible to developing ischaemia. 
 
3.4 Conclusion 
The splanchnic region plays an important role in the regulation of circulating 
blood volume and systemic blood pressure: along with peripheral tissue, it shows 
intense vasoconstriction, regulated by sympathetic activity and the release of 
endogenous hormones, during stress, facilitating redistribution of blood volume and 
blood flow to vital organs. The resulting hypoxia renders the gut mucosa susceptible to 
damage and bacterial translocation, ultimately contributing to immunological 
impairment, sepsis, shock and the development of multiple organ failure.  
Monitoring this region is therefore vital in order to prevent or limit the degree 
and duration of these ischaemic episodes and optimize clinical treatment. 
The next chapter will summarize the theory, advantages and disadvantages of 
some of techniques in research or currently employed in the clinical setting in the 
measurement of upper gastrointestinal tissue perfusion, focusing on intraluminal, 
minimally invasive methods. 
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Chapteƌ 
4 
 
 
 
CURRENT TECHNOLOGIES FOR MONITORING PERFUSION OF THE 
GASTROINTESTINAL TRACT 
The adequacy of global perfusion and oxygenation has been conventionally 
assessed by measuring vital signs, urine output, cardiac output, global oxygen delivery 
and chemical indicators of metabolic activity such as arterial pH or lactate concentration 
in the blood [51], [52]. However, optimizing parameters of global perfusion does not 
guarantee that the oxygen is actually delivered to any specific microvascular bed or the 
tissue that it serves, and studies have revealed the gut to be particularly sensitive to 
ischaemia [4], [52].  Gastrointestinal mucosal perfusion deficits have been associated 
with hypoxic injury and decrease in barrier function, ultimately leading to systemic 
inflammatory response and multiple organ failure [53]. Techniques such as angiography, 
either visceral or CT (computed tomography) or MR (magnetic resonance) based 
reconstruction methods, provide only anatomical vessel information and possibly 
assessment of blood flow in major veins [6]. Even though these may allow identification 
of splanchnic stenosis, which causes vasoconstriction and occlusive ischaemia, 
information on actual ischaemia is imperative. 
In current practice, it is the subjective visual analysis and judgement of colour by 
the surgeon that is considered the gold standard to determine splanchnic 
microcirculation viability [54]. There is a need for a reliable, quantitative method for 
assessing splanchnic perfusion to identify patients at highest risk of ischaemic organ 
failure and death and/or guide therapeutical interventions and resuscitation. 
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The gastrointestinal tract is readily accessible and may provide crucial 
information about perfusion of the rest of the gastro-splanchnic bed. This chapter 
provides an outline of the techniques that have been evaluated for intraluminal 
monitoring of perfusion of this region and their limitations, focusing on studies within 
the stomach and duodenum. 
 
4.1 Polarographic sensors 
The polarographic PO2 electrode has been considered the gold standard for 
measuring tissue partial oxygen tension (PtO2) [55]. The electrode can be inserted into 
the submucosa layer with a needle or catheter electrode or placed on the surface of 
tissue with an array of electrodes [56]. It gives a direct quantitative measurement of the 
average PO2 of tissue cells, capillaries and larger blood vessels in the vicinity of the 
electrode, providing an assessment of tissue perfusion and oxygen consumption [56], 
[57]. The literature provides PO2 values for normoxia and hypoxia for different organs, 
and these are used to evaluate the metabolic state of the organ. However, the 
functionality and the dynamic blood flow distribution for the different organs must be 
taken into account for correct interpretation of tissue oxygenation data [55]. 
 
Figure 4.1: A Clark electrode, temperature sensor included for temperature correction of 
measurements (in: http://www.laserfocusworld.com/articles/2008/03/bioprocess-monitoring-
photonics-takes-a-new-look-at-bioprocesses.html) 
 Davies and Brink were the first to apply O2 polarography to animal tissue [58]. 
Clark and colleagues have greatly improved the technology and the Clark electrode has 
become mainstream. The Clark electrode is based on the reduction of oxygen to 
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hydroxyl ions (OH-) when exposed to a polarizing voltage of 0.7 V [21]. It consists of a 
platinum cathode and a silver anode immersed in a potassium chloride solution and 
covered by a polypropylene oxygen-permeable and electrically insulating membrane. A 
schematic of a Clark cell can be seen in Figure 4.1. Oxygen diffuses through this 
membrane at a rate proportional to its partial pressure and undergoes reduction at the 
cathode. The current generated between the two electrodes will also be proportional to 
the oxygen tension in the sample. To aid O2 migration to the skin surface, the sensor is 
heated to 42-45°C, dilating capillaries, decreasing O2 solubility and shifting the 
oxyhaemoglobin curve to the right [58]. Miniature Clark-type electrodes were used by 
Kram and colleagues to measure oxygen tension in the surface of brain, liver, 
gallbladder, stomach, jejunum, ileum, colon and kidney of 10 patients during invasive 
surgery [59]. They have found it to be a repeatable and practical method to assess local 
oxygen delivery. Values were dependant on both arterial oxygen partial pressure and 
local blood flow, providing a good assessment of tissue perfusion. A precision thermistor 
corrected the Clark electrode temperature dependant variations. 
After oesophagectomy, there is a significant risk of development of anastomotic 
leakage due to ischemia. Cooper and colleagues have measured changes in tissue 
oxygen tension in the gastric fundus adjacent to the site of anastomose, in eight patients 
undergoing the procedure [60]. It was noted that PtO2 was halved after mobilization of 
the stomach while there was no significant change in arterial oxygen concentration, 
mean arterial pressure or oxygen delivery. Devascularisation was found to be the most 
important surgical determinant of gastric tissue oxygen tension. Also focusing on the 
influence of tissue oxygenation on anastomotic healing, Jacobi and colleagues used a 
Clark-type oxygen electrode for submucosal measurements in 33 patients undergoing 
oesophagogastrostomy [61]. To avoid dislocation for 84h after the operation, the 
electrode was fixed to the skin by a single microclip. There was no significant decrease 
of PtO2 during the operation, besides after mobilization, akin to the results from the 
study by Cooper and colleagues. Postoperatively, patients with anastomotic leakage 
showed a significant increase in PtO2 levels, suggesting a disorder in O2 consumption. It 
was noted that, due to individual differences, it would be more accurate to assess the 
adequacy of tissue perfusion by analysing PtO2:PaO2 ratio instead. 
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 The main drawback of these oxygen electrodes is their limited area of 
measurement, with penetration depths of about 15µm [56]. PO2 measurements must 
be made at multiple sites in order to detect hypoxic areas in tissue. The use of a needle 
electrode is invasive and may potentially lead to tissue damage or an infection. 
Calibration is another downfall of this method. It requires a sample being drawn from 
the tissue in observation and analysed in vitro in a blood gas analyser [21]. Technical 
developments have helped in this area, but the sensor used by Kram and colleagues 
needed a 20 minute procedure for preparation and a 2 point calibration using a sterile 
solution and room air [59]. A temperature sensor is usually included in the electrode to 
correct for temperature variations [60]. 
 Although the polypropylene sheath helps to some extent, the tip of the electrode 
needs to be kept clean [21] as coagulating blood on the surface of the electrode will 
interfere with the results. Acquisition time is prolonged to ensure stabilization of the 
electrode and the assessment can take up to 45 minutes [58]. The other downfall is that 
with this method oxygen is consumed in the process of measurement. 
 
4.2 Gastric tonometry 
Gastric tonometry has been developed as a minimally invasive method of 
monitoring the adequacy of perfusion of the gastrointestinal tract using measurements 
of local mucosal carbon dioxide tension (PCO2). Tonometry is based on the physiological 
principle that during ischemia, anaerobic cellular metabolism will lead to increased 
carbon dioxide tension in the tissue. When the level of oxygen delivered is inadequate, 
the rate of synthesis of the energy carrying molecule ATP fails to meet the demands of 
tissue [62]. By-products of ATP hydrolysis, that would be consumed during synthesis 
from oxidative phosphorilation, start accumulating including ADP, inorganic phosphate 
and hydrogen ions [63]. Acidity in the cell is locally buffered by bicarbonate ions resulting 
in an increase of CO2 levels [6], [64]. An alternative or additional explanation for this 
increase is that there may be an inadequate washout of CO2 due to low blood flow [64]. 
By the diffusion theory, the PCO2 of the lumen of hollow visceral organs is assumed to 
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be in equilibrium with the PCO2 of the surrounding tissue, and an increased intraluminal 
PCO2 may therefore indicate impaired perfusion of the mucosa. 
The gastric tonometer consists of a catheter with a gas permeable silicon balloon 
located at its tip. It can be inserted nasogastrically or rectally into the gut lumen. Figure 
4.2 shows the tonometer catheter in place. Traditionally, the balloon is filled with saline 
solution. CO2 diffuses from the intraluminal space and equilibrates through the semi 
permeable membrane of the balloon. After an equilibration period, this fluid is 
withdrawn and tested using a blood gas analyser. This procedure is both personnel 
intensive and time consuming, with an equilibration period of 30 to 90 minutes [65], 
[66] making this method less responsive to rapid changes in splanchnic perfusion. 
Normal saline has no buffering ability and CO2 is easily lost if not dealt with 
anaerobically. Furthermore, due to instability of carbon dioxide in saline solution, 
certain blood gas analysers will consistently underestimate the PCO2 by as much as 60% 
[67]. Air has since replaced saline solution as the tonometric medium; it is pumped 
through the balloon and through an external closed circuit where the PCO2 is 
determined by an infrared detector on a semi-continuous base [52]. With an 
equilibration period within 20 to 30 minutes [64], [68] this may still not be an adequate 
response time. 
 
Figure 4.2: Gastric tonometer in place; note the inflated balloon (in: 
http://www.clinicalwindow.liitin.net/cw_issue_02_article5.htm) 
From the measurement of PCO2 with the tonometer it is possible to derive an 
index of gastric mucosal pH (pHi) using the modified Henderson-Hasselback equation: 
Tonometer 
balloon 
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 ݌ܪ� = ͸.ͳ + ݈݋݃ଵ଴ [ ܪܥܱଷ−ܲܥܱଶ ሺ௦௧௘௔ௗ௬−௦௧௔௧௘ሻ × Ͳ.Ͳ͵] Equation 4.1 
  
, where 6.1 is the pK (logarithm of dissociation constant) for the HCO3-/CO2 system in 
plasma at 37°C, and 0.03 is the solubility of CO2 in plasma at that temperature [63]. The 
measurement of arterial bicarbonate is obtained from an arterial blood gas sample. 
However, there are concerns over the validity of the calculated value for pHi and 
discrepancies have been found under some physiological conditions [63]. The 
Henderson-Hasselback equation assumes the value of PCO2 in the intraluminal space to 
be in equilibrium with the mucosal PCO2 and that arterial bicarbonate level equals that 
of the gastrointestinal mucosa, which is valid for stable physiological conditions but may 
be affected in situations of low flow or no flow [62]. Assessment of the gradient between 
gastric PCO2 and arterial PCO2 or end tidal PCO2 has been proposed as a more reliable 
index of gastric perfusion [64], [67]. Known as the PCO2 gap, it accounts for the 
influences of respiratory dysfunction and metabolic abnormalities [63], correcting the 
effect of systemic PCO2 and pH on gut PCO2 [67]. 
Gastric tonometry has demonstrated a good accuracy in estimating perfusion of 
tissue when compared to other extensively used parameters such as cardiac index [65], 
mean arterial blood pressure, base excess or arterial pH [69]. It has been shown to be a 
useful prognostic tool [52], [65], [70], providing clinicians with an opportunity to limit 
the degree and duration of cell hypoxia [62]. However, enteral feeding and gastric 
secretion may cause an increase in CO2 production by titration of acid with bicarbonate, 
thereby introducing additional errors to the assessment of gastric PCO2 [52], [71]. Many 
clinicians administer drugs to suppress gastric acid secretion and prevent back diffusion 
of CO2 but in the process risking a possible increase in bacterial overgrowth and 
increased risk of infection [63]. In order to avoid this problem, some researchers have 
suggested using other monitoring sites, in particular the oesophagus [72]. 
Gastric tonometry is the only practical technique for assessing gastrointestinal 
perfusion that is approved for clinical use [64]. As PCO2 is directly linked to blood flow, 
tonometry is a useful prognostic tool to detect hypovolaemia, but may not be valid in 
states of shock, when blood flow is normal or elevated [52], [73]. 
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There seems to be no published articles on tonometry on the duodenum but it is 
iŵpoƌtaŶt to Ŷote WalleǇ͛s work on small bowel tonometry [74]. Walley and colleagues 
have studied 10 pigs subjected to progressive haemorrhage plus 5 control pigs at 30 
minute intervals where gastric tonometry, small bowel tonometry and other 
heamodynamics parameters were evaluated. In most of the animals, it was found that 
gut anaerobic metabolism occurred before whole body anaerobic metabolism, with 
small bowel tonometer PCO2 increasing prior to the onset of anaerobic metabolism. It 
was also found to be closely related with superior mesenteric vein PCO2. Gastric PCO2 
results, on the other hand, were less reliable, with the critical PCO2 gap (difference 
between tonometric reading and arterial PCO2) to be greater and have more inter-
animal variability, making it an inferior method for detecting gut hypoperfusion. 
 
4.3 Laser Doppler flowmetry 
Laser Doppler flowmetry (LDF) has emerged as a valuable tool for perfusion 
monitoring because of its non-invasive nature and the ability to yield continuous and 
real time measurements of microvascular blood flow. Microcirculation is composed of 
the capillaries that deliver oxygen and nutrients to cells and the other vessels – 
arterioles, venules and arteriovenous anastomoses – that feed and drain the capillary 
network and play an important role in regulation of temperature. LDF is very versatile 
and has been used to evaluate capillary blood flow in the gastrointestinal tract, kidney, 
myocardium, skeletal muscle, bone, teeth, retina, skin and brain in experimental and 
clinical situations [75]. 
LDF relies on the Doppler Effect. When coherent light is directed towards a tissue 
and encounters a moving object, such as a red blood cell, the reflected photons undergo 
a change in frequency, called a Doppler shift. The velocity at which blood cells are 
moving is in the order of millimetres per second in the microcirculation. This gives rise 
to a minute Doppler Shift of about 10-11 times smaller than the frequency of incident 
light [76]. Laser light makes the ideal light source for this application as it is highly 
monochromatic. 
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The laser Doppler flowmetry probe uses an emitting optic fibre bundle which 
applies laser light to the tissue and a receiving optic fibre bundle returns the reflected 
light for analysis. The distance between transmitting and receiving fibres (usually 0.25 
mm), the wavelength of the laser light and the characteristics of tissue determine the 
penetration depth: for human skin it is of 1 to 2 mm, but in the GI tract may be up to 6 
mm [76]–[78]. 
The optical mixing of frequency shifted light and non-frequency shifted light give 
rise to a photocurrent. The magnitude and frequency distribution of this photocurrent 
carries information on speed and concentration of the moving blood cells traversing the 
scattering volume [79]. Rather than overall tissue blood flow, it determines the flux of 
red blood cells, measured in arbitrary perfusion units. The signal may exhibit vasomotion 
oscillations with a rate of 10 to 25 oscillations per minute [80] due to microvascular 
processes such as myogenic or neurogenic related metabolic activities [76]. 
Prior to clinical use, the system can be calibrated by immersing the distal tip of 
the probe in a reference solution to read 0 and 250 perfusion units [77]. As this can be 
a cumbersome procedure, flux is sometimes expressed as a relative change from 
baseline [81]. 
LDF has been used as a quantitative, reproducible method for assessment of 
blood flow and perfusion to determine organ viability. Studies in animals have shown an 
almost linear correlation between the laser Doppler signal and the blood perfusion of 
feline small intestine segments [82] and of the stomach of dogs with gastric dilatation-
volvulus [75]. Sigurdsson and colleagues monitored the blood flow in the kidney, liver, 
pancreas and gastric, jejunal and colonic mucosa in anaesthetized pigs during surgery 
and haemorrhagic shock [80]. It was found that the oscillations, characteristic of the 
laser Doppler flowmetry signal, were unrelated to central haemodynamic parameters, 
respiratory movements or level of anaesthesia and that they disappeared during severe 
blood loss and during administration of cathecolamines. This suggests that these 
oscillations are indeed locally mediated and that these auto regulatory mechanisms are 
disrupted by states of shock. 
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Leung and colleagues have monitored laser Doppler flowmetry on the 
duodenum of 27 rats [83]. The group showed it correlated with hydrogen gas clearance, 
another method of assessing blood flow. The animals were subjected to reduced 
perfusion due to haemorrhagic hypotension, or hyperaemia due to perfusion with 
hydrochloric acid. They also found the values of laser Doppler flowmetry varied in 
relation to the dose of acid used, but not in the long term (30 minutes), suggesting a 
transient rather than permanent acid effect on the mucosa of the duodenum of the rats. 
In humans, LDF has shown 100% sensitivity and 92.9% specificity in determining 
viability of intestine [75]. Kvernebo and colleagues have examined blood circulation in 
six areas of the stomach, in the distal oesophagus and the duodenum in 34 healthy 
patients [82]. The regional differences in the microcirculation network and blood flow 
can be observed in Figure 4.3. 
 
 
Figure 4.3: Regional circulatory difference in the stomach and lower oesophagus. The mean 
value is shown with 95% confidence interval [82] 
The group described not only vasomotion oscillations in their signals but also 
fluctuations synchronous with the heart rate, respiration and peristalsis. 
 Limitations of LDF include the small sampling area and the necessity of contact 
between the probe and the tissue being sampled, which may influence local perfusion. 
Whilst heavy pressure may cause reduction in the flux value, no contact resulted in noisy 
recordings from movements of the gastric wall, respiration or motion artefact [82]. The 
angle of the probe to the tissue is usually kept between 0 to 60° from the perpendicular 
axis [82]. The sampling volume of the laser Doppler probe is dependent upon its 
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geometry, but is usually 1mm3 [76]. Single measurements may not be representative of 
overall perfusion. 
Scanning Laser Doppler Flowmetry (SLDF) appears to address these limitations 
of single-point measurement. A collimated laser beam scans the tissue area and the 
reflected Doppler shifted beam is received by a series of mirrors [70]. Thousands of 
individual measurements of tissue perfusion are made and converted into a colour 
coded image (colour perfusion image map). 
Boyle and colleagues have studied the stomach of 16 patients undergoing 
oesophagectomy. Recorded scanning laser Doppler images show large falls in perfusion 
iŶ all paƌts of the stoŵaĐh folloǁiŶg ŵoďilizatioŶ, Ŷot ŶotiĐeaďle to the suƌgeoŶ͛s eǇe 
(Figure 4.4) [70].  No significant differences in pulse rate, mean arterial pressure or 
central venous pressure were detected. Acquisition time is approximately 4 minutes per 
scan which may be too long to obtain information on certain dynamic processes. Also, 
the probability of movement artefacts increases with acquisition time. 
a)  b)  
 
Figure 4.4: Colour perfusion image map using SLDF of the stomach before mobilization (a) and 
after mobilization (b). Before mobilization, the recorded levels of perfusion were uniform in 
the three regions of interest defined in the images. Following mobilization, there were large 
falls in the recorded perfusion detected in all parts of the stomach.[70] 
 
4.4 Pulse oximetry 
Pulse oximetry provides non-invasive continuous monitoring of arterial blood 
oxygen saturation (SpO2), using a combination of spectrophotometry and 
photoplethysmography (PPG). Its efficiency and affordability has made it a standard of 
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care present in most operating theatres, intensive care units and during transport of 
critically ill patients [8]. 
 
Figure 4.5: Handheld commercial pulse oximeter (in: http://ari-cn.com/pulse-oximeter-c-
29.html) 
Like other oximetry spectrophotometric techniques, pulse oximetry operates on 
the principle that the absorption spectra for oxygenated haemoglobin and 
deoxygenated haemoglobin are different [84]. Based on Beer-Laŵďeƌt͛s laǁ, it is 
possible to determine the concentration of these absorbers by shining light of two 
specific wavelengths through a vascular tissue bed. The light emerging from the skin is 
detected by a photodetector mounted either opposite or side by side to the light 
sources. It is assumed that the pulsatile photoplethysmographic (PPG) signals 
synchronous with the cardiac cycle are attributable only to the arterial blood component 
[9], [85]. 
 Currently available pulse oximeters use 660 nm in the red region of the spectrum 
and 880 nm in the infrared region to estimate the percentage of oxygen bound to 
haemoglobin from the ratio of absorption of light at these two wavelengths. Known as 
the ratio of ratios, it divides the pulsatile (AC) component for the PPG by the 
corresponding non pulsatile (DC) component [84]: 
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 ܴ = �ோ�ூோ = ቀ�ܥܦܥቁோቀ�ܥܦܥቁூோ 
Equation 4.2 
  
 
Calibration of pulse oximeters is done by experimentally derived calibration 
curves relating the functional haemoglobin saturation to the ratio of ratios. 
Pulse oximetry has demonstrated good accuracy in measuring arterial oxygen 
saturation in the stomach and other splanchnic organs. Garcia-Granero and colleagues 
have used in situ photoplethysmography to assess the perfusion of the stomach, 
duodenum, jejunum and colon of 22 mongrel dogs during midline laparotomy [86]. With 
progressive external compression being applied to the organ surface, it was found that 
perfusion values decreased progressively and were linearly correlated to arterial 
pressure, at a higher index for the stomach and duodenum than for the more distal parts 
of the gastrointestinal tract. Since the compression periods were short in this study, 
there was no time for the autoregulatory response to ischemia to be triggered. 
Servais and colleagues set out to develop a wireless pulse oximetry probe to 
monitor intra-operatively tissue oxygenation [87]. Their device, WiPOX, was tested in 
the stomach, intestines and kidneys of anaesthetized rats and swine, with high accuracy 
compared to commercially available pulse oximeters, before being used in human trials. 
They found pulse oximetry to allow detection of early ischemia, despite tissue appearing 
normal to the surgeon, and that body fluids, such as blood, ascites or bile, didŶ͛t 
interfere with the oximeter accuracy. Hickey and colleagues have also obtained good 
quality PPG signals from the large bowel, small bowel, liver and stomach during open 
laparotomy [5]. Measurements were done using a handheld fibre optic pulse oximetry 
sensor in 17 human patients. 
These studies have shown pulse oximetry to be a useful tool for the intra-
operative assessment of splanchnic perfusion and ischemic tissue detection. However 
they rely on a highly invasive procedure – open laparotomy – for access to the target 
organ. A less invasive technique that allows not only intraoperative monitoring but also 
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pre-operative diagnostic and assessment, and prolonged postoperative monitoring 
would be invaluable. Intraluminally monitoring could provide a possible alternative. 
In July 2014, after the patient trials described later on in this thesis took place, 
Jacquet-Lagrèze and his team published an article describing a PPG sensor for evaluation 
of duodenum mucosal perfusion [88]. It was tested in 13 piglets, 7 of which received an 
iŶfusioŶ of ‘iŶgeƌ͛s laĐtate solutioŶ ǁith a suspension of live Pseudomonas aeruginosa, 
in order to induce septic shock. 
 
 
a) 
 
b) 
Figure 4.6: a) Tip of the monitoring device. 1 - enteral feeding tube, 2 – inflatable cuff, 3 - PPG 
sensor. b) Photograph of the monitoring device [88] 
The monitoring device was based on an enteral feeding tube with designated 
lumens for aspiration of gastric contents and delivery of nutrients and/or drugs (Figure 
4.6). The photoplethysmographic sensor was located in an inflatable balloon near the 
tip of the tube. The sensor consists of a 905 nm infrared emitter 12 mm apart from a 
photo detector. The monitoring device also included a pressure sensor allowing for safe 
inflation of the balloon. Even though the cuff allows for a good contact between the 
sensor and the mucosa, it was inflated for 5 minutes every 6 minutes which can 
introduce artefact at important time points. 
The PPG device was inserted in the duodenum of the piglets following a median 
laparotomy and gastrostomy. A laser Doppler probe was also positioned on the serosa 
of the intestinal wall a few centimetres distal to the inflatable balloon of the PPG device. 
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Parameters were recorded every 15 minutes for over 2 hours. It was found that during 
septic shock there was a significant decrease in AC and DC PPG amplitudes. The PPG 
parameters were correlated to the laser Doppler signal and to blood lactate levels, 
especially at 60 minutes after infusion. However, there was no correlation with global 
circulation parameters (heart rate, mean arterial pressure and cardiac index). Actually, 
it was shown that decreases in the AC and the DC PPG signals preceded the decrease in 
mean arterial pressure. 
Jacquet-Lagrèze and colleagues acknowledge the fact that they resorted to 
gastrostomy instead of taking advantage of the less invasive capabilities of their device. 
Even though their study required a laparotomy for use of the laser Doppler, the PPG 
monitoring device could have been inserted via the mouth of the piglet and threaded 
through the GI tract to its final position in the duodenum avoiding extra surgical 
procedures and the risks associated with them. Also, the sensor appears to have been 
developed as a possible alternative to laser Doppler, and the group points at the 
pulsatile PPG sigŶal͛s seŶsitivity to heamodynamic changes and the possibility for it to 
reflect microcirculation. There was no justification given to the absence of a second 
emitter wavelength and thus negating the possibility of further oximetric analysis. 
 More recently some groups have expanded the research of pulse oximetry into 
the application of different wavelengths. It has been shown that near infrared radiation 
penetrates deeper into biological tissue and that carboxyhaemoglobin has a small 
optical absorption in this range, which would result in minimal interference to pulse 
oximetry calculations [89]. López Silva and colleagues have developed a transmittance 
pulse oximetry system employing 750 and 850 nm to the mesentery root, mesocolon, 
gastric wall and aorta of one large white pig during laparotomy [90]. It was found that 
the signals from the aorta had the greatest amplitudes comparing to the other sites. 
There was a gradient in the amplitude of the pulsating component from the aorta to the 
gastric wall, mesocolon and mesentery root that can be attributed to a physiological 
decrease in pressure with distance to the heart or to differences in optical response of 
each tissue. Fast Fourier transform (FFT) analysis has shown a peak frequency around 
the heart rate in all cases, while respiratory frequency was seen only in the aorta. A 
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frequency peak, higher than the respiratory rate, seen in the gastric wall, was linked to 
peristaltic movements. 
 
4.5 Visible light spectroscopy 
Visible light spectroscopy (VLS) is a more recently introduced oximetry 
spectrosphotometric method for detection of hypoxaemia and ischemia. As the name 
suggests, employs only a visible portion of the spectrum to measure the concentration 
of each of the major forms of haemoglobin (oxyhaemoglobin, deoxyhaemoglobin and 
optionally methaemoglobin and carboxyhaemoglobin). 476 to 584 nm (blue to yellow 
light) penetrates the skin by approximately 1 mm within the capillary bed [54], [91]. This 
allows for a measured saturation more closely related to tissue oxygen saturation. VLS 
shares the pulse oximetry qualities of non-invasiveness, continuous measurements and 
affordability. 
Friedland and colleagues developed a fibreoptic catheter based VLS oximeter to 
be inserted in the accessory channel of an endoscope [92]. This device was used in 30 
healthy volunteers and in 3 patients diagnosed with chronic mesenteric ischemia 
treated by percutaneous stenting to evaluate GI mucosal perfusion. Measurements 
were made from the oesophagus, stomach, duodenum, jejunum and colon. It was found 
that normal mucosal saturation was 72% in the stomach and 66% in the duodenum. The 
measurements taken before stenting intervention were statistically different, as low as 
19% in the second part of the duodenum of the second patient; this value increase to 
51% post-stenting. The application of oximetry to confirm the success of endovascular 
treatment shows the versatility and importance of these techniques to monitor 
perfusion of the GI tract. However, Friedland and colleagues decided for taking 
measurements at a specific times (namely pre and post-stent) and did not demonstrate 
the possibilities of continuous monitoring. 
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4.6 Conclusion 
There is a trend towards less invasive techniques, to provide safer bedside 
monitoring and allow a more precise earlier detection of organ dysfunction [56]. The GI 
tract is readily accessible and already a fundamental monitoring site in current daily 
practice. It is no wonder different intraluminal techniques have been developed to 
assess the perfusion of the splanchnic region. Not only do they have an advantage over 
the very invasive laparotomy based procedures, all have been reported to produce 
accurate results. However, they inherently have limitations when it comes to the 
technique used for measurement or calibration procedure needed. Both polarographic 
sensors and gastric tonometry require an extended period of time for equilibration of 
electrodes, during which valuable information about certain physiological processes 
could be lost. Calibration for the polarographic sensors involves drawing blood and a 
temperature sensor needs to be included for temperature variation corrections. 
Technology advances have greatly improved the gastric tonometry technique allowing 
for measurements to be made semi-continuously, after equilibration, and it has become 
the only technique available for clinical use. However it measures tissue pH, which may 
be influenced by disparate mechanisms unrelated to perfusion [87]. Laser Doppler 
flowmetry has shown good promise but it is an indicative of blood flow and not 
oxygenation of the tissues. It is also limited by arteriovenous shunting, which causes 
non-nutrient flow [87]. 
Pulse oximetry has become a widely accepted method for estimation of oxygen 
for its simplicity, for being inexpensive and not requiring calibration. It has proven to be 
reliable in measurements within the gastrointestinal tract and for that reason it is the 
chosen technology for evaluation of the perfusion of the duodenum in patients 
undergoing elective open laparotomy. 
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Chapteƌ 
5 
 
 
 
PULSE OXIMETRY 
The principle of pulse oximetry was conceived in 1972 by Japanese bioengineer 
Takuo Aoyagi. It relies on the difference in absorption spectra of oxygenated and 
reduced haemoglobin and on the pulsatile nature of arterial blood to selectively 
measure the arterial blood oxygen saturation of living tissue [21], [93]. 
Before that, World War II had seen the biggest advances in the measurement of 
blood oxygenation brought on by the needs of military pilots. In 1940 J.R. Squire 
developed an oximeter for use on the web of the hand. It addressed the problem of 
differentiating arterial blood by mechanical compression of tissue to squeeze out the 
blood for initial zero setting [94]. This method was later adopted by Wood in 1942 in his 
ear piece oximeter. E.A.G. Goldie and Glenn Milikan also developed their oximeters in 
that year [94]. In the 1960s, Shaw developed an eight wavelength ear oximeter, later 
marketed by Hewlett-Packard, that achieved arterialisation by heating the ear [95]. It 
was large, heavy and needed frequent calibration. 
By the 1980s, Nellcor, Inc had produced a smaller, less expensive, accurate 
microprocessor-based pulse oximeter that needed no user calibration [21]. Pulse 
oximetry has since become a standard monitoring device in hospital critical care units 
and surgical theatres, even gaining the moniker of the 5th vital sign after heart rate, 
blood pressure, respiration rate and temperature [96]. 
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This chapter aims to give a description of the theoretical background of pulse 
oximetry and the techniques of photoplethysmography and spectrophotometry that 
form the basis of it. It will also describe the pulse oximeter probe and provide a brief 
overview on the recent advances in analysis of the pulse oximetry signals to monitor 
venous oxygen saturation. 
 
5.1 Photoplethysmography 
Photoplethysmography (PPG) is a non-invasive optical technique that can be 
used to detect blood volume changes in the vascular bed of tissue [97]. Light is 
transmitted to the skin where it undergoes reflection, absorption and multiple 
scattering by tissue and blood. The modulated light level which emerges is measured 
using a suitable photodetector. 
The pulsatile component of the PPG signal, with a typical bandwidth of 0.5 to 20 
Hz [21], is often called the AC component (Figure 5.1). It is found to be synchronous with 
the heart rate, and its trough of greater absorption is assumed to be related to the influx 
of arterialized blood into tissue during systole. 
 
Figure 5.1: The electrocardiogram (ECG) and corresponding AC PPG signal [97] 
By convention, the PPG signal is inverted so that the AC component correlates 
positively with this influx of blood and to the blood pressure waveform [98]. 
The shape or contour of the pulsatile component has two defined phases [97]: 
the rising edge of the pulse, usually known as anacrotic phase, is attributed to systole, 
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and the falling slope of the pulse, the catacrotic phase, attributed to the period of 
diastole. A distinguishable characteristic of the catacrotic phase is the dicrotic notch, 
seen between the systolic and diastolic peaks, in Figure 5.2. 
 
Figure 5.2: A typical PPG waveform [99] 
The AC component is superimposed on a slowly varying baseline, the DC 
component, representing absorption from non-pulsating components such as skin, 
bones and venous blood.  
5.1.1 Origin of the PPG waveform 
The amount of light that is received by the photodetector is known to be 
influenced by changes in haemodynamics during the cardiac cycle and by other 
physiological conditions [100], [101]. However there is no consensus on the exact 
mechanism that forms the optical pulsations. 
The woƌd photoplethǇsŵogƌaphǇ, fƌoŵ the gƌeek ͞plethǇsŵos͟, to iŶĐƌease, 
implies a change in volume in the field of view of the probe. As mentioned before, the 
AC component is normally assumed to be related to the rapid filing of the vascular bed 
of tissue by the stroke volume delivered during the cardiac cycle that is then drained 
into the venous system [102]. The extra volume of blood in the arteries causes an 
increase in transmural pressure and subsequently an increase in the diameter of the 
vessels. In terms of Beer-Laŵďeƌt͛s laǁ of speĐtƌophotoŵetƌǇ (see section 5.2.1), which 
relates the absorption of light to the properties of the compound in the solution through 
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which the light is travelling, this translates to an increase in optical density or increase 
in path length and could explain the increase in absorption of radiation.  
An alternative explanation is that the waveform could instead represent pulsatile 
venous flow, supplied by arterio-venous anastomoses [103]–[105]. 
Yet, in vitro studies have demonstrated a pulsatile waveform is obtained where 
volumetric changes should not be possible [106], [107]. This includes a recent study 
using haemolysed and whole blood flowing through a 2 mm diameter acrylic tube [108]. 
Human pulsatile blood pressure was simulated by a roller pump. It was found that with 
whole blood, the PPG AC signal varied with the pressure pulse. No pulsatile signals were 
recorded with haemolysed blood. 
D͛Agƌoso aŶd HeƌtzŵaŶ were the first to suggest the role of red blood cell 
orientation in the generation of the optical pulse. It is thought that the red blood cells 
align their major axis parallel to the direction of flow during diastole and perpendicularly 
during systole, not only increasing the light absorption path length through blood but 
also contributing to changes in reflectance [106]. This could be the result of changes in 
velocity of flow felt in the vessels throughout the cardiac cycle [106], [109]. It can be 
seen in Figure 5.3 [110], how analogous the measured mean velocity flow of blood in an 
in vitro experiment is to the PPG waveform. 
 
Figure 5.3: Change in mean velocity during pulsatile flow of a suspension of normal canine 
erythrocytes in plasma [110] 
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5.2 Blood oxygenation measurement using absorption 
spectrophotometry 
Oximetry is the optical measurement of oxygen saturation in blood and is based 
on the principles of spectrophotometry. 
In spectrophotometry, light of a ĐeƌtaiŶ ǁaǀeleŶgth, λ, is used to iƌƌadiate a 
sample of interest. This incident light will get absorbed when the energy of the photon 
corresponds to a potential energy transition associated with the electrons of the particle 
it interacts with. The definite value of this energy transition is related to the molecular 
composition and structure of the light absorbing substance, i.e. chromophore, present 
ǁithiŶ the saŵple. The light that isŶ͛t aďsoƌďed eŵeƌges at the otheƌ eŶd, aĐƌoss a 
known sample path length, where it is measured by a photodetector. 
The fraction of incident light that passes through the sample is called 
transmittance, T, and is defined by the following equation: 
 ܶ = ܫܫ଴ Equation 5.1   
, where I0 is the intensity of the incident light and I is the intensity of the 
transmitted light. Unscattered absorbance, A, also referred to as the optical density of 
the medium, is defined as the negative natural logarithm of the measured 
transmittance. 
5.2.1 Beer-Laŵbert’s law 
Beer-Laŵďeƌt͛s laǁ states that aďsoƌďaŶĐe is diƌeĐtlǇ pƌopoƌtioŶal to the 
concentration of the absorbing chromophore and to the optical path length of the light 
through the medium: 
 � = �ሺ�ሻܿ݀  Equation 5.2 
 
, where ε(λ) is the extinction coefficient or absorptivity of the chromophore at a 
specific wavelength λ, c is the concentration of the absorbing chromophore and d is the 
optical path length. Concentration of the chromophore is measured is mmol L-1 and the 
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extinction coefficient will then be expressed in L mmol-1 cm-1. It is also common to 
express concentration in mol L-1, which is called a molar, M. 
 If more than one absorber is present in the medium, the properties of Beer-
Laŵďeƌt͛s laǁ aƌe still ǀalid. EaĐh aďsoƌďeƌ ǁill ĐoŶtƌiďute its paƌt to the total 
absorbance, which will be a superposition of the individual absorbing processes. It is 
given by Equation 5.3 for a medium with n different absorbers. 
 �௧ = �ଵሺ�ሻܿଵ݀ + �ଶሺ�ሻܿଶ݀ + ⋯ + �௡ሺ�ሻܿ௡݀ = ݀ ∑ ��ሺ�ሻܿ�௡�=ଵ  Equation 5.3   
, where εi(λ) and ci refer to the extinction coefficient and concentration of each 
chromophore i iŶ the ŵediuŵ. It ĐaŶ ďe Ŷoted that ďǇ usiŶg ŵoŶoĐhƌoŵatiĐ light it isŶ͛t 
possible to differentiate between the individual contributions of each absorber in the 
medium. This problem can be solved by measuring At at different wavelengths, provided 
that the extinction coefficients for all absorbers are known. The absorbance needs to be 
measured for a number of wavelengths equal or greater than the number of absorbing 
chromophores. The individual concentration of each absorber is obtained by solving a 
set of simultaneous equations. When Beer-Lambert͛s laǁ is applied to oximetry, two 
wavelengths are used in order to study oxyhaemoglobin and deoxyhaemoglobin. 
Beer-Laŵďeƌt͛s laǁ is ďased on the assumption that the sum of transmitted and 
aďsoƌďed light eƋuals the iŶteŶsitǇ of iŶĐideŶt light. This doesŶ͛t take iŶto ĐoŶsideƌatioŶ 
other physical processes including reflection of the light at the surface of the medium or 
scattering of light in the medium. 
5.2.2 Optical properties of haemoglobin  
Oximetry by absorption spectrophotometry relies on the change of absorption 
of light with the percentage of oxygen bound to haemoglobin. As haemoglobin binds 
with oxygen, the shape of the quaternary structure of its molecule changes (as 
mentioned in chapter 2), which alters its absorption spectrum proportionately [95]. 
Figure 5.4 shows how the extinction coefficients of fully oxygenated (HbO2) and fully 
deoxygenated haemoglobin (Hb) vary in the wavelength range of 200 to 1100nm. Within 
the visible and near infrared spectrum of radiation, the main absorber in blood is 
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haemoglobin, whether oxygenated or deoxygenated. Outside this window of radiation, 
other constituents in blood play a major role in absorption. Water is a very strong 
absorber in the ultraviolet and far infrared spectrum and the pigment melanin in tissue 
will absorb at shorter wavelengths [97]. 
 
Figure 5.4: Absorption spectra of oxyhaemoglobin (HbO2) and deoxyhaemoglobin (Hb) showing 
the extinction coefficients from the ultraviolet to the near infrared ranges (in: 
http://www.medphys.ucl.ac.uk/research/borl/sheddinglight/background.htm) 
It can be clearly seen in Figure 5.4 that the absorbance of light in the red region 
of the spectrum, around 670nm, is much higher for deoxyhaemoglobin than for 
oxyhaemoglobin. In the region of 805 to 1000nm, representative of near infrared, is 
oxyhaemoglobin that becomes more absorptive. At 805nm the extinction coefficients of 
both species are equal. This is called an isosbestic wavelength. These differences in 
absorption spectra give blood its characteristic coloration: bright red when oxygenated 
and a darker colour when saturation is reduced, like in venous blood. 
Conventional pulse oximeters function by measuring absorption of blood at two 
different wavelengths, usually 660 and 880 to 940 nm [89], one at each side of the 
isosbestic wavelength. The choice of these wavelengths is based on two criteria. Firstly 
a large difference in extinction coefficient between the two species will result in 
detectable changes in absorption even with small changes in saturation. Another 
criterion is the relative flatness of the absorption spectra around the chosen 
wavelength. This avoids bias being introduced by shifts in peak wavelength of the 
emitters. Although the curves are not flat at around 660nm, they are considerably flatter 
than at shorter wavelengths. 
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5.2.3 Functional oxygen saturation 
The main purpose of haemoglobin is to bind with oxygen in the pulmonary 
capillaries and release it in the lower saturation environment of the systemic capillaries. 
Haemoglobin species that are able to bind reversibly with oxygen are called functional 
haemoglobins. Oxyhaemoglobin and deoxyhaemoglobin are known as functional 
haemoglobins. 
The functional haemoglobin saturation, also referred to as functional oxygen 
saturation (SaO2), is determined by the ratio of the amount of oxyhaemoglobin present 
to the total amount of the oxyhaemoglobin and deoxyhaemoglobin. Another way to 
define this ratio is to use the concentration values cHbO2 and cHb. Functional SO2 is 
expressed in percentage. 
 ܱܵܽଶ = ܪܾܱଶܪܾ + ܪܾܱଶ × ͳͲͲ% = ܿு௕�2ܿு௕ + ܿு௕�2 × ͳͲͲ% 
 Equation 5.4 
 
 
Under normal physiological conditions arterial blood is saturated at 95 to 99% 
and venous blood at 70 to 75% [111]. 
Beeƌ Laŵďeƌt͛s laǁ eƋuatioŶ foƌ ŵultiple aďsoƌďeƌs (Equation 5.3) can be applied 
assuming only these two species are present: 
 �ሺ�ሻ = �ு௕�2ሺ�ሻܿு௕�2݀ + �ு௕ሺ�ሻܿு௕݀ = [�ு௕�2ሺ�ሻܱܵଶ + �ு௕ሺ�ሻሺͳ − ܱܵଶሻ](ܿு௕�2 + ܿு௕)݀ 
 
Equation 5.5 
  
, where ܱܵଶ = ܿு௕�2 ሺܿு௕�2 + ܿு௕ሻ⁄  from Equation 5.4. 
Although most of the haemoglobin in a healthy individual is functional 
haemoglobin, they are not the only haemoglobin species present. So called 
dysfunctional haemoglobin species can also be found in blood in lower concentrations, 
such as carboxyhaemoglobin and methaemoglobin. Each of these forms of haemoglobin 
has its own extinction coefficient curve and thus additional wavelengths are needed to 
determine their concentration in a sample. ConǀeŶtioŶal pulse oǆiŵetƌǇ doesŶ͛t 
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account for dysfunctional haemoglobins, which can lead to errors (further information 
in section 5.5.2). 
 
5.3 Pulse oximetry 
Pulse oximetry takes advantage of the time dependant photoplethysmographic 
signal received at the photodetector to discriminate between arterial blood and other 
absorbers in tissue. Assumed to be caused exclusively by changes in the arterial blood 
volume associated with the cardiac cycle it allows pulse oximetry to utilize Beer 
Laŵďeƌt͛s laǁ to estimate arterial blood oxygen saturation in vivo without the need for 
additional zeroing procedures. 
5.3.1 MaŶipulatioŶ of the Beer Laŵbert’s law 
ApplǇiŶg Beeƌ Laŵďeƌt͛s laǁ to pulse oǆiŵetƌǇ is Ŷot ǁithout soŵe iŵpoƌtaŶt 
assuŵptioŶs aŶd siŵplifiĐatioŶs. FiƌstlǇ, Beeƌ Laŵďeƌt͛s laǁ is oŶlǇ ǀalid foƌ 
homogeneous and clear mediums with negligible scattering. However, visible and near 
infrared light are strongly scattered by human tissue [103], [112]. Also, there should be 
no reaction between the absorbent and its solvent and no possibility of a photochemical 
reaction either [95]. Neither blood nor the other absorbants present in living tissue meet 
these criteria [21], [84].  
With multiple scattering and absorption occurring in tissue, the actual path 
length of the detected light is instead of a well-defined constant, a mixture of the 
surviving independent photon paths [103]. The detected photons travelling longer 
distances provide more interaction with blood and allows for the light to bypass the 
bone [84] while the detected photons with shorter routes result in larger amplitudes of 
the PPG waveform. In order to account for the combining effects of scattering, the 
optical path length is replaced by an effective mean path length, dmax, assumed 
equivalent for both wavelengths throughout the cardiac cycle. 
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Figure 5.5: Absorbed and transmitted light in living tissue. Time t1 corresponds to diastole 
while t2 corresponds to systole (adapted from [21]) 
As mentioned before, pulse oximetry relies on the variation in intensity of 
transmitted light throughout the cardiac cycle to differentiate the absorption 
contribution of arterial blood. According to the photoplethysmographic method, during 
diastole (t1, shown in Figure 5.5), the attenuation of light observed is due to the DC 
components in the tissue under study (non-pulsating arterial blood, venous blood and 
other tissue). Beeƌ Laŵďeƌt͛s laǁ ŵaǇ ďe ǁƌitteŶ as a liŶeaƌ ĐoŵďiŶatioŶ of aďsoƌďaŶĐes 
of each component/contributor present: 
 �ሺݐଵሻ = �௦��௡ + Aୠ୭୬ୣ + A୴ୣ୬୭୳ୱୠl୭୭ୢ + ⋯ = �஽஼  Equation 5.6 
  
During systole (t2, shown in Figure 5.5) the influx of arterial blood results in an 
increase in the absorbance of both red and infrared light by haemoglobin, creating the 
pulsating AC component of the photoplethysmograph: 
 �ሺݐଶሻ = �௦��௡ + Aୠ୭୬ୣ + A୴ୣ୬୭୳ୱୠl୭୭ୢ + ⋯ + A୮୳lୱୟ୲i୬gୟ୰୲ୣ୰iୟl = �஽஼ + ��஼  
 
Equation 5.7 
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By analysing the absorbance for a certain wavelength at the time of diastole and 
again during systole and subtracting them we are left with only the change in 
absorbance due to the AC photoplethysmographic component, the pulsating arterial 
ďlood, siŶĐe the tissue͛s ĐoŶĐeŶtƌatioŶs of the otheƌ ĐoŶstitueŶts doŶ͛t ĐhaŶge oǀeƌ this 
time period. 
 �ሺݐଶሻ − �ሺݐଵሻ = ��ሺ�ሻ[ܿ�ሺݐଶሻ − ܿ�ሺݐଵሻ]݀௠௔௫ = ��ሺ�ሻ∆ሺܿ�ሻ݀௠௔௫ 
 
Equation 5.8 
  
, where εi(λ) and ci represent the extinction coefficient and concentration of the 
absorber i, in this case referring to pulsating arterial blood. 
The amplitude of the AC photoplethysmographic signal at red and infrared 
wavelengths is sensitive to changes in arterial oxygen saturation because of the 
differences in extinction coefficient of oxyhaemoglobin and deoxyhaemoglobin at these 
two wavelengths. Like in Equation 5.5 it is assumed that only these two haemoglobin 
species are present: 
 �ሺݐଵሻ − �ሺݐଶሻ = [�ு௕�2ሺ�ሻܱܵଶ+ �ு௕ሺ�ሻሺͳ − ܱܵଶሻ]∆ሺܿ�ሻ݀௠௔௫  Equation 5.9  
 
In terms of the transmitted light this can be written as: 
 �ሺݐଵሻ − �ሺݐଶሻ = −݈݊ (ܫ݋ݑݐሺݐଵሻܫ�݊ ) + ݈݊ (ܫ݋ݑݐሺݐଶሻܫ�݊ ) = ݈݊ ቌܫ݋ݑݐሺݐଶሻܫ�݊ܫ݋ݑݐሺݐଵሻܫ�݊ ቍ = ݈݊ (ܦܥ + �ܥܦܥ ) = ݈݊ (ͳ + �ܥܦܥ) ≈ �ܥܦܥ 
 Equation 5.10 
 
 
, where DC represents the unchanging intensity offset received by the photodetector 
and AC the varying transmitted intensity due to the pulsatile arterial blood. The 
unknown input intensity Iin cancels since it is assumed to be constant. 
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In pulse oximetry, the arterial oxygen saturation is determined from the ratio, R, 
of the absorption at red (R) and infrared (IR) wavelengths. Applying Equation 5.9, this 
ratio can be expressed as: 
 �ሺ�ோሻ�ሺ�ூோሻ = ܴ= [�ு௕�2ሺ�ோሻܱܵଶ + �ு௕ሺ�ோሻሺͳ − ܱܵଶሻ]∆ሺܿ�ሻ��݀௠௔௫[�ு௕�2ሺ�ூோሻܱܵଶ + �ு௕ሺ�ூோሻሺͳ − ܱܵଶሻ]∆ሺܿ�ሻ���݀௠௔௫ 
 
 Equation 5.11 
 
A fuƌtheƌ assuŵptioŶ ŵade is to ĐoŶsideƌ eƋual the ΔĐi terms, which refer to the 
pulsatile ĐhaŶges iŶ tissue͛s ďlood ĐoŶĐeŶtƌatioŶ that Đauses the deteĐted light leǀels to 
modulate. Equation 5.11 can be written as: 
 �ሺ�ோሻ�ሺ�ூோሻ = ܴ = �ு௕�2ሺ�ோሻܱܵଶ + �ு௕ሺ�ோሻሺͳ − ܱܵଶሻ�ு௕�2ሺ�ூோሻܱܵଶ + �ு௕ሺ�ூோሻሺͳ − ܱܵଶሻ  Equation 5.12  
 
Solving Equation 5.12 for SO2 we get Equation 5.13. Now SO2 is referred to as 
SpO2: SO2 measured by pulse oximetry. 
 ܵ݌ܱଶ = �ு௕ሺ�ோሻ − ܴ�ு௕�2ሺ�ூோሻܴ[�ு௕�2ሺ�ூோሻ − �ு௕ሺ�ூோሻ] + �ு௕ሺ�ோሻ − �ு௕�2ሺ�ோሻ  Equation 5.13  
5.3.2 Calibration 
EaƌlǇ pulse oǆiŵeteƌs used the Beeƌ Laŵďeƌt͛s laǁ ŵodel to Đoŵpute the ǀalues 
of blood oxygenation [84]. However instruments based on this simplistic theoretical 
ŵodel teŶd to giǀe eƌƌoŶeous estiŵates as Ŷot oŶlǇ aƌe the Beeƌ Laŵďeƌt͛s laǁ͛s 
conditions not strictly met but also the wavelength of the light sources utilized in pulse 
oximetry can vary up to 15 nm [21] within a batch, and the assumed set of extinction 
coefficients used is no longer correct. 
Calibration of modern pulse oximeters is done by empirical methods instead. 
Healthy volunteers that range in age, gender and skin colour are asked to breathe in gas 
mixtures progressively with less oxygen and more nitrogen making them progressively 
hypoxic. The measured ratio of AC/DC signals from the red and infrared 
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photoplethysmographs, known as ratio of ratios (Equation 5.14), is then correlated to 
discrete samples of arterial blood analysed with a Co-oximeter [95]. 
 ܴ = �ோ�ூோ = ቀ�ܥܦܥቁோቀ�ܥܦܥቁூோ Equation 5.14  
 
The US Food and Drug administration (FDA) recommends 15% of the volunteers 
to be darkly pigmented [113]. Prescreening blood tests are done to ensure the levels of 
dyshaemoglobins are within normal ranges. 
An empirical calibration curve relating the functional haemoglobin saturation to 
the ratio of ratios is obtained from the collected data. Each manufacturer uses a unique 
calibration curve, not necessarily but normally in the form of a linear equation expressed 
as: 
 ܵ௣ܱଶ = ܽ − ܾܴ Equation 5.15 
, where a=110 and b=25 or a=118.8 and b=25.6 [114]. 
The biggest problem associated with this procedure is the ethics of deliberately 
desaturating healthy subjects below a certain point due to the risk of hypoxic brain 
damage. For this reason, it is then necessary to extrapolate the calibration curve for 
values of SpO2 below 80% [95]. Research is being done to evaluate the possibility of in-
vitro calibration with human blood in an artificial circulation, or checking calibration of 
pulse oximeters with non-blood samples [95]. 
 
5.4 Pulse oximeter probes 
A conventional pulse oximeter probe consists of two small emitters of the 
selected wavelengths and a photodetector highly sensitive to these wavelengths. These 
components are assembled inside a reusable spring-loaded clip, a flexible probe or a 
disposable adhesive wrap [9], designed to protect the photodetector from ambient light 
76 
interference. A flexible cable connects the probe to the pulse oximetry unit. It supplies 
the probe with electric power and carries the signal from the photodetector. 
 There are two main operational configurations used in pulse oximeter probe 
design: transmission and reflection. These are discussed below along with an overview 
on the semiconductor components of the PPG probe. 
5.4.1 Transmission pulse oximeter probe  
Transmission mode is the most commonly applied in commercially available 
pulse oximeters. In this mode, the emitters are mounted opposite the photodetector, 
which detects the amount of light transmitted through the pulsating arterial bed. Figure 
5.6 illustrates the relative positions of the optical components. 
 
Figure 5.6: A photoplethysmographic probe used in transmission mode [115] 
To be effective, the sensor must be placed somewhere in the body where 
transmitted light can be readily detected [116]. This criterion restricts the locations in 
the body where transmission mode can be used to peripheral sites such as the fingers, 
toes, eaƌ loďes, Ŷasal septuŵ aŶd iŶ iŶfaŶts͛ feet aŶd palŵs. 
The photodetector should be placed as close to the skin in a snug fit, with a 
constant but light pressure on the tissue so that the light ĐaŶ͛t ďǇpass the tissue [84]. 
However, an increase in the pressure the pulse oximeter sensor exerts on the skin will 
result in vasoconstriction of the vessel leading to a decrease in AC signal amplitude and 
thus a decrease in the AC/DC ratio [117].  Excessive force could cause trauma to tissue 
[21]. 
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5.4.2 Reflectance pulse oximeter probe 
In the reflectance mode of operation the emitters and photodetector are 
mounted side by side facing the tissue. A general reflectance probe is shown on Figure 
5.7. 
 
Figure 5.7: A photoplethysmographic probe used in reflection mode [115] 
 The measurement of arterial blood oxygen saturation by reflectance pulse 
oximetry is based on the intensity of the light reflected back from tissue. As light from 
the emitters enters the tissue it is diffused in all directions. In order to detect the most 
of the backscattered radiation, the photodetector must be able to detect light from an 
area concentric with the emitters. 
The separation between the emitters and the photodetector has an effect on the 
quality of the photoplethysmographic signals received. The light intensity received at 
the photodetector decreases roughly exponentially as the separation between optical 
components increases [116]. On the other hand, if placed too closely, the photodetector 
will be saturated due to increased reflection from the blood free stratum corneum and 
epidermal layers in the skin [21]. A different technique used to enhance the quality of 
the photoplethysmographs is to use a large emitter driver current. Light intensity 
increases the effective penetration depth of the incident light and the area of pulsatile 
vascular bed illuminated. 
Despite the fact that in vitro experiments suggest that in reflectance mode an 
increase in blood volume increases the amount of light reflected back to the 
photodetector, in vivo the relationship is similar to the transmission mode. It is thought 
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that the light reflecting back from deeper structures will undergo further absorption by 
superficial blood vessels [98]. 
The ƌefleĐtaŶĐe ŵode doesŶ͛t suffeƌ the saŵe ƌestƌiĐtioŶs as the tƌaŶsŵissioŶ 
mode when it comes to sensor placement. Reflectance probes can be placed virtually 
on any part of the body where light reflection due to tissue can be expected, including 
in the intraluminal spaces of the human body. Also, because reflectance mode probes 
are usually adhered to the patient, they may not exert enough pressure to collapse the 
venous system, so venous oscillations can be more significant than in transmission mode 
[98]. 
5.4.3 Light emitting diodes 
The choice of a suitable emitter for pulse oximetry involves not only 
considerations of size and cost but also the requirement for a monochromatic light 
source for the spectrophotometric measurement of haemoglobin concentration [84]. 
Historically, the eight wavelength oximeter marketed by Hewlett-Packard made use of 
a tungsten-iodine lamp with a high output of light within the 650 to 1050 nm range [21] 
and the pulse oximeter described by Yoshida and colleagues employed a quartz halogen 
lamp [115]. Both devices had to be used in combination with light filters for wavelength 
selection and bulky fibre optics to transmit the light. The breakthrough for pulse 
oximetry came with the advent of light emitting diodes (LED) in the 1980s, which 
allowed for smaller, easier to use and cheaper devices [118]. 
LEDs are characterized by high light emitting efficiency over a narrow wavelength 
band, superior to other methods such as cathode, high-temperature and 
photoluminescence. In terms of monochromaticity, laser light would be an excellent 
choice but an expensive and fragile one due to the need for optical fibers to guide the 
light to the patient [84]. Although not strictly monochromatic, LEDs eliminate the need 
for optical fibres, and have become standard in pulse oximeters. 
1.1.1.1 Principle of operation 
An LED is an optoelectronic semiconductor diode that produces light by injection 
electroluminescence [119]. 
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Semiconducting material can be doped with impurities in order to change its 
ability to conduct electrical current, adding free electrons (n-type material) or creating 
holes where electrons can go (p-type material). In a diode, where n- and p-type of the 
same semiconductor material meet, equilibrium is reached between the free carriers 
and a region of free space is formed: the depletion region. The bulk of the 
semiconductor however remains unaffected and retains its original conductivity type 
[119]. 
When forward bias voltage is applied across the diode, the potential across the 
depletion region is lowered. Injected carriers from both sides are able to cross the p-n 
junction into the region of opposite polarity (Figure 5.8). As electrons recombine with 
holes, the energy associated with the recombination transition is released as photons 
according to the Equation 5.16 [119]: 
 ܧ݃ = ℎ �ܿ Equation 5.16 
  
 
The composition of the semiconductor influences the band gap energy (Eg) and 
diĐtates the ǁaǀeleŶgth ;λͿ of the eŵitted photoŶs [119].  
 
Figure 5.8: The p-n junction under forward bias showing injection electroluminescence. (in: 
http://en.wikipedia.org/wiki/Light-emitting_diode) 
 
80 
The current-voltage characteristics of an ideal diode are given by [120]: 
 � = �଴ [݁�݌ ( ݁��݇ܶ) − ͳ]  Equation 5.17 
 
,where β represents the ideality factor. In forward bias, the current will increase 
exponentially with voltage. If reverse bias is applied across the diode, when the p-type 
region is connected to the negative terminal and the n-type to the positive terminal of 
the voltage source, the internal potential barrier is increased and the current saturates 
at i0 (Equation 5.17). No carrier injection takes place and, consequently, no light is 
emitted. 
1.1.1.2 LEDs in pulse oximetry 
 LEDs are ideally suited for pulse oximetry as they have a high efficiency of 
emission over a narrow wavelength band. Due to the diode behaviour characteristics, 
specified by Equation 5.17, the LEDs are preferentially driven by a constant current 
source [119]. This allows for precise control of illumination intensity by linearly varying 
the supplied current, essential when differences in absorption of the red and infrared 
wavelengths and the variation in thickness and pigmentation of the area under study 
[115] could result in either saturation of the photodetector or, on the other hand, an 
insignificant portion of light being detected. 
Another important characteristic of LEDs for use in pulse oximetry is their fast 
response time to changes in the drive current. A switching speed of the order of 
microseconds allows for high frequency multiplexing of the LEDs, faster than the 
required for the arterial pulsatile waveform (≈1 s-1 = 1 Hz) [21]. An added advantage of 
pulsed operation is that small LEDs used in pulse oximetry are able to tolerate 
substantially higher current levels than if they were constantly on [21]. 
The common emitter wavelength of 660 nm for the red region and 880 nm or 
940 nm for the infrared region, are readily available in the market at a relatively low 
cost. The problem is that the exact peak wavelength of any single LED can vary by as 
much as 15 nm [21]. A shift in emitted wavelength leads to erroneous calculations of 
SpO2 as the pulse oximeter is working with a different set of extinction coefficients to 
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the one specified for the calibration curve. The error is more significant in the red region 
because of the steep slope of the absorption spectra of oxyhaemoglobin and 
deoxyhaemoglobin at these wavelengths. 
5.4.4 Photodetector 
Photodiodes are the detectors of choice as they have an output linear to the 
incident light intensity, are sensitive to the wavelengths used in pulse oximetry and have 
faster response times than other devices, such as the photocell [21]. 
5.4.4.1 Principle of operation 
The photodiode consists of a p-n junction which is operated in reverse bias. 
When a semiconductor diode is operated in reverse bias, the majority carriers are 
prevented to cross the p-n junction and the minimal current seen is result of electrons 
and holes being pulled away from depletion region [119]. If a photon strikes the 
depletion region, its energy is absorbed by the semiconductor to create an electron-hole 
pair. The internal electrical field across the junction will cause the electron and hole to 
separate, generating electric current [120]. 
The detection of charge separation of the electrons and holes can be done in two 
ways. The photovoltaic mode is when a light induced voltage can be measured between 
the p and n regions of an open-circuit photodiode. In pulse oximetry the 
photoconductive method is used. Operated under reversed bias, the external current 
flowing is directly proportional to the incident light. This also means faster response, 
better stability with temperature variations and greater dynamic range [120]. 
Like with LEDs, the wavelength of photon is dependent on the material used and 
the physical depth of the p-n junction: only photons possessing energy equal or higher 
than the band gap energy will be readily absorbed by the semiconductor [119]: 
 ℎ �ܿ = ܧ� Equation 5.18  
 
The range of spectral response can span up to seven decades, even though the 
sensitivity of the photodiode varies significantly, being higher for wavelengths closer to 
the bang gap energy [120]. The photodiode is unable to distinguish between the 
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different wavelengths used in pulse oximetry and for that reason the pulse oximetry 
processing system needs to include multiplexing. 
The main disadvantage of photodiodes is the presence of a reversed bias leakage 
current in even in dark conditions (absence of light), known as dark current. 
 In order to improve performance, an intrinsic region is incorporated in the 
structure of the photodiode. Placed between the n and p regions, this very lightly doped 
material will effectively widen the depletion region, maximising the absorption of 
photons [119]. The PIN diode has virtually eliminated the standard p-n junction 
configuration, including in pulse oximetry probes. 
 
5.5 Limitations of Pulse Oximetry 
5.5.1 Calibration assumption 
As described previously, the calibration for modern pulse oximeters is done by 
experimentally derived calibration curves. Several problems are associated with this 
method. Firstly, ethical considerations prevent deliberately desaturating a healthy 
subject due to the risk of inducing hypoxic brain injury [95]. It is then necessary to 
extrapolate the calibration curve values below 80%. This leads to inaccuracy and bias at 
these low levels. Also, the number and spacing of the calibration points affects the fitting 
of the calibration curve derived from them [95]. 
5.5.2 Dyshaemoglobins 
Pulse oximetry makes use of only two wavelengths of light to distinguish 
between oxyhaemoglobin and deoxyhaemoglobin. However other haemoglobin species 
can also be found in blood in lesser concentrations, most significantly 
carboxyhaemoglobin (COHb) and methaemoglobin (MetHb). These are called 
dyshaemoglobins as they are unable to bind to oxygen or interfere with the ability of 
the haemoglobin molecule to release oxygen to tissue. The presence of these species 
causes inaccuracy in pulse oximetry readings [3], [8]. 
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COHb is caused by the inhalation of carbon monoxide commonly from tobacco 
smoke and the internal combustion engine [95]. Its absorption at the red range is very 
high like oxyhaemoglobin, leading to overestimation of oxygen saturation to as much as 
1% for every 1% of COHb circulating [95]. Methaemoglobin, on the other hand, absorbs 
highly at both red and infrared wavelengths, driving the ratio R to unity with SpO2 
approaching 85% [21], [95]. MetHb can be induced by drugs, including anaesthetics, and 
it formed by oxidation of haemoglobin from the normal ferrous state (Fe2+) to the ferric 
state (Fe3+) [21].  
 When the presence of dyshaemoglobins is suspected, investigation should be 
supplemented with in-vitro blood gas analysis. 
5.5.3 Dyes and nail polish 
Intravenously administered dyes methylene blue, indigo carmine and 
indocyanine green all absorb strongly at 660 nm causing falsely low SpO2 readings [95], 
[122]. 
 In theory, skin pigmentation and other surface light absorbers, such as nail polish 
oƌ dƌied ďlood, shouldŶ͛t Đause iŶteƌfeƌeŶĐe iŶ ƌeadiŶgs as theǇ aƌe ĐaŶĐelled out iŶ 
calculations for their non-pulsatile nature. However it has been found that black, blue 
and green nail polishes can cause inaccurate SpO2 readings [21], [122]. The presence of 
onychomycosis, a fungal infection which causes the nails to discolour to a yellow or 
green colour, can also cause low SpO2 readings [123]. Solutions to these problems 
include placing the probe sideways on the finger or using nail polish remover.  
 
5.5.4 Optical interference 
Interference from ambient light, sources including sunlight and fluorescence 
surgical lights, affects all pulse oximeters [21]. In order to reduce this effect, probes are 
maŶufaĐtuƌed of a ďlaĐk opaƋue ŵateƌial that doesŶ͛t tƌaŶsŵit light oƌ aƌe eŶĐlosed iŶ 
an opaque plastic housing [21]. Another solution is to incorporate in the clock timing 
sequence a period where both light emitters are turned off and the photodetector 
receives only ambient light, the influence of which is subsequently eliminated. 
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Optical shunt is another type of optical interference. It occurs when light from 
the emitters reaches the photodetector without passing through a pulsatile arteriolar 
bed [21]. Correct probe positioning is crucial to avoid this problem. 
5.5.5 Motion artefact 
The AC component of the photoplethysmographic signal accounts for only 1 to 
2% of the total absorption [95] which renders the pulse oximeter very sensitive to 
vibrations and pressure. Motion artefact, such as shivering, seizure activity and exercise, 
results in false or erratic heart rate displays or distorted photoplethysmographic 
waveforms [21]. Transient interference can also occur with surgical diathermy [124] and 
evoked potential monitors and nerve stimulators placed on the same extremity [123]. 
A common method used to reduce the error due these artefacts is through 
averaging the saturation values over several seconds before they are displayed [21]. 
More recently, leading pulse oximetry manufacturers have introduced advanced digital 
signal processing algorithms with improved performance [9]. Another method 
employed is to synchronize the pulse oximetry measurements with the R wave of the 
patieŶt͛s eleĐtƌoĐaƌdiogƌaŵ [21].  
5.5.6 Inadequate pulsatile signals 
Pulse oximetry relies on the presence of adequate photoplethysmographic 
pulsations to calculate a value of SpO2 [21]. In states of hypovolaemia, hypothermia or 
vasoconstriction, conventional pulse oximetry sites, such as the finger, toe or ear lobe, 
can be compromised by poor peripheral perfusion leading to erroneous readings or 
complete failure [121]. 
Local vasodilating drugs or a warming blanket are used to increase local 
vascularisation and enhance the plethysmographic pulsations [21]. The forehead and 
nose have been investigated as alternative measuring sites for pulse oximetry with 
contradictory results: Rosenberg and colleagues report no improvement comparing to 
the finger probe [121] while Cheung and colleagues have found forehead probes to be 
stable at low saturations [21]. Kyriacou and colleagues have found an oesophageal 
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probe to be more reliable than a finger probe in cases of compromised peripheral 
perfusion, since central blood flow is preferentially preserved [125]. 
The use of the sphygmomanometer for measuring arterial blood pressure 
induces vasoconstriction, which renders the pulse oximeter unusable. It is then 
advisable to place the pulse oximeter probe on the opposite limb for the length of the 
measurement. 
 
5.6 Monitoring of venous oxygen saturation 
Recent advancements in computing technology and digital signal processing 
have enabled processing of the PPG waveform beyond the calculation of arterial blood 
oxygen saturation [105], [107]. 
The measurement of oxygen saturation in venous blood, SvO2, provides 
information on tissue oxygen consumption and blood flow. 
The pulse oximetry approach to measuring venous oxygen saturation requires a 
variation in volume in the venous compartment disparate to the arterial blood pulsation. 
One of the approaches used so far has been to apply a low pressure, at around 25mmHg, 
to the forearm. Light absorption is compared before and after venous occlusion [126]. 
However, this method does not allow for continuous measurement, as it relies on 
discrete interventions, and it may lead to potential complications such as venous stasis 
and thrombosis [11]. 
Another approach for generating an artificial venous pulse consists of inflating 
and deflating a small cuff tied to the base of the finger (Figure 5.9). The cuff is inflated 
at a frequency of 6.5 to 8 Hz to a pressure below 40 mmHg [127], which is greater than 
venous pressure to allow for venous pooling, but lower than diastolic pressure as so not 
to interfere with the perfusion of the finger. A conventional pulse oximeter probe is 
placed on the same finger. The 6.5 to 8 Hz frequency modulation of the venous blood 
volume is processed the same way the arterial pulsations are to obtain the AC and DC 
components of the ratio of ratios [127]. 
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Figure 5.9: Principle of operation of digital pressure cuff method of measuring venous blood 
oxygen saturation [127] 
It was noted previously that the PPG waveform is influenced by positive pressure 
ventilation and that this has an effect on the tissue blood volume. An algorithm, VenSat, 
was developed and assessed [11] to verify whether the respiratory modulation would  
enable the measurement of venous oxygenation from the PPG waveform. The pulse 
oximetry ratio of ratios is taken as the peak to trough amplitude of the DC waveform 
divided by the DC offset for both wavelengths [11]. 
 ܴ�௘௡ௌ௔௧ = (|ܦܥ|ܦܥ )ோ(|ܦܥ|ܦܥ )ூோ 
 Equation 5.19 
 
 
It was found that the VenSat algorithm yields lower saturation values than the 
SpO2 value. In data collected with an oesophageal PPG probe, the VenSat derived 
saturations were around 80%, which is within the physiological range of venous 
saturations [11]. 
Although it cannot replace the measurement of mixed venous oxygen saturation 
at the pulmonary artery, the non-invasive monitoring of peripheral venous oxygenation 
may serve as an early indicator of an imbalance in oxygen supply and demand in tissue 
and act as a warning sign of the early phases of shock [11], [127]. 
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Chapteƌ 
6 
 
 
 
DEVELOPMENT OF A TWO CHANNEL DUAL WAVELENGTH PPG 
PROCESSING SYSTEM 
A prototype dual wavelength PPG processing system has been designed as part 
of this thesis and developed to allow continuous and simultaneous monitoring of two 
PPG probes, one designed for intraluminal placement and the other one for placement 
in the finger. It drives the optical components of the PPG sensors as well as detecting 
and pre-processing the signals from the photodetector prior to digitisation. It also 
accommodates an ECG channel and an airway pressure channel to detect the patieŶt͛s 
ventilation flow. 
This chapter describes the different components of the PPG processing system, 
its construction and the performance evaluation tests conducted. A complete circuit 
schematic of the PPG processing system circuit is included in Appendix 1. The system 
was originally designed for a dual PPG probe and therefore includes extra circuitry not 
necessary with a single unit PPG probe. The extra circuitry will not be included in the 
description below. 
 
6.1 Instrumentation 
A block diagram representation of the system can be seen in Figure 6.1: 
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Figure 6.1: Block representation of the dual wavelength PPG acquisition system, including the 
ECG channel and the airway pressure channel 
The red and infrared LEDs are driven by a constant current source realised with 
a basic operational amplifier circuit connected to a transistor. The two LEDs are 
alternately illuminated using a four state clock, programmed into the multiplexer. 
The photodetector produces a current proportional to the light power 
backscattered from tissue. This current is fed into the PPG processing system to be 
converted into a voltage signal and amplified by the transimpedance amplifier. 
Representing light from both LEDs in sequence, the photodiode signal is then 
demultiplexed using sample and hold circuitry. This operation is synchronized to the 
switching of LEDs by the same clock inputs from the multiplexer. 
 
Intral minal     
and fin r       
PPG probes 
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The individual red and infrared signals from each of the two photodetectors are 
passed through filtering and amplification stages to separate AC and DC PPG 
components before digitisation. 
This system incorporates a 3 lead ECG channel, used as a timing reference for the 
intraluminal and finger probes. Signals originating from electrodes placed in the body 
are transferred to an instrumental amplifier before undergoing further filtering and 
amplification to be digitised along with the PPG signals. 
An airway pressure sensor is also included in the processing system to allow 
identification of the respiratory modulation in the PPG signals and enable computation 
of local venous blood saturation. 
For protection against electrical risk during clinical trials, the PPG processing 
system is powered by two lead acid batteries and cannot be powered by mains. 
6.1.1 Multiplexing 
A crucial element of the pulse oximeter system is the timing of the LEDs and 
synchronization with the detected light backscattered from tissue. As the photodiode is 
unable to distinguish between different wavelengths of light, the two LEDs (red and 
infrared wavelengths) are alternately switched on and off. Each LED is controlled by a 
different clock signal, and the timing sequence for this project was decided upon to 
include periods when both LEDs are off; this equates to each signal having a duty cycle 
of 25%. With a multiplexing frequency of 300 Hz, the pulse width of each individual clock 
signal has a value of 834 µs (the rise time of the LEDs is of 1.5 µs, which is within the 
pulse width of the clocks). A diagram depicting both timing clock signals can be seen on 
Figure 6.2:  
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Figure 6.2: Diagram of four-state timing clock signals. 
These timing signals are provided by a programmable 8 bit AVR microcontroller, 
which controls both the switching of the LEDs and the sample and hold circuit on the 
demultiplexing stage. The chip selected for this project was the Atmel ATtiny2313 
(Atmel Corporation, USA), ideal for its high performance with low power consumption 
and smaller package. It executes a C code compiled using AVR Studio 4 (Atmel 
Corporation, USA), a development environment that provides a project management 
tool, source file editor, simulator and programming interface for the AVR STK500 Flash 
Microcontroller Starter Kit (Atmel Corporation, USA). 
6.1.1.1 Source code 
The source code programmed into the microcontroller is as follows: 
1 #include <avr\io.h> 
2 #include <util\delay.h> 
3 
4 int main (void) 
5 { 
6 DDRB = 0x03; 
7 while (1)  
8 { 
9  PORTB = 0b00000001; 
10  _delay_us(834); 
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11  PORTB = 0b00000000; 
12  _delay_us(834); 
13  PORTB = 0b00000010; 
14  _delay_us(834); 
15  PORTB = 0b00000000; 
16  _delay_us(834); 
17 } 
18 } 
 
The header files lines 1 and 2 include the appropriate IO definitions for the device 
in use and select the <util/delay.h> library. This contains routines for the delay function 
used later in the code. The program is then initialized and declares the input and output 
functionality of PORTB in line 6. The hexadecimal 0x03 defines pin 0 and pin 1 of port B 
as outputs. These will be output ports of the timing clock signals. 
The timing sequence is achieved with use of the delay function in a while loop. 
While (1) creates a loop that will never end, as the condition always remains true. The 
first statement within the while loop, liŶe ϵ, seleĐts piŶ Ϭ as ͚ϭ͛. This ǁill ĐoƌƌespoŶd to 
the high time of clock 1, where the red LED turns on and its contribution to the 
photodetector input is selected at the sample and hold circuit. The delay function is 
called and so pin 0 will staǇ ͚ϭ͛ foƌ 834 µs. The delay function accepts only a known 
ĐoŶstaŶt as aŶ eǆpƌessioŶ. LiŶe ϭϭ tuƌŶs ďoth piŶs to ͚Ϭ͛ aŶd the delaǇ fuŶĐtioŶ is Đalled 
again for 834 µs. The clock for the infrared is selected high at line 13 when pin 1 is 
seleĐted as ͚ϭ͛. The delaǇ fuŶĐtioŶ eŶsuƌes it is ͚ϭ͛ foƌ 834 µs when both pins are turned 
to ͚Ϭ͛ agaiŶ. 
6.1.2 Current driver 
LEDs, like other diodes, follow the ideal diode equation [119] according to which 
the current through it varies exponentially with the voltage supplied. For this reason the 
preferred method to drive the LED is with a constant current source. This can be 
achieved with a high precision, low noise operational amplifier (OPA2227 Burr-Brown, 
USA) and a series NPN transistor (2N3904 ON Semiconductors, UK) (Figure 6.3). 
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Figure 6.3: LED current driver circuit 
When a negative feedback is applied around the OpAmp (operational amplifier) 
through the transistor, the voltage at the inverting output approaches the value of the 
voltage at the non-inverting input. This makes the voltage through the resistor equal to 
Vin. The ĐuƌƌeŶt thƌough it ĐaŶ ďe deƌiǀed usiŶg Ohŵ͛s laǁ. 
In an NPN transistor, current flowing into the base results in a proportionally 
larger current to flow between the collector and the emitter, and so it is said that the 
current at the collector is approximately equal to the emitter current. As per Equation 
5.16, the collector current is as given by Equation 6.1. 
 ܫܿ = ��ܴ݊ Equation 6.1 
  
The voltage input to the OpAmp is connected to the output clock signal of the 
ŵiĐƌoĐoŶtƌolleƌ foƌ the ĐoƌƌespoŶdiŶg LED ǁaǀeleŶgth. “o, ǁheŶ the logiĐ iŶput is ͚ high͛, 
Vin is 5 V. A variable resistor R2, in series with a fixed 62 Ω resistor R1, was used for 
flexibility in selecting the most favourable current to drive the LEDs to achieve different 
brightness for different situations. The variable resistor can be set between 0 and 500 
Ω:  
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For R2= 0 Ω: 
 ܫܿ = ��ܴ݊ = ͷ�͸ʹΩ = ͺͲ.͸݉�  Equation 6.2 
 
For R2= 500 Ω: 
 ܫܿ = ��ܴ݊ = ͷ�͸ʹ + ͷͲͲΩ = ͺ.ͻ݉�  Equation 6.3 
 
And so the current range available in this configuration is 8.9 mA to 80.6 mA, 
which is below the peak forward currents accepted by both LEDs. 
Four current drivers were included to allow different currents to be supplied not 
only to red and infrared emitters but also to the intraluminal PPG probe and the finger 
PPG probe. 
The OpAmp is supplied in the positive input by a voltage of +12 V and on the 
negative input by -12 V. 100 nF decoupling capacitors were added for stability. 
6.1.3 Transimpedance amplifier 
The red and infrared LEDs, driven by the circuit described above, will illuminate 
the tissue under investigation. The reflected photons are absorbed by the 
photodetector, which generates a flow of current linearly proportional to the incident 
power [128]. This generated current is converted to voltage by a transimpedance 
amplifier. Two transimpedance amplifiers are used in the processing system, one for 
each PPG sensor. 
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Figure 6.4: Transimpedance amplifier circuit 
A transimpedance amplifier (Figure 6.4) translates the output from a very high 
impedance current source to a low impedance OpAmp output. This configuration 
ensures a voltage across the photodetector equal to zero for all light intensities, due to 
the virtual ground that the operational amplifier (OPA227 Burr-Brown, USA) maintains 
at the inverting input. 
Current flows through the feedback resistor and creates a voltage at the output, 
with a gain equal to the value of the resistor: 
 �݋ݑݐ = −ܫܴ݂݀  Equation 6.4 
 
The value of the feedback resistor (Rf=R1+R2) should be made as big as possible 
as it is the biggest source of noise of this circuit [21]. In series with a 75 kΩ resistor, it 
was chosen to include a 50 kΩ variable resistor to accommodate for different probes 
and situations. The very high gain at which the transimpedance amplifier is operated 
gives the signal a tendency for oscillation. A capacitor in the feedback loop improves 
stability and avoids gain peaking. 
6.1.4 Demultiplexing 
The mixed output of each transimpedance amplifier is fed into two sample and 
hold circuits (LF398, National Semiconductor, USA) for demultiplexing (Figure 6.5). This 
circuit is capable of taking an instantaneous sample of the input signal and then holding 
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the saŵpled ǀalue iŶ a holdiŶg ĐapaĐitoƌ. It tƌaĐks the iŶput sigŶal ǀoltage ǁheŶ a ͚high͛ 
logic signal is received. The output follows the input with only a minimal offset voltage. 
WheŶ the logiĐ iŶput is ͚loǁ͛, the Đhaƌged ĐapaĐitoƌ ƌetaiŶs its ǀalue, isolated fƌoŵ 
subsequent variations at the input. The capacitor will influence the acquisition time of 
the sample and hold circuit and also the rate of change of the output when the logic 
sigŶal is ͚loǁ͛. 
The logic signal used to trigger the sample and hold circuits is the same as the 
one that drives the current source of the corresponding LED wavelength, so the voltages 
corresponding to the reflected signals deriving from the red or infrared LEDs are the 
outputs of this circuit.  
 
Figure 6.5: Sample and hold circuit. The top LF398 receives clock 1 to output the 
photodetector signal correspondent to the red LED, while the bottom LF398 circuit 
corresponds to the infrared LED 
6.1.5 Signal conditioning 
Conditioning of the demultiplexed red and infrared signals is provided within the 
circuit by analogue filters. AC and DC components of the PPG signals are separated, 
filtered and amplified for a better signal-to-noise ratio when the waveforms are to be 
digitised. 
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For isolating the AC component, a band pass filter was designed using the Sallen 
and Key topology with unity gain. A 2nd order low pass filter to reject the low frequency 
band of the DC component was cascaded to a 2nd order high pass filter in order attenuate 
the high frequency noise, including switching noise from the multiplexer. The OpAmp 
used for this design was the OPA4277 by Burr-Brown. 
The unity gain Sallen and Key configuration for the low pass filter can be seen in 
Figure 6.6. 
 
Figure 6.6: Unity gain Sallen and Key low pass filter 
The cut off frequency for this filter is given by: 
 ݂ܿ = ͳʹ�√ܴଵܴଶܥଵܥଶ Equation 6.5 
  
The values of both resistors and both capacitors were kept the same for 
simplification: 
 ݂ܿ = ͳʹ�ܴܥ  Equation 6.6 
 
The value of resistors chosen was 360 kΩ and for the capacitors was 22 nF which 
gives a filter cut off frequency of 20.09 Hz. 
The unity gain Sallen and Key configuration for the high pass filter is as shown in 
Figure 6.7. It is achieved by swapping the resistors and capacitors in each of its poles. 
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Figure 6.7: Unity gain Sallen and Key high pass filter 
Its cut off frequency is given by the same equation as the low pass filter. In this 
case it was chosen to be around 0.5 Hz in order to not only eliminate the DC component 
of the PPG but also to attenuate the effect of the respiratory component (0.2 to 0.3 Hz) 
from the AC signal. The value of resistors used was 3.3 MΩ and the value of capacitors 
was 100nF, which corresponds to a cut off frequency of 0.48 Hz. 
The AC portion of the signal accounts for only 1 to 2% of the total amplitude of 
the PPG. An amplification stage was added in order to optimise the range of signal to be 
digitised using the data acquisition card. 
An inverting amplifier was designed for this stage. A diagram of the circuit can 
be seen in Figure 6.8. 
 
Figure 6.8: Inverting amplifier for the AC PPG signal 
The amplifier output is related to the input by the equation: 
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 �௢௨௧ = − ܴʹܴͳ ��௡ Equation 6.7 
  
With a closed loop gain of: 
 � = ܴʹܴͳ Equation 6.8 
  
The resistor values were chosen to be 330 kΩ for R2 and 3.9 kΩ for R1, which 
translates in a gain applied to the input voltage of 84.62. 
In order to extract the DC component of the signal, needed for calculation of R 
value for oxygen saturation, a low pass filter was designed using the unity gain Sallen 
and Key topology. The selected values for resistors and capacitors were 2.2 MΩ and 0.47 
µF, respectively. This equates to a cut off frequency of 0.15 Hz. 
6.1.6 ECG 
Development of a 3 lead electrocardiogram (ECG) channel is described in this 
section. 
Three electrodes are placed on the right arm or right side of the chest (red lead), 
the left arm or left side of the chest (yellow lead) and left leg or lower left side of the 
chest (green lead). The configuration decided for use is the bipolar lead I, where red and 
yellow leads are monitored for biopotentials and the green lead is used as ground [129]. 
These voltages are fed into a differential amplifier in order to detect the differential 
signal between the bipolar lead amidst the common voltage at the two electrodes. 
Instrumental amplifier INA114AP from Burr-Brown was used for this purpose. 
The INA114 general purpose instrumentation amplifier (Figure 6.9) is a three 
OpAmp design providing high common rejection ratio (115dB) and a very high input 
impedance (1010Ω). The gain of the instrumentational amplifier can be set with an 
external resistor, RG, to up to 10000. It is given by: 
 ܩ = ͳ + ͷͲ݇Ωܴͳ  Equation 6.9 
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The resistor R1 value chosen was 560 Ω, providing a gain of 90 to the 
instrumentation amplifier. Decoupling capacitors of 0.1 µF were added for stability and 
noise reduction. 
 
Figure 6.9: Instrumentation amplifier used for the ECG channel 
Just like with the PPG signal, the ECG signal rides on a large offset and so an 
inverting amplifier was added for optimization before it is digitised. A diagram of the 
circuit can be seen in Figure 6.10. The operational amplifier chosen for this stage and for 
the filtering stage was the TL084 (Texas Instruments, USA). 
 
Figure 6.10: Inverting amplifier circuit for the ECG signal 
The resistor values for R1 and R2 were chosen to be 10 kΩ and 100 kΩ, 
respectively. By Equation 6.8 this provides a gain of 10 to the output signal of the 
instrumentational amplifier. 
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A bandpass filter was used to remove DC level and environmental artefacts. 
Figure 6.11 shows the high pass and low pass Sallen and Key filters used. The cut off 
frequency for this filter configuration is given by Equation 6.5. 
 
Figure 6.11: ECG bandpass filter implemented with Sallen and Key topology 
For the high pass filter, the values of resistors and capacitors were chosen as 1 
MΩ and 1 µF for a cut off frequency of 0.16 Hz. The low pass filter was chosen to have a 
cut off frequency of 40.83 Hz, with resistors and capacitors values of 3.9 kΩ and 1 µF. 
6.1.7 Airway pressure 
A standard sterile gas sampling line, used in capnography measurements, will be 
used to ŵoŶitoƌ the patieŶt͛s ƌespiƌatoƌǇ floǁ ƌate. This ǁill alloǁ ideŶtifiĐatioŶ of the 
respiratory modulation in the PPG signals and subsequently enable computation of local 
venous blood saturation. The gas sampling line will be connected to the ventilator side 
of the airway adaptor so is separated from the patient by a bacterial filter. 
The selected component for airway pressure sensing was the 40PC001B1A 
(Honeywell S&C, USA), which accepts a bi-directional pressure range of ±50 mmHg with 
an accuracy of 0.2%. It was not deemed necessary to calibrate the system as only the 
frequency and shape of the positive pressure ventilation flow will be analysed. 
6.1.8 Power supply 
The power supply for the circuit was provided by two heavy duty 12 V sealed 
lead-acid batteries (NP 1.2-12, Yuasa, Japan), with a 1.2 Ah 20-hour rate capacity. They 
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were connected in a parallel configuration which gives an improved capacity rating to 
the circuit, and consequently a longer battery time before discharge. 
A series configuratioŶ is ŵoƌe ĐoŵŵoŶlǇ used ǁith the ďatteƌies͛ juŶĐtioŶ aĐtiŶg 
as a virtual ground for the circuit. However, it is possible for the batteries to discharge 
unevenly, in which case a DC offset would emerge. A low power DC-DC converter was 
introduced to achieve a dual output +/-12V and ground rail from the 12VDC supplied by 
the batteries. The model chosen was the THD 15-1222N from TracoPower, which has 
precisely regulated output voltage. An input filter (Figure 6.12) was added in order to 
meet level B conducted emissions. 
 
Figure 6.12: Input filter for the DC-DC converter 
The current being drawn by the circuit is 150 mA on the positive rail and 80 mA 
on the negative rail during normal operation. The DC-DC converter chosen is able to 
output a maximum current of 250 mA. 
In contrast to the rest of the circuit, the multiplexing microcontroller requires a 
supply voltage of 5V. The voltage regulator (Figure 6.13) chosen for this purpose was the 
LM2931 (National Semiconductors, USA) that provides a fixed DC output voltage of 5 V, 
regardless of variations in input current or input voltage, within its operating range of 
26 V. 
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Figure 6.13: Voltage regulator circuit 
The capacitors were included to help maintain the stability. 
6.1.9 Data acquisition 
The output signals from the PPG and ECG filters and the output of the air 
pressure sensor are passed onto a 16-bit data acquisition card (NI USB-6212, National 
Instruments, USA) for analogue to digital conversion. It interfaces with a laptop 
computer and is powered via a USB cable. The software designed for control of the 
operation of the card and the acquisition of signals is the subject of the next chapter. 
 
6.2 Mechanical construction 
A complete schematic of the described PPG circuit was replicated in Altium 
Designer (Altium Limited, Australia) for design of the PCB and to generate the Gerber 
and NC drill files needed for manufacture. Routing and placement of the different 
components within the PCB board was decided by dataflow and pre-defined design 
rules. Width of tracks was kept at 0.5 mm, while power lines were made thicker at 0.7 
mm. Hole sizes were kept uniform at 1.3 mm, constrained by the availability of drilling 
bits for the CNC machine. Electrical clearance between components and tracks was 
defined as 0.4 mm. The final dimensions of the PCB board were 185x143 mm. 
The PCB board was constructed on a double sided 1 oz copper clad epoxy glass 
FR4 board with 1.6 mm thickness (149060, Kelan, UK). Fabrication was from the done 
by milling with a CNC machine (Mega 700-001 Bench drill/router, Mega, UK). After 
milling and drilling, the copper board was polished and tinned for 15 minutes in a 
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saturated solution of tin plating crystals. Both through-hole and surface mounted 
components were mounted on the board by hand soldering techniques. 
The circuit board, power supply and data acquisition card are enclosed in an 
aluminium instrument case (M5625305F, METcase, UK), size w250 x d260 x h150 mm. 
There are no moving parts: all parts are screwed to the bottom of the instrument case. 
The connections to the two pulse oximetry probes, the ECG leads and the connector for 
the gas sampling line are mounted on the front panel next to the power on-off switch 
as shown in Figure 6.14. Connection to the PPG probes is done through a Lemo Redel 8 
way panel mounted receptacle (PXG.M0.8GG.NG, Lemo, Switzerland), while the ECG 
leads cable is connected by a mini 6 pin DIN and a luer to tubing panel mounted adapter 
made of medical grade PVDF is used for the gas sampling line (FTLLB210-J1A, Value 
Plastics, Inc, USA). Connection from the data acquisition card to the computer is 
mounted on the back panel (Figure 6.15). 
 
Figure 6.14: Photograph of the study monitoring system (1 Power on/off switch with blue light 
indicator, 2 ECG receptacle, 3 Gas sampling line luer connector, 4 Intraluminal PPG probe 
connector, 5 Finger PPG probe connector) 
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Figure 6.15: Photograph of the back panel of the study monitoring system (1 USB port for data 
acquisition) 
The total weight of the main processing unit is 3.4 Kg. 
 
6.3 Performance evaluation 
The PPG processing system was evaluated by bench tests for validation and 
performance of its different components. 
Both the current drivers for the emitters and the sample and hold circuitry for 
demultiplexing are controlled by the timing clock signals of the multiplexing 
microcontroller. Its outputs measured with an oscilloscope can be seen in Figure 6.16. 
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Figure 6.16: Output of the microcontroller showing the timing clock signals 
Both timing clock signals can be clearly observed as square waves ranging from 
0 V to 5 V at the programmed frequency of 300 Hz. 
The output of each transimpedance amplifier is a mixed PPG signal as the 
photodeteĐtoƌ doesŶ͛t diffeƌeŶtiate ďetǁeeŶ the ƌed aŶd iŶfƌaƌed ǁaǀeleŶgths. Figure 
6.17 shows the output of one of the two transimpedance amplifiers in the circuit. The 
effect from the infrared wavelength can be seen as the higher amplitude component. 
The feedback capacitor is effective in reducing overshooting artefacts. 
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Figure 6.17: Output of the transimpedance amplifier, showing both the red and infrared 
components 
The sample and hold circuitry provides a simple method of splitting the output 
of the transimpedance amplifiers into their red and infrared components. Figure 6.18 
shows the output of two adjacent sample and hold circuits used to demultiplex the 
signal originating from one photodetector. Both circuits receive the same 
transimpedance amplifier output but a different timing clock signal, synchronizing to the 
red emitter current driver (a) and the infrared emitter current driver (b) for its sensor. It 
can be observed how its output follows the output of the transimpedance amplifier 
while the timing clock is high and keeps that value until the next clock. 
107 
a)  
b)  
Figure 6.18: Sample and hold output (green) for the red (a) and infrared (b) wavelengths as 
measured with the oscilloscope. The clocks timing signals (blue) and the output of the 
transresistance amplifier (orange) are also represented 
The frequency response of the band-pass filter that preconditions the PPG 
signals before digitization was verified experimentally using the 1 V sine wave output of 
a waveform generator at different frequencies. The results can be seen in Figure 6.19 in 
parallel to simulation done in NI Multisim 10 (National Instruments, USA) of the same 
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bandpass filter. Since the gain for this filter is 1 and the values of resistors and capacitors 
are equal then the quality factor of the filter, Q factor, is 0.5 by the expression: 
 ܳ = √݉݊݉ + ͳ  Equation 6.10 
 
, where m is the ratio of the resistors and n is the ratio of the capacitors. 
 
 
Figure 6.19: Frequency response of the PPG bandpass filter. Experimental results are 
represented by red diamonds, superimposed on simulation in Multisim in blue 
Figure 6.19 shows the frequency response of the PPG bandpass filter, with the 
cut off frequency delineated at the quality factor 0.5. The experimental cut off frequency 
was then at approximately 0.5 Hz for the lower cut off point and 25 Hz for the higher. 
Simulation in Multisim and experimental results were also obtained for the low 
pass filter (Figure 6.20). 
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Figure 6.20: Frequency response of the PPG low pass filter. Experimental results are 
represented by red diamonds, superimposed on simulation in Multisim in blue 
 Since the quality factor is the same as for the band pass filter, it can be seen in 
Figure 6.20 the experimental cut off frequency is approximately 0.15 Hz. 
Figure 6.21 shows the AC PPG signals for the intraluminal probe and the finger 
probe as they are transferred to the DAQ card for further analysis. The test was 
conducted using an indicator finger in lieu of the duodenal mucosa. 
 
Figure 6.21: Sample red and infrared AC PPG signals from the intraluminal and the finger PPG 
probes as measured on the oscilloscope 
 
0
0.2
0.4
0.6
0.8
1
0.01 0.1 1 10 100 1000
M
a
g
n
it
u
d
e
Frequency (Hz)
110 
 The output AC PPG signals to be digitised contain little noise and their definable 
features (peak and dicrotic notch) can be clearly distinguished. 
 Like the filters implemented for PPG signal processing, the bandpass filter used 
in the ECG channel is of unity gain with both resistors and capacitors of same value, 
giving it a quality factor of 0.5. According to Figure 6.22, the experimental low cut off 
frequency is approximately 0.15 Hz and the high cut off frequency is near 40 Hz. 
  
Figure 6.22: Frequency response of the ECG bandpass filter. Experimental results are 
represented by red diamonds, superimposed on simulation in Multisim in blue 
Figure 6.23Figure 6.23 shows the output of the ECG channel as measured on the 
oscilloscope. 
 
Figure 6.23: ECG signal as measured on the oscilloscope 
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The output of the airway pressure channel was also evaluated on the 
oscilloscope (Figure 6.24). During clinical trials, the gas sampling line will be connected 
to the patieŶt͛s ŵeĐhaŶiĐal ǀeŶtilatioŶ sǇsteŵ. Hoǁeǀeƌ foƌ ďeŶĐh testiŶg, foƌĐed 
breathing was used instead to obtain a comparable waveform. 
 
Figure 6.24: Airway pressure signal during forced breathing as measured on the oscilloscope 
It was noted previously that the airway pressure channel is not calibrated. The 
offset and amplitude of the waveform are not relevant to this study and will not be 
displayed. 
As the PPG processing system is battery operated, it was deemed necessary to 
investigate how long the system can operate within its specifications after a full charge. 
So, in order to test its running time, the +12 V and -12 V power lines, outputting from 
the DC-DC converter, were connected to a data acquisition device to measure and 
record the changes in voltage. Figure 6.25 shows the graph of voltage over time of this 
experiment. 
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Figure 6.25: Changes in voltage of the power lines during a cycle run of the processing system 
It can be seen from Figure 6.25 that the batteries had run continuously for over 
6 hours before the DC-DC ĐoŶǀeƌteƌ ĐouldŶ͛t output +ϭϮ V aŶd -12 V anymore and the 
processing system stopped its normal functioning. 
 
6.4 Conclusion 
A two channel dual wavelength PPG processing system has been successfully 
developed to accommodate both the intraluminal PPG probe and the finger PPG probe 
as well as an ECG channel and an airway pressure channel. The two PPG channels were 
built electrically identical in order to enable quantitative comparison between the PPG 
signals obtained from the intraluminal PPG probe and the peripheral finger PPG probe. 
Each section of the processing system was bench tested to ensure its correct and 
accurate performance. The signals measured on the oscilloscope are of good signal to 
noise ratio and suitable for digitisation for further analysis. 
After digitization, the signals are transferred to a laptop computer for saving, 
processing and real time display using a Virtual Instrument implemented on LabVIEW, 
to be covered in the next chapter. The computer used is the Dell Lattitude 6510 (Dell, 
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USA), with an Intel Core i5 (2.5GHz), 2 GB RAM, Windows 7 64-bit OS and 160 GB HDD. 
During clinical studies the laptop computer will run off its internal batteries. 
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DEVELOPMENT OF A DATA ACQUISITION VIRTUAL INSTRUMENT 
The main processing unit, described in the previous chapter, requires the use of 
a Virtual Instrument (VI) for the effective acquisition and real time display of the PPG, 
ECG and airway pressure outputs. The programming environment chosen for the 
development of this VI was LabVIEW (National Instruments, USA), which provides full 
integration to the analogue to digital conversion hardware installed in the main 
processing unit enclosure. 
After a brief introduction to LabVIEW and its capabilities, this chapter aims to 
give a detailed description of the software written on LabVIEW, from saving of the raw 
digitised signals for offline analysis to improving access to real time data through the 
Front Panel and its extra features. 
 
7.1 About LabVIEW 
NI LabVIEW (National Instruments, USA), standing for Laboratory Virtual 
Instrument Engineering Workbench, is a graphical programming environment optimised 
for instrument control, data acquisition and processing and real time display of acquired 
data. It uses high-level language, G, to represent programming actions graphically 
instead of the more traditional lines of text used by other languages, such as C, C++ or 
Java. LabVIEW follows a dataflow model, where the flow of data through the wires and 
nodes on the Block Diagram determines the execution order of the VIs or functions. VIs, 
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or virtual instruments, are LabVIEW programs that imitate actual instruments by their 
operation and appearance. Interaction with the user when the program is running is 
done through controls and indicators on the Front Panel. The graphical nature of 
LabVIEW allows for a faster program development, being more intuitive but still 
maintaining the same programming concepts and the standard data types, loops, event 
handling, variables and debugging capabilities as other languages. 
7.1.1 Data acquisition hardware 
As explained in the previous chapter, interface between the main processing unit 
and the laptop computer is done via a data acquisition card, responsible for analogue to 
digital signal conversion. National Instruments offers a wide range of data acquisition 
(DAQ) devices to be used in conjunction with the LabVIEW software. 
The device that was selected for this project is the Multifunction Data Acquisition 
NI USB-6212 (National Instruments, USA), featuring 16 analogue inputs with a 16 bit 
resolution at a sampling rate up to 400 kS/s and a maximum voltage range of -10 V to 
+10V. This DAQ card also includes two analogue output channels, 32 digital I/O lines and 
two 32-bit counter outputs. It communicates with the computer via USB port and does 
not require external power. The main selection criteria for this device was the capability 
of supporting a large number of analogue inputs and high resolution which is essential 
when acquiring physiological signals. 
7.2 Development of the Virtual Instrument for data acquisition using 
LabVIEW 
A virtual instrument was implemented, as part of this project, in LabVIEW to 
acquire, process and display the PPG, ECG and airway pressure signals outputs of the 
main processing unit. It consists of various features programmed to perform the 
following tasks: 
 To accurately digitise and acquire the PPG, ECG and airway pressure 
signals.  To save all the acquired raw data.  To filter and display in real time all signals. 
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 To calculate and display the ratio R and SpO2 from all three PPG sensors.  To calculate and display heart rate from the ECG signal. 
The complete Block Diagram can be seen on Appendix 2. 
7.2.1 Algorithm for data acquisition 
The first task required for the Virtual Instrument to perform is to communicate 
with the data acquisition card for continuous acquisition of the 10 output signals from 
the main processing unit: infrared and red AC intraluminal, infrared and red DC 
intraluminal, infrared and red AC finger, infrared and red DC finger, ECG and airway 
pressure signals. 
The chosen DAQmx VI for data acquisition was the DAQ Assistant Express VI. NI-
DAQmx software enables the control and programming of the DAQ card from within the 
LabVIEW environment and was introduced to optimize performance. As part of the 
Express VI Development Toolkit, this function allows for interactive configuration 
through a dialogue box. 
When the DAQ Assistant Express VI is first initialized, it displays a dialogue box 
for the creation of the task of acquiring the analogue inputs from the DAQ card. At this 
point, a set of 14 virtual channels is created for measuring voltage from the specified 
physical channels of the DAQ card corresponding to the 8 PPG signals, the ECG signal 
and the airway pressure signal. 
The subsequent dialogue box allows for configuration of channel-specific 
settings (Figure 7.1). The input terminal configuration was chosen to be RSE (referenced 
single-ended) where the voltage is measured with respect to ground, also connected to 
the DAQ card. Maximum and minimum values were configured to +10 and -10 V. Under 
timing settings, the acquisition mode was set to Continuous Samples, for continuous 
acquisition until the VI is stopped, giving the option to specify Samples to Read and the 
Rate of acquisition in Hertz. These were defined as 20 and 200 Hz respectively. The 
sampling rate was chosen to satisfy the Nyquist criterion of the sampling theory, where 
the sampling frequency needs to be at least twice the highest frequency present in the 
signal. In order to satisfy this criterion for both PPG and ECG signals, a frequency of 
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Figure 7.1: Configuration dialog box of the DAQ Assistant Express VI, showing details of the 
physical channels in the DAQ card 
200Hz was chosen. The Samples to Read parameter determines the buffer size and the 
number of samples to read from the buffer for each channel in each iteration. Other 
configurable settings on the dialogue box include the option to name and order the 
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virtual channels, corresponding to the physical connections to the DAQ card. Clicking 
the OK button saves the settings and returns to the block diagram. 
The ͞data͟ output of the DAQ Assistant Express VI is represented by a dark blue 
wire (Figure 7.2) and contains the samples read from the task, along with their timing 
information. 
Like other software packages, DAQmx includes an error in/out condition 
connecting the different VIs. The army green wire that represents this error contains 
information relevant to it including its status (Boolean 1 for occurred error), code (if 
status is true, this is a non-zero error code) and source. This allows for the programer to 
include Boolean logic to halt the program in case of an error being detected. The General 
Error Handler, placed at the end of the dataflow, returns a description of the error and 
displays it in a dialog box (Figure 7.2). 
 
Figure 7.2: Data acquisition algorithm in LabVIEW 
Other parameters of the DAQ Assistant Express VI iŶĐlude ͞stop͟/͞stopped͟ aŶd 
͞task out͟. “iŶĐe the aĐƋuisitioŶ ŵode ǁas seleĐted to ĐoŶtiŶuouslǇ aĐƋuiƌe saŵples, 
the VI ǁill ƌuŶ uŶtil the ͞stop͟ iŶput is the BooleaŶ ͞tƌue͟ ;BooleaŶ tǇpe is ƌepƌeseŶted 
ďǇ a dotted gƌeeŶ ǁiƌeͿ. The output ͞stopped͟ ǁill tuƌŶ to BooleaŶ ͞tƌue͟ ǁheŶ this 
oĐĐuƌs, as ǁell as ǁheŶ the eƌƌoƌ ĐoŶditioŶ is ͞tƌue͟. ͞Task out͟ ĐoŶtaiŶs a ƌefeƌeŶĐe to 
the task that can be wired through a purple wire to other DAQmx VIs. 
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In order for the DAQ Assistant Express VI to run continuously, it needs to be 
inserted within a loop condition. This is achieved with a While Loop. This loop repeats 
the code within its subdiagram until a specific condition occurs. A Boolean logic stop 
button in the Front Panel connected to the While Loop͛s Condition Terminal ;͞“top if 
tƌue͟ ĐoŶditioŶ seleĐted; a ͞CoŶtiŶue if tƌue͟ ĐoŶditioŶ is also aǀailaďleͿ halts the 
execution of all programs within the loop. Other features of the program are also 
included within this loop so that they will execute continuously until this stop button is 
hit. The Condition Terminal is also driven by the status of the error condition. 
 A For Loop is also included inside the While Loop to aid the calculation of ratio R 
and SpO2, detailed in section 5.3.1. A For Loop executes its subdiagram a set amount of 
times, in this case 20. With a sampling frequency of 200 Hz this allows the collection of 
400 samples, corresponding to 2 seconds of data to be used for the calculation of the 
ratio of ratios and SpO2. The Boolean stop button on the Front Panel is wired to a stop 
condition inside the For Loop so that it also halts its execution. 
7.2.2 Algorithm for saving acquired data 
An algorithm (Figure 7.3) for saving the PPG, ECG and air pressure data to a file 
was included in this VI to enable offline analysis. It was decided that only the raw signals 
from the DAQ Assistant Express VI would be saved in order to preserve as much 
information as possible. 
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Figure 7.3: Algorithm for saving acquired data on LabVIEW, which also records a time stamp 
with a hours, minutes and seconds format (%H:%M:%S) 
The Write to Measurement File VI writes data to a text based measurement file 
or a binary measurement file with or without headers. Like the DAQ Assistant Express 
VI, it opens a dialogue box with different configuration options of the type of file to be 
created (Figure 7.4). The LabVIEW measurement file, with extension *.lvm, was the 
chosen file format for this VI. It is a tab-delimited text file that can be opened in either 
a spreadsheet or text-editing application. It includes a file header section with 
information about the data, including date and time, followed by the data arranged in 
rows and columns. It was chosen to use the tab character as a separator. The Action 
option in the dialogue box configures the way the file is saved: it was chosen to save the 
data in one file only and to prompt the user for a file name just once, instead of every 
time the Write to Measurement File VI executes. 
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Figure 7.4: Dialog box for Write to Measurement File VI 
When executed, the Write to Measurement File VI receives the output of the 
DAQ AssistaŶt Eǆpƌess VI iŶto its ͞“igŶals͟ paƌaŵeteƌ iŶput. A BooleaŶ logiĐ ƌeĐoƌd 
ďuttoŶ iŶ the FƌoŶt PaŶel ĐoŶŶeĐted to the ͞eŶaďle͟ iŶput prompts its execution. This 
ďuttoŶ ǁas desigŶed ǁith a ŵeĐhaŶiĐal aĐtioŶ of ͞“ǁitĐh ǁheŶ pƌessed͟ ǁhiĐh eŶaďles 
the user to start, pause the recording of the data and restart it again. The data will 
continue to be acquired into the same file. When the recording is started for the first 
time since the program is run, a dialogue box appears prompting the user to input a 
filename and select the destination folder. To note that this VI, just like the DAQmx VI, 
includes an error condition that is connected to a General Error Handler at the end of 
the program. 
An event recording function was designed to capture a time stamp and save it 
along with the raw signal data. It is important to account for certain events during clinical 
trials such as induction of anaesthesia, drugs, change in ventilation mode, etc., and mark 
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the time they occurred to later be correlated to the acquired signals and facilitate offline 
analysis. 
This event recording function was accomplished with a Get Date/Time in Seconds 
VI, which returns a time stamp of the current time. This was then formatted by a Format 
Date/Time String VI into a time string only. Date information is already included in the 
header of the created text file. The time format code used shows the time stamp into a 
hour, minute and second format (%H:%M:%S) and is wired by a pink wire to the Format 
Date/Tiŵe “tƌiŶg VI. This foƌŵatted stƌiŶg is theŶ ǁiƌed iŶto the ͞CoŵŵeŶt͟ paƌaŵeteƌ 
input of the Write to Measurement File VI. A Boolean logic event button was included 
in the Front Panel to control when this function occurs. Since the Get Date/Time in 
“eĐoŶds VI doesŶ͛t haǀe aŶ ͞eŶaďle͟ iŶput, this ǁas doŶe usiŶg a Case “tƌuĐtuƌe ǁith a 
BooleaŶ seleĐtoƌ teƌŵiŶal. WheŶ the ͞tƌue͟ ĐoŶditioŶ is ŵet, the Get Date/Tiŵe iŶ 
Seconds VI is executed; otherwise nothing happens. 
It was decided to add the record time into the saved file as well. Since the record 
button is outside the For Loop, it would have inserted a timestamp for each iteration. 
Some logic was used to insure only the first timestamp is written in the saved file, which 
also includes the use of shift registers. These sit directly opposite in the sides of a loop 
structure and are able to shift the data stored at the right register to the left register to 
be used in the next iteration. 
7.2.3 Algorithm for continuous signal display 
A Waveform Chart was used to display in real time the acquired signals (Figure 
7.5). This VI can display one or more plots of data acquired at an automatic constant 
rate. It provides assurance to the end user of this VI that the instrumentation is 
functioning and that signals are of good quality for significant post processing and 
analysis. 
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Figure 7.5: Filtering and waveform display algorithm 
The output of the DAQ Assistant Express VI includes all acquired signals. In order 
to display the signals from each PPG sensor in a separate graph, as well as the signals 
from the ECG and the airway pressure, Split Signals Function and Merge Signals Function 
VIs were utilized. As their names suggest, they split signals into its component signals 
and can merge two or more signals together into a single output. The resulting signals 
retain the original time information. 
The x-axes of all graphs were configured to show the latest 10 second of data, 
while the y-axes were selected differently for each type of signal. The y-axis for the PPG 
graphs was configured to a value range of -10 to +10 V, but this can be adjusted during 
measurements to better visualize the signals. It was not deemed necessary to include 
the DC signals in the graphs, so only the AC photoplethysmographs are displayed. For 
the ECG and airway pressure graphs, the y-axes were set to autoscale, in which the scale 
is adjusted automatically to reflect the incoming data. 
Despite the signal conditioning already provided in the main processing system, 
the acquired signals may still have some noise, which may include quantisation noise, 
added to the signal during digitisation. Two digital filters were therefore implemented 
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in LabVIEW before displaying the PPG and ECG signals (Figure 7.5). The chosen VI for this 
task was the Filter Express VI. The filter for the AC PPGs was defined as a low pass, 6th 
order Butterworth filter with a cut-off frequency of 10 Hz, while the filter for the ECG 
signal was a band pass filter, with a low cut-off frequency of 0.5 Hz and a high cut-off 
frequency of 15 Hz. All specifications are selected in a dialogue box, alike the ones from 
the previously described VIs. 
7.2.4 Algorithm for the calculation of ratio and SpO2 
It has been mentioned previously that calibration of modern pulse oximeters is 
done by comparison of arterial blood gas samples analysed in a CO-oximeter with the 
measured ratio, R, of AC/DC signals from the red and infrared PPGs. It must be stressed 
however that this is an uncalibrated system and, in order to derive SpO2, an existing 
empirical calibration curve [21] will be used: 
 ܵ݌ܱଶ = ͳͳͲ − ʹͷܴ Equation 7.1 
After acquisition and filtering, a Collector VI is employed inside the For Loop to 
collect the input signals and return the most recent data. It creates an internal buffer to 
store the individual points and discard the oldest points. The newest points are passed 
out of the For Loop. The maximum number of samples per channel was specified to be 
1000. After 20 iterations of the For Loop, each channel contains 400 points of data. 
Collected at a rate of 200 samples/ second, this equates to 2 seconds of data for each 
signal (approximately the duration of 2 heart beats) which is sufficient for the estimation 
of the AC or DC components used in calculating the ratio R. With the For Loop it is 
possible to achieve an almost continuous collection of data and calculation of SpO2; as 
it is being called inside the While Loop, a new value is calculated every 2 seconds. 
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Figure 7.6: Algorithm for calculation and display of ratio of ratios and SpO2 values from both 
the intraluminal PPG probe and the finger PPG probe 
In order to calculate the PPG AC and DC amplitudes to be used in calculating the 
ratio R, an Amplitude and Level Measurements VI was introduced. This VI displays a 
dialogue box with voltage measurement options to be applied to the signals, including 
mean, RMS (root mean square), positive and negative peak, peak to peak, cycle average 
and cycle RMS. The acquired signals were divided into AC and DC PPGs and the mean 
voltage measurement was applied to the DC PPGs, while the peak to peak voltage 
measurement was applied to the former. 
The ratios of AC/DC for both red and infrared wavelengths were calculated using 
a numeric function of division. The quotient of these two ratios gives the value of R, as 
described by Equation 5.14. The empirical calibration curve depicted in Equation 5.15 is 
also implemented with the use of numeric functions. 
Because the calculation of the ratio R and SpO2 needs to be repeated for all 3 
PPG sensoƌs, this algoƌithŵ ǁas desigŶed as a suďVI iŶ oƌdeƌ to siŵplifǇ the ŵaiŶ VI͛s 
Block Diagram. 
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Figure 7.7: SubVI for calculation of ratio of ratios and SpO2 values 
The inputs and outputs of this subVI (Figure 7.7) are added as connections to the 
terminal of the custom designed icon of the subVI that can be placed in the main VI 
(Figure 7.5). 
 
Figure 7.8: Icon and connection diagram of the subVI with ratio of ratios and SpO2 values as 
outputs 
The calculated SpO2 is then displayed along with the ratio R value in the Front 
Panel. In the case of the saturation falling below 75%, the SpO2 value will turn to red. 
This is achieved with a Select VI wired to two Colour Box Constants and the Boolean 
result of a Less or Equal? VI. Its result is inputted into a SpO2 display Property Node, 
which allows changing the properties, including colour, of a reference in the Front Panel 
directly from the Block Diagram. 
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7.2.5 Algorithm for the calculation of heart rate 
A Collector VI is also employed to pass the ECG signal out of the For Loop, which 
is then inputted into a Tone Measurements Express VI for calculation of the frequency 
of the acquired signal. 
 
Figure 7.9: Dialog box for the Tone Measurements Express VI. The ͞“aŵple Data͟ aŶd ͞“aŵple 
‘esult͟ are examples and were not obtained as part of this work. 
Like the previously described Express VIs, the Tone Measurements Express VI 
displays a dialogue box with further options (Figure 7.9). The single tone frequency 
option was selected and the VI allows for search in a specific frequency range: the 
approximate frequency was selected to be 1 Hz and for the VI to search within ±5% of 
this frequency. The output was multiplied by 60 using the numeric function 
multiplication in order to display beats per minute instead of Hertz in the Front Panel. 
The heart rate value will turn red when it falls below 50 or raises above 100 beats per 
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minute. This was achieve in a similar way to the SpO2 values, with a Select VI, a Colour 
Box Constant, a Less or Equal? VI and a Property Node. 
 
Figure 7.10: Algorithm for the calculation and display of heart rate 
7.2.6 Front panel 
Figure 7.11 shows a capture of the Front Panel when the program is running. It 
shows in prominence the AC PPG signals from the intraluminal PPG probe (labelled 
͞DuodeŶuŵ͟) and from the finger PPG probe (͞Finger͟), the ECG signal (͞ECG͟) and the 
airway pressure (͞Air͟), over a period of 10 seconds. It was decided not to display the 
DC PPG signals, as it is common practice in commercial devices. 
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Figure 7.11: Still of the Front Panel of the LabVIEW VI when it is running 
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For the PPG signals, different colours were chosen to quickly differentiate 
between sensors. The warmer colours (red and yellow) represent the waveforms 
corresponding to the red LED, while the cooler colours (turquoise and blue) correspond 
to the infrared LED. The two PPG waveform graphs have the same amplitude range: -10 
to +10 V. This range can be adjusted during clinical trials. The calculated values of ratio 
R and SpO2 are also displayed next to the waveform graphs. The SpO2 values for both 
channels were rounded to the closest digit as is common practice in commercial pulse 
oximeter devices. As mentioned previously, the SpO2 value will turn red if the saturation 
falls below 75%. The heart rate value is also displayed and will turn red outside of the 
50 to 100 beats per minute range. The airway pressure waveform is also displayed. 
Also displayed on the Front Panel a button for the event recording and a time 
display for when it is pressed, along with the stop button. Because it is called from within 
a For Loop, it takes a couple of seconds for the stopping action to come into effect. 
7.3 Conclusion 
The Virtual Instrument was successfully designed and implemented in LabVIEW 
to be used in conjunction with an intraluminal PPG probe and a finger PPG probe and 
the main processing unit described in chapter 6. It allows for full control of digitisation, 
saving, processing and real time display of the PPG, ECG and airway pressure signals. It 
also estimates and displays SpO2 and heart rate every 2 seconds. The VI did not 
noticeable slow down or crash during tests and the time stamps were confirmed to be 
recorded along with the raw signals. 
The successful completion of the virtual instrument, along with the developed 
hardware, enables progression of the research to the stage of clinical studies. 
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IN VIVO INVESTIGATION OF PPG SIGNALS FROM THE DUODENUM 
DURING OPEN LAPAROTOMY 
The vital need to monitor the perfusion of the splanchnic region in critically ill 
patients has not yet been met by existing techniques. This chapter presents the findings 
from a study evaluating the feasibility of photoplethysmography acquired intraluminally 
from the duodenum in 9 patients undergoing open laparotomy. 
The specifications of the intraluminal PPG probe and finger PPG probe, used in 
conjunction with the processing system described in chapter 6, are also detailed. 
8.1 Instrumentation 
The PPG probe utilised for this study was previously developed by the Biomedical 
Engineering Research Group at City University London for intraluminal oesophageal 
monitoring in clinical research studies [125], [130], [131]. This reflectance 
photoplethysmographic probe consists of a surface mounted photodetector flanked by 
a red and an infrared surface mounted light emitting diode (LED) on each side. The 
emitters selected for this probe were the CR10HRT (ELCOS GmbH, Germany) for the red 
emitters and CR50IRH (ELCOS GmbH, Germany) for the infrared emitters, with a peak 
wavelength of 655 nm and 880 nm, respectively, and the selected photodetector was 
the CFD10 (ELCOS GmbH, Germany), with a spectral response range between 500 and 
1000 nm. Their opto-electronic characteristics and packaging details are shown in Table 
8.1, in Table 8.2 and in Table 8.3. 
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Table 8.1: Opto-electronic and package characteristics of the red emitter.  
Table 8.2: Opto-electronic and package characteristics of the infrared emitter. 
Electrical/optical characteristics at TA=25°C 
Peak emission wavelength: 655 nm (typ) 
Luminous intensity (at IF=20 mA): 15.0 mcd 
Power dissipation: 130 mW 
Forward voltage (at 20 mA): 1.8 V (typ) 
Min. reverse voltage: 5 V 
Reverse leakage current: 100 µA 
Peak forward current (at 10µs): 800 mA  
Continuous forward current: 75 mA 
Light emission angle: 180° 
Operating temperature: -25°C  to +80°C 
Soldering temperature (10 s): 250°C 
  
All dimension in milimeters 
Electrical/optical characteristics at TA=25°C 
Peak emission wavelength: 880 nm 
Radiated power (100 mA) / (20 mA): 9.2 mW / 2.0 mW 
Power dissipation: 130 mW 
Forward voltage (100 mA) / (20 mA): 1.65 V / 1.35 V 
Min. reverse voltage: 8.0 V 
Reverse leakage current: 100 µA 
Peak forward current (at 10µs): 800 mA  
Continuous forward current: 75 mA 
Light emission angle: 160° 
Operating temperature: -25°C  to +80°C 
Soldering temperature (10 s): 250°C 
 
All dimension in milimeters 
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Table 8.3: Opto-electronic and package characteristics of the photodetector. 
Electrical/optical characteristics at TA=25°C  
Peak wavelength sensitivity: 880 nm 
Range of spectral bandwidth (50%): ϱϬϬ … ϭϬϬϬ Ŷŵ 
Active area: 7.34 mm2 
Sensitivity (at VR=5 V, EV=1kLx): 85 nA/Lx 
Junction capacitance (at VR=3 V, f=1 MHz): 50 pF 
Open circuit voltage (at EV=1kLx): 365 mV 
Light reverse current (at VR=5 V, EV=1kLx): 85 mA (typ) 
Reverse dark current (at VR=10 V): 5 nA (typ) 
Reverse voltage (at 25°C): 32 V 
Power dissipation: 200 mW 
Operating temperature: -25°C to +80°C 
Soldering temperature (10 s): 260°C 
 
All dimension in milimeters 
 
The probe was constructed using surface mounted components soldered onto a 
manually etched, epoxy glass copper clad, single sided PCB (dimensions: 20 mm x 3.5 
mm x 1.0 mm) (Figure 8.1 top). The distance between the emitters and the 
photodetector is 5 mm.  Experimental studies have shown a separation of 4 to 5 mm 
provides the best sensitivity in terms of detecting adequate photoplethysmographic 
signals [21]. 
An electrically and optically identical reflectance finger PPG probe was also used 
to enable comparison of the duodenum mucosal measurements with the traditional PPG 
sensor location. The layout of the finger PPG probe is shown in Figure 8.1 (bottom). 
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Figure 8.1: Layout of the surface mounted components on the board for the intraluminal and 
for the finger PPG probes (measurements in mm) 
A shielded 6 core cable from a pulse oximeter was used for carrying the power 
to the LEDs from the main processing unit and also the detected PPG signals from the 
photodetector. The intraluminal and the finger PPG probes have been manufactured 
with a mini 6 pin DIN connector. A converter was manufactured to allow connection to 
the 8 contact plug PAG.M0.8GL.AC52G (Lemo Redel, UK) installed in the main processing 
unit. 
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Figure 8.2: Photograph of the intraluminal PPG probe (left) and of the finger PPG probe (right). 
8.1.1 Approved probe sheathing method for sterilization and electrical insulation 
The intraluminal PPG probe was designed to fit into a transparent disposable 21 
French gauge gastro-duodenal tube (0391.21, Vygon, UK), a latex free 125 cm long tube 
with four lateral eyes and a closed end. 
The use of this commercially available, sterile, CE marked, single patient use 
gastro-duodenal tube ensures sterility and avoids cross contamination during clinical 
trials. Tube gauge French 21 is routinely utilized in anaesthetics and has been approved 
to be used in this study by clinical collaborators, by the ethics committee to which this 
study was presented to and by the Clinical Physics and Infection Control department at 
Barts Health NHS Trust where the study took place.  
As noted, the gastro-duodenal tube is manufactured with four side eyes. In order 
to prevent digestive tract secretions and blood from reaching the electronic and optical 
components of the intraluminal PPG probe during clinical trials, these side drainage 
holes have to be completely sealed. The method approved by Clinical Physics and 
Infection Control encompasses cutting the solid, round-ended closed tip of a smaller 
gastric tube and inserting it into the French 21 gastro-duodenal tube. The French 14 
gauge gastric tube RT-2014 (Pennine Healthcare, UK) was chosen. This is a Ryles tube 
made of medical grade PVC, latex free with four side eyes and a closed end. 
A water pressure test was undertaken to test the efficacy of the seal the French 
14 tube achieves. A bladder syringe filled with water was used to apply pressure to a 
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column of water within the sealed gastro-duodenal tube. Figure 8.3 shows the setup of 
the water pressure test. No water was noted to drip through the tight seal, even at high 
pressure sufficient to blow apart the connection of the bladder syringe with the gastric 
tube. 
 
Figure 8.3:  Water pressure test in progress. 
In theatres, just prior to starting the clinical trial on the volunteer, both gastric 
tubes (the French 21 and the French 14 tubes) were opened from their sterile packaging 
onto a trolley covered with a sterile drape. A member of the research team in sterile 
gloves cut the tip of the French 14 tube and inserted it into the most proximal 
(uppermost) side drainage hole of the French 21 gastro-duodenal tube in the direction 
of the open top of the tube, until this short segment was entirely contained within the 
lumen of the outer French 21 tube. An air pressure test was conducted in a sterile 
manner at this stage to ensure a tight seal. Another member of the research team then 
fed the intraluminal PPG probe into the proximal, open ended port of the French 21 
gastro-duodenal tube, ensuring that the tube remains sterile. The sheathed probe was 
then ready to be inserted via the mouth into the stomach of the patient. Two new tubes 
were used for each patient recruited to the study, and disposed of at the end of each 
clinical trial. 
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The approved sealing protocol included undertaking a final air pressure test and 
visual inspection of the probe after it was removed at the end of the clinical trial. In the 
event of contamination, the intraluminal PPG probe would be permanently disposed of 
in order to avoid transmitting infection to a subsequent patient. 
Figure 8.4 shows the intraluminal PPG probe inside the gastro-duodenal tube. 
Figure 8.4: (top left) Tips of the 21 Fr tube and 14 Fr tube. (top right) 21 Fr tube sealed. 
(bottom) Intraluminal probe inside the sealed gastric tube 
During clinical trials the finger PPG probe was covered with a CE marked single 
patient use adhesive (Tegaderm, 3M, USA) to further reduce the risk of cross 
contamination between patients. Like the gastric tubes, this adhesive was disposed of 
at the end of each clinical trial. 
Both probes were also tested for electrical isolation. Electrical continuity was 
tested with one tip on the sensor surface and the other tip on the electrical connections 
of the terminating plug. The intraluminal probe was placed inside the gastro-duodenal 
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tube and the finger probe was covered with an adhesive as they would be during the 
study. No current passed between continuity probe tips. 
 
8.2 Clinical trial protocol 
Ethical approval was obtained from the NHS Research Ethics Committee and 
from the Barts Health NHS Trust Research and Development to recruit adult ASA I to III 
patieŶts foƌ the ĐliŶiĐal studǇ ͞Evaluation of a new method of monitoring upper 
gastrointestinal arterial pulsation and oxygen saturations using an intra-luminal opto-
electƌoŶiĐ pƌoďe͟. 
As part of the application for ethics approval, the PPG main processing system 
and both intraluminal and finger PPG probes were assessed by the Clinical Physics and 
Infection Control department at Barts Health NHS Trust for conformity to the 
ƌeƋuiƌeŵeŶts of the Tƌust͛s poliĐǇ aŶd appƌoǀed foƌ theiƌ iŶteŶded puƌpose iŶ this 
research study (Appendix 3). 
Nine patients (6 male and 3 female, mean age (±SD): 67.1 ± 9.3) undergoing 
elective open laparotomy were recruited for this study following informed written 
consent. Table 8.4 suŵŵaƌizes the patieŶts͛ details. Patients with oesophageal 
pathologies or blood clotting disorders were excluded from the study. 
Table 8.4: Details of the patieŶts ƌeĐƌuited foƌ the ĐliŶiĐal studǇ ͞EǀaluatioŶ of a Ŷeǁ ŵethod 
of monitoring upper gastrointestinal arterial pulsation and oxygen saturations using an intra-
luminal opto-eleĐtƌoŶiĐ pƌoďe͟. 
Patient study number Sex Age Procedure 
1 Male  79 Liver resection 
2 Male 67 Liver resection 
3 Female 73 Liver resection 
4 Male 74 Open cholecystectomy 
5 Male 59 Liver resection 
6 Female 55 Liver resection 
7 Female 52 Pancreatectomy 
8 Male 67 Pancreatectomy 
9 Male 78 Liver resection 
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The study was observational only aŶd patieŶts͛ suƌgiĐal aŶd aŶaesthetiĐ 
management were as per routine. After induction of anaesthesia and tracheal 
intubation, the intraluminal PPG probe was inserted under direct vision into the 
oesophagus by a clinical member of the research team and placed in the stomach. In 
addition to the routine theatre monitoring, the finger PPG probe was attached to the 
patieŶt͛s fiŶgeƌ aŶd the 3 lead ECG positioned on the chest in a bipolar lead I 
configuration. A gas sampling line ǁas attaĐhed to the patieŶt͛s ďƌeathiŶg ĐiƌĐuit oŶ the 
circuit side of the filter to avoid contamination.  
After the abdominal incision, as soon as convenient, the surgeon milked the 
intraluminal PPG probe by hand from the stomach into the duodenum, where it was left 
for the duration of the study. PPG traces from the intraluminal probe were recorded 
simultaneously with the PPG traces from the finger probe, the ECG trace and the air 
sensing trace. The main processing unit was turned off during periods when surgical site 
artefact rendered the intraluminal PPG traces unviable for SpO2 calculation. 
The surgeon was asked to review the position of the intraluminal PPG probe 
occasionally to ensure it remained in the duodenum. 
The intraluminal PPG probe was removed at the end of the surgical procedure, 
ďefoƌe eǆtuďatioŶ aŶd patieŶts͛ ǁakeŶiŶg. 
OďseƌǀatioŶs fƌoŵ the patieŶt͛s ƌoutiŶe ŵoŶitoƌiŶg eƋuipŵeŶt ǁeƌe ƌeĐoƌded 
throughout the study. These included the SpO2 values from the peripheral commercial 
pulse oximeter (OxyTip+ OXY-F-B, Datex Ohmeda, GE Healthcare, USA), the blood 
pressure (arterial catheter on radial artery), the heart rate and mechanical ventilation 
parameters (inspired O2 concentration (FiO2), Positive Airway Pressure (PAP) and 
Positive End-Expiratory Pressure (PEEP)). In the case report forms were also recorded 
the results from the arterial blood gas samples performed as part of the routine 
anaesthetic care of the patients. 
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8.3 Data analysis and results 
Data recorded using the main processing unit and the virtual instrumentation 
sǇsteŵ ǁas saǀed uŶdeƌ the patieŶt͛s studǇ Ŷuŵďeƌ foƌ offliŶe aŶalǇsis. 
During the pre-trial health and safety checks for patient 4, it was found that the 
ĐoŶŶeĐtoƌ foƌ the fiŶgeƌ PPG pƌoďe ǁas faultǇ. It ǁas the ĐliŶiĐal Đollaďoƌatoƌ͛s deĐisioŶ 
to proceed with the study. For this patient, no peripheral PPG signals were acquired, and 
therefore there is no reference with which to compare the intraluminal signals. This 
problem was rectified before the recruitment of the next patient. 
The recorded signals were scrutinised and appraised for the presence of surgical 
site artefact. Periods with loss of recognisable effect of cardiac frequency modulations 
were rejected. 
In some patients it was necessary to place the finger PPG probe in the same arm 
as the non-invasive blood pressure monitoring cuff. The periods when the cuff inflation 
would cause a great dampening of the finger PPG amplitudes were also rejected to avoid 
bias.  
A macro was then written in LabChart (ADInstruments, New Zealand) to evaluate 
the resulting data every two seconds. Cyclic measurements for all PPG channels were 
recorded for further analysis detailed below. 
 
Measurable PPG traces at both infrared and red wavelengths were obtained in 
the duodenum of all nine patients. 
Figure 8.5 depicts photoplethysmographic signals of good quality and high signal 
to noise ratio obtained from the duodenum in one patient for a 20 second interval. It 
can be seen that the acquired traces are synchronous with the peripheral finger PPG and 
the ECG signals, and thus attributable to the arterial blood pulsation. A moderate 
respiratory modulation can be detected in both intraluminal and peripheral signals. It 
can also be noted from Figure 8.5 that the intraluminal PPG signals have greater 
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respiratory induced variations than the ones obtained from the peripheral PPG probe. 
The airway pressure trace was included for comparison. 
 
Figure 8.5: AC and DC PPG signals obtained from the duodenum and finger. ECG and airway 
flow is included 
Since all patients were undergoing major surgical procedures, the quality of the 
PPG signals was degraded at times when the surgical team was manually handling the 
patieŶt͛s aďdoŵiŶal oƌgaŶs. The data ƌeĐoƌded ǁeƌe also affeĐted ďǇ diffeƌeŶt 
intraoperative events, some of which will be examined further. For the purpose of 
evaluating whether the duodenum is a feasible site for PPG measurements, a sample of 
the stable PPG signals from each patient were selected for analysis. 
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For each patient, the mean and standard deviation of the AC and DC amplitudes 
were calculated by averaging the infrared and red PPG amplitudes over approximately 
1:30 to 2 minutes. Table 8.5 shows the results for both the intraluminal and the 
peripheral probe AC amplitudes while Table 8.6 shows the results for the DC amplitudes. 
Table 8.5: Mean (± SD) AC amplitudes for intraluminal and peripheral PPG probes 
  Duod IR AC (V) Duod Red AC (V) Finger IR AC (V) Finger Red AC (V) 
P1 8.45 ± 1.48 2.76 ± 0.78 2.80 ± 0.39 0.73 ± 0.09 
P2 5.46 ± 1.09 2.57 ± 0.74 8.17 ± 1.02 2.25 ± 0.27 
P3 3.19 ± 0.52 1.34 ± 0.44 7.39 ± 1.17 1.63 ± 0.35 
P4 3.69 ± 0.70 1.30 ± 0.42 N/A N/A 
P5 3.73 ± 0.75 0.99 ± 0.30 11.42 ± 1.27 3.43 ± 0.42 
P6 5.99 ± 0.64 1.73 ± 0.36 8.14 ± 0.54 2.44 ± 0.18 
P7 6.26 ± 1.86 3.52 ± 1.51 9.74 ± 0.33 2.89 ± 0.14 
P8 13.37 ± 3.33 4.61 ± 1.37 6.56 ± 1.79 1.69 ± 0.60 
P9 5.85 ± 1.05 1.97 ± 0.47 6.76 ± 0.39 2.45 ± 0.15 
 
Table 8.6: Mean (± SD) DC amplitudes for intraluminal and peripheral PPG probes 
  Duod IR DC (V) Duod Red DC (V) Finger IR DC (V) Finger Red DC (V) 
P1 3.27 ± 0.07 2.27 ± 0.03 2.01 ± 0.02 0.96 ± 0.00 
P2 2.78 ± 0.16 2.19 ± 0.07 1.62 ± 0.01 0.91 ± 0.00 
P3 3.03 ± 0.04 2.04 ± 0.02 1.91 ± 0.13 0.92 ± 0.03 
P4 3.55 ± 0.06 2.33 ± 0.03 N/A N/A 
P5 3.14 ± 0.01 2.69 ± 0.01 2.09 ± 0.03 1.39 ± 0.00 
P6 3.11 ± 0.02 2.65 ± 0.01 1.98 ± 0.01 1.36 ± 0.00 
P7 4.24 ± 0.07 3.39 ± 0.06 2.20 ± 0.02 1.47 ± 0.01 
P8 1.02 ± 0.02 0.70 ± 0.01 2.28 ± 0.16 1.19 ± 0.04 
P9 2.85 ± 0.02 1.50 ± 0.02 1.93 ± 0.02 1.32 ± 0.01 
 
In order to provide a comparison between PPG sites, the mean of means AC and 
DC PPG amplitudes for the intraluminal and the peripheral probes were calculated from 
the values of Table 8.5 and Table 8.6. Figure 8.6 illustrates the mean of means of AC 
amplitudes for the duodenum and the finger PPG probes, while Figure 8.7 shows the 
mean of means of the DC amplitudes. 
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Figure 8.6: Mean of means AC amplitudes 
 
Figure 8.7: Mean of means DC amplitudes 
By observing Figure 8.6 and Figure 8.7, it can be seen that the AC amplitudes are 
comparable in both sites, while the DC amplitudes are larger in magnitude in the 
duodenum than in the finger. 
Although this is an uncalibrated system, the extracted photoplethysmographic 
data was used for computation of blood oxygen saturations from both the duodenum 
and the finger sensors. Table 8.7 shows the mean SpO2 values obtained for the same 
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patient data samples used above. The SpO2 values obtained at these times using a 
commercial pulse oximeter, part of the patieŶts͛ ƌoutiŶe ŵoŶitoƌiŶg, aƌe also iŶĐluded. 
Table 8.7: Mean SpO2 (± SD) for the intraluminal PPG probe and the finger PPG probe, and 
commercial pulse oximeter values 
  Duod SpO2 Finger SpO2 Comm SpO2 
P1 98.28 ± 2.18 96.29 ± 1.14 99 
P2 94.97 ± 3.51 97.78 ± 0.30 98 
P3 94.23 ± 5.24 98.41 ± 2.36 99 
P4 96.56 ± 3.42 N/A 99 
P5 102.25 ± 1.73 98.70 ± 0.24 99 
P6 101.52 ± 1.30 99.05 ± 0.44 100 
P7 92.67 ± 3.75 98.97 ± 0.30 100 
P8 97.42 ± 2.39 97.56 ± 2.91 99 
P9 93.71 ± 2.87 96.74 ± 0.24 99 
 
Figure 8.8 shows the mean of means SpO2 from all three sensors - duodenum 
PPG probe, finger PPG probe and commercial pulse oximeter. 
 
Figure 8.8: Mean of means SpO2 for the intraluminal PPG probe, the finger PPG probe and the 
commercial pulse oximeter 
It can be noted from Figure 8.8 that the peripheral PPG probe is in good 
agreement (97.93%) with the commercial pulse oximeter (99.1%). The results obtained 
with the duodenum PPG probe have more variance in terms of SpO2, with the mean of 
mean value (96.84%) showing an underestimation of approximately 2% in comparison 
with the commercial device. 
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It was mentioned previously that a moderate respiratory modulation is 
detectable in the PPG signals obtained. These variations were more visible in the 
intraluminal signals in Figure 8.5. These could have an effect on the calculated SpO2 
values shown on Figure 8.8. 
In order to isolate the pulsatility of arterial blood, a frequency domain algorithm 
was applied to the data. The PPG signal was subjected to a Fourier transform and the 
frequency of interest, in this case the heart rate, was identified. The ratio of ratios R 
variable needed to compute the saturation from the equation SpO2=110-25R (detailed 
in chapter 5), is achieved from the spectral amplitude of the red and infrared AC signals 
at heart rate. The denominator is selected as the spectral amplitude of the 
corresponding DC signals at zero frequency. The same process was repeated at the 
ventilation rate. This has been shown to yield lower saturation values [10], [11] and is 
presumed to represent the saturations from the venous vascular bed. 
Below, in Table 8.8, are the obtained blood saturations using the frequency 
domain method at both the cardiac and respiratory frequencies for the intraluminal and 
the finger probes. 
Table 8.8: Frequency domain SpO2 values for the intraluminal and the finger PPG probes 
  
Duod SpO2 
Cardiac 
Finger SpO2 
Cardiac 
Duod SpO2 
Resp 
Finger SpO2 
Resp 
P1 
100.90 100.28 96.16 98.29 
P2 
96.21 98.24 91.94 91.48 
P3 
101.73 101.09 93.76 95.85 
P4 
101.21 N/A 79.69 N/A 
P5 107.64 99.21 100.59 100.08 
P6 
102.40 99.60 104.15 98.74 
P7 
97.74 99.07 91.58 96.55 
P8 99.53 100.43 99.71 97.42 
P9 
98.05 99.38 95.65 98.57 
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Figure 8.9 shows the mean SpO2 from the values from Table 8.8, alongside the 
SpO2 values calculated before using the time domain method and also the values from 
the commercial pulse oximeter. 
 
Figure 8.9: Frequency and time domain SpO2 values for the intraluminal PPG probe and the 
finger PPG probe (highlighted in a darker colour) and mean commercial pulse oximetry values 
(in light blue) 
 
Figure 8.10: Scatter graph of mean SpO2 values obtained using frequency and time domain 
algorithms for the intraluminal PPG probe and the finger PPG probe, in comparison to the 
ĐoŵŵeƌĐial pulse oǆiŵeteƌ ǀalues. The diffeƌeŶt Đolouƌs iŶdiĐate eaĐh patieŶt͛s “pO2 values 
and the black line represents the mean of means SpO2 for each calculation method. 
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The mean SpO2 values obtained using the frequency domain method at the 
cardiac frequency are clearly of higher magnitude than the ones obtained using the time 
domain method. Both intraluminal and peripheral values are nearer to the commercial 
SpO2 value at 100.59 ± 3.15 and 99.66 ± 0.84, respectively. The respiratory frequency 
estimation produced lower saturation values than the other calculations. It can be also 
noted in Figure 8.9 that the time domain calculations fall between the cardiac and 
respiratory frequency SpO2 calculations. 
8.3.1 Other events 
The study at hand was conducted on patients undergoing laparotomy as part of 
elective surgery. During major surgery, both predictable and unpredictable events can 
have an effect on the patient and therefore on the haemodynamic variables being 
monitored.  
It was referred previously that the data recorded from some of the patients were 
affected by such events. Here we will focus on two such cases. In these two situations, 
there were measurable traces during the event and also 10 to 20 minutes before and 
after where the patients were stable and their vital signs were within the normal limits. 
8.3.1.1 Case 1 
DuƌiŶg patieŶt ϭ͛s iŶteƌǀeŶtioŶ, poƌtal ǀeiŶ ĐlaŵpiŶg ĐoŵpouŶded ďǇ aŶ 
elevated central venous pressure and blood loss, lead to a situation of hypotension. 
Portal vein clamping is used as a method of controlling bleeding during liver 
resection and of better preservation of organ function in the postoperative phase. 
However, this method of inflow control can increase the risk of ischaemic injury and 
splanchnic congestion [132]. 
AC and DC PPG signals obtained from the duodenum and finger at three different 
time-points (before, during and after portal vein clamping) shows the changes in PPG AC 
and DC waveform amplitude and morphology before, during and after the event. 
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Figure 8.11: AC and DC PPG signals obtained from the duodenum and finger at three different 
time-points (before, during and after portal vein clamping) 
 
Table 8.9 shows the SpO2 values calculated using the time and frequency domain 
methods for each period: before, during and after the portal vein clamping. Systolic and 
diastolic blood pressures are also included, along with the commercial pulse oximeter 
values. 
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Table 8.9: Blood pressure and time and frequency domain SpO2 calculations before, during and 
after portal vein clamping 
 
Before PVC During PVC After PVC 
Systolic pressure 84 55 100 
Diastolic pressure 45 32 53 
Time domain:    
Duod calc SpO2 93.87 ± 6.04 68.31 ± 14.76 77.07 ± 3.18 
Finger calc SpO2 96.82 ± 1.78 95.29 ± 3.27 89.80 ± 9.79 
Frequency domain:    
Duod SpO2 cardiac 98.33 87.98 77.90 
Finger SpO2 cardiac 100.62 100.55 97.21 
Duod SpO2 resp 86.68 69.70 77.79 
Finger SpO2 resp 91.69 85.36 79.24 
Comm pulse oximeter 98 97 98 
 
A change in SpO2 can be noted for every PPG signal on Table 8.9 throughout this 
event, both intraluminally and peripherally. The results from the duodenum probe 
shows a decrease in SpO2 during the portal vein clamp. It is important to notice the 
differences between the time domain and frequency domain results. The time domain 
calculations yield a greater drop during clamping than those on the frequency domain, 
converging after clamp to the same value as the respiratory frequency calculation. On 
the other hand, the time domain results obtained from the finger probe show a decrease 
in SpO2 but mainly after portal vein clamping. 
There is no major change in the values obtained from the commercial pulse 
oximeter. 
In terms of amplitudes of the PPG signals, the changes can be visualised in Figure 
8.12 and Figure 8.13. 
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Figure 8.12: Mean AC PPG amplitudes before, during and after portal vein clamping 
 
Figure 8.13: Mean DC PPG amplitudes before, during and after portal vein clamping 
The biggest change in amplitude of PPG signals happened in the AC signals. There 
was a reduction in amplitudes during portal vein clamp and an increase afterwards. This 
was also true for the finger PPG signals, as could be seen in Figure 8.11. 
8.3.1.2 Case 2 
Patient 8 became hypotensive during the surgical procedure. Figure 8.14 shows 
the changes in amplitude and morphology of the intraluminal and peripheral PPG signals 
throughout this event. 
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Figure 8.14: AC and DC PPG amplitudes obtained from the duodenum and the finger at three 
different time-points (before, during and after hypotensive event) 
From Figure 8.14 it can be noted that there is respiratory modulation in the 
waveforms obtained from the duodenum PPG probe. This is not as noticeable in the 
finger PPG waveforms. There is also a decrease in amplitude in the intraluminal signals 
during the hypotensive event, with the opposite effect seen for the peripheral probe. 
Figure 8.15 and Figure 8.16 demonstrate these changes graphically. 
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Figure 8.15: Mean AC PPG amplitudes before, during and after hypotensive event 
 
Figure 8.16: Mean DC PPG amplitudes before, during and after hypotensive event 
 The SpO2 values before during and after the hypotension event were calculated 
using the time and frequency domain methods and can be seen in Table 8.10. Systolic 
and diastolic blood pressures are also included, along with the commercial pulse 
oximeter values. 
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Table 8.10: Blood pressures and time and frequency domain SpO2 calculations before, during 
and after hypotensive event 
 
before During After 
Systolic pressure 90 60 88 
Diastolic pressure 55 38 45 
time domain:    
Duod calc SpO2 97.42 ± 2.39 103.91 ± 1.96 88.94 ± 3.90 
Finger calc SpO2 97.56 ± 2.91 96.86 ± 0.45 97.82 ± 0.29 
frequency domain:    
Duod SpO2 cardiac 99.53 100.08 89.44 
Finger SpO2 cardiac 100.43 99.99 99.16 
Duod SpO2 resp 99.71 100.34 85.96 
Finger SpO2 resp 97.42 97.43 99.76 
Comm pulse oximeter 99 99 99 
 
Table 8.10 shows a decrease in intraluminal SpO2 not during but after the 
hypotension episode had been resolved. Time and frequency domain calculations show 
the same trend. No significant change can be seen in either the finger PPG probe 
calculations or the commercial pulse oximeter values. 
8.3.2 Gastric measurements 
As part of their procedure, all patients had a nasogastric tube inserted for 
aspiration of gastric contents. This causes gastric decompression, enabling 
measurements to be obtained from the stomach lining. As noted before, the surgeon 
was asked to review the position of the intraluminal probe and in some patients it was 
found located in the stomach. As detailed below, PPG signals can be successfully 
recorded under these conditions. As soon as convenient, the intraluminal probe was 
replaced in the duodenum. 
Measurable PPG traces were obtained from the stomach of 3 patients. 
Figure 8.17 depicts photoplethysmographic signals of good quality and high 
signal to noise ratio obtained from the stomach lining in one patient for a 10 second 
interval. It can be seen that the acquired traces are synchronous with the peripheral 
finger PPG and the ECG signals, and thus attributable to the arterial blood pulsation. 
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Figure 8.17: AC and DC PPG signals obtained from the stomach and finger. ECG is included 
Like with the data obtained from the duodenum, a sample of good quality signals 
collected from the stomach for each patient were analysed. Table 8.11 and Table 8.12 
show the average and standard deviation of the gastric and peripheral AC and DC 
amplitudes. 
Table 8.11: Mean (± SD) AC PPG amplitudes from gastric and peripheral measurements  
  Gastric IR AC (V) Gastric Red AC (V) Finger IR AC (V) Finger Red AC (V) 
P2 4.68 ± 0.98 1.51 ± 0.48 6.28 ± 1.67 1.41 ± 0.34 
P3 4.84 ± 1.03 2.33 ± 1.18 7.41 ± 0.61 1.41 ± 0.12 
P6 4.07 ± 0.41 1.50 ± 0.34 12.38 ± 0.50 3.92 ± 0.16 
-1
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
A
m
p
li
tu
d
e
 (
V
)
Time (hh:mm:ss)
  
3 
 
 
 
0 
 
 
 
-3 
 
2 
 
 
 
0 
 
 
 
-2 
 
2 
 
 
0 
 
 
 
-2 
 
 
1 
 
0 
 
-1 
 
E
C
G
  
  
  
  
  
  
F
in
g
e
r 
R
e
d
  
  
  
  
   
  
   
F
in
g
e
r 
IR
  
  
  
  
  
  
   
  
  
   
  
G
a
st
ri
c 
R
e
d
  
  
  
  
  
   
  
  
 G
a
st
ri
c 
IR
 
155 
Table 8.12: Mean (± SD) DC PPG amplitudes from gastric and peripheral measurements 
  Gastric IR DC (V) Gastric Red DC (V) Finger IR DC (V) Finger Red DC (V) 
P2 2.73 ± 0.12 2.03 ± 0.01 1.81 ± 0.10 0.98 ± 0.03 
P3 3.38 ± 0.11 2.48 ± 0.14 1.87 ± 0.05 0.84 ± 0.01 
P6 3.02 ± 0.01 2.30 ± 0.01 2.00 ± 0.02 1.36 ± 0.01 
 
The mean of means of the AC and DC amplitudes were calculated from the 
results shown in Table 8.11 and Table 8.12. Figure 8.18 and Figure 8.19 provide a 
comparison between the measurements taken from the stomach and the ones obtained 
from the peripheral finger PPG probe. 
 
Figure 8.18: Mean of means AC PPG amplitudes from gastric and peripheral measurements 
 
Figure 8.19: Mean of means DC PPG amplitudes from gastric and peripheral measurements 
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 The results obtained from the stomach show a similar pattern to the ones 
obtained from the duodenum, when comparing to the finger PPG probe. In Figure 8.18 
it can be seen that the AC amplitudes are comparable to the finger, but slightly smaller 
in magnitude, while Figure 8.19 shows the stomach DC amplitudes to be of greater 
magnitude than the finger ones. 
Table 8.13 shows the mean SpO2 values obtained for the same patient data 
samples used above. The mean of means is also included for all 3 probes – intraluminal 
PPG probe, peripheral PPG probe and commercial pulse oximeter. 
Table 8.13: Mean (± SD) and mean of means of SpO2 calculations from gastric and peripheral 
measurements and commercial pulse oximeter values 
  Gastric SpO2 Finger SpO2 Comm SpO2 
P2 99.04 ± 2.93 99.52 ± 0.76 98 
P3 93.90 ± 5.27 99.45 ± 0.61 99 
P6 97.97 ± 1.86 98.37 ± 0.23 100 
Mean of means 96.97 ± 2.21 99.11 ± 0.53 99.0 ± 0.82 
 
It can be seen from Table 8.13 that the SpO2 values calculated for the data 
obtained from the probe placed in the stomach have a greater variance than the ones 
calculated and obtained from the finger probes. This lead to a mean of means SpO2 
calculation underestimation of approximately 2%. The finger PPG probe results were in 
good agreement with the commercial pulse oximeter values. 
Frequency domain calculations were done for the same selected data for 
comparison to the time domain calculations. 
Table 8.14: Frequency domain SpO2 calculations for gastric and peripheral PPG probe 
  
Gastric SpO2 
cardiac 
 Gastric SpO2 
resp 
Finger SpO2 
cardiac 
Finger SpO2 
Resp 
P2 99.83 93.64 99.97 93.09 
P3 96.91 88.34 100.94 98.39 
P6 103.51 86.48 98.97 98.85 
Mean 100.08 ± 2.70 89.49 ± 3.04 99.96 ± 0.80 96.77 ± 2.62 
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Like the results from the duodenal position, Table 8.14 shows that, using the 
frequency domain calculation at the cardiac frequency, the value of SpO2 in the stomach 
is greater than the one calculated using the time domain algorithm and, so, in greater 
agreement to the commercial pulse oximeter values. The respiratory frequency 
calculations produced lower saturations with the greatest differences seen for the 
gastric measurements. 
 
8.4 Discussion 
 Good quality PPG signals with large amplitudes were obtained from all patients 
recruited for the clinical study. However, since all measurements were obtained during 
the regular surgical procedures, the data was at times compromised by motion artefact. 
So, in order to evaluate the accuracy of measurements obtained from the duodenum, a 
sample was selected of the best signals from each patient collected at periods of 
haemodynamical stability. This was evaluated from the patieŶts͛ ƌoutiŶe ŵoŶitoƌiŶg 
parameters, which were recorded on the case report forms. 
Analysis of the mean of means PPG amplitudes showed the AC amplitudes to be 
comparable to the ones obtained with the finger PPG probe while the DC amplitudes 
were greater for both infrared and red wavelengths. Regional differences in vascularity 
may account for these differences; it is known that the luminal mucosa of the mid 
gastƌoiŶtestiŶal tƌaĐt has paƌtiĐulaƌlǇ high ǀasĐulaƌ deŶsitǇ. IŶ ĐoŶtƌast, the fiŶgeƌ͛s 
external surface of the epidermis is composed of layers of dead tissue characterized by 
the heavy presence of keratinocytes and thickened plasma membranes [13]. The 
differences in tissue type and volume of blood lead to changes in the path length of the 
light travelling through the tissue under investigation. 
Calculation of SpO2 values showed an underestimation of the intraluminal probe 
of approximately 2% when compared to the commercial pulse oximeter. Considering 
this is an uncalibrated system, the difference is not alarming. This difference was not 
seen for the finger PPG probe. 
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The obtained PPG signals presented with moderate modulation at respiratory 
rate. Ventilator artefact has been described before when monitoring 
photoplethysmographs from internal organs [5], [133], and could possibly have a 
detrimental effect on the estimation of SpO2. It has also been hypothesized before that 
the respiratory modulations on the tissue blood volume, brought on by changes in 
thoracic pressure, could enable the measurement of venous oxygenation [104]. A 
frequency domain algorithm was therefore applied to the data in order to isolate the 
cardiac cycle modulations of the PPG signals. In pulse oximetry it is assumed that this 
allows differentiation of the arterial blood component from the venous blood and other 
tissues. The calculated SpO2 values are of higher magnitude and also closer to the finger 
probe SpO2 values and the commercial pulse oximeter values. 
The frequency domain algorithm was also applied at the respiratory frequency. 
This yielded lower saturation values in the calculations for both intraluminal (94.80 ± 
6.63 %) and finger (97.12 ± 2.47 %) PPG probes.  These results are within the 
physiological range expected for venous blood oxygen saturations. 
During the clinical trials, two patients experienced hypotension. PPG signals 
obtained before, during and after these events showed noteworthy variations. SpO2 
calculations for patient 1 showed a significant decrease during hypotension from 93.87% 
to 68.31%. Same as seen before, frequency domain calculations yielded saturations of 
higher magnitude for the cardiac frequency and of lower magnitude for the respiratory 
frequency, suggesting the time domain results may be affected by respiratory 
modulation. 
Considering the frequency domain calculations, however, there was a 10% 
decrease in saturation for the cardiac frequency during the hypotensive event. The 
respiratory frequency yielded a much lower saturation at 69.70%. These results could 
signify the onset of hypoxia in the gut and the ability of photoplethysmography to detect 
it. 
Finger SpO2 calculations and commercial pulse oximeter values did not 
demonstrate this change, even though the respiratory frequency calculation for the 
finger PPG probe during the event showed a decrease to a saturation of 85.36%. Patient 
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1 was undergoing a portal vein clamp as part of his procedure and was in an unstable 
situation of elevated central venous pressure and blood loss. This could explain a 
reduced global venous blood oxygenation. 
After the event, when monitored haemodynamic variables were back to normal 
values, the calculated saturations for the duodenum and the respiratory frequency 
calculation for the finger probe converged to a value of approximately 78%.  
It was described before in section 3.3 that the splanchnic area is prone to hypoxia 
in situations of hypotension and hypovolaemia, which may lead to ischaemia and shock. 
AŶ iŵďalaŶĐe iŶ oǆǇgeŶ deŵaŶd/supplǇ ƌesultiŶg fƌoŵ the ƌegioŶ͛s ŵetaďoliĐ aŶd 
mechanic regulations may explain this lowered saturation. Also, the collateral 
arrangement of blood vessels into intramural and extramural capillary beds [7] could 
possibly lead to a propagation of the cardiac blood flow pulse into the venous 
compartment. 
Patient 8 also experienced a reduction in amplitude during his episode of 
hypotension and a decrease in calculated SpO2 afterwards corroborates the splanchnic 
region vulnerability on being the last to regain adequate flow and thus being more prone 
to developing hypoxia. 
In 3 patients, the intraluminal probe was found to have fallen into the stomach. 
Since a nasogastric tube inserted for aspiration caused gastric decompression, good 
quality measurements were obtained from the gastric lining. The results were similar to 
the duodenum, with higher DC PPG amplitudes than the finger PPG probe. An 
underestimation of 2% was found when comparing time domain SpO2 calculations to 
the commercial pulse oximeter, and this difference was cancelled when frequency 
domain calculations were applied. The mucosa layer of the stomach and its blood supply 
are similar to the duodenum and therefore similar results are to be expected. 
Nevertheless, the sample size is too small for further considerations regarding 
photoplethysmography from the gastric mucosa. 
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CONCLUSION 
The goal of this research was to evaluate the feasibility of using the technique of 
photoplethysmography intraluminally in the duodenum in order to measure the 
haemodynamic changes occurring in the splanchnic circulation. Bespoke hardware and 
data acquisition virtual instrumentation were developed to be used in conjunction with 
existing intraluminal PPG probe during clinical trials on 9 patients undergoing open 
laparotomy. 
A two channel dual wavelength PPG processing system was successfully 
developed to accommodate two PPG probes. These were an intraluminal probe and a 
finger probe, both custom developed within the Biomedical Research Lab and used in 
previous studies. This portable, battery powered system also included an ECG channel 
aŶd aŶ aiƌǁaǇ pƌessuƌe ĐhaŶŶel to deteĐt the patieŶt͛s ǀeŶtilatioŶ floǁ. Afteƌ 
digitisation, the PPG, ECG and airway pressure signals were transferred to a laptop 
computer for saving, processing and real time display using a Virtual Instrument 
implemented on LabVIEW. The system was evaluated in the laboratory and it was found 
that good quality PPG signals could be obtained from the finger of a healthy volunteer. 
Ethical approval was obtained from the NHS Research Ethics Committee and 
from the Barts Health NHS Trust Research and Development for the clinical study 
͞Evaluation of a new method of monitoring upper gastrointestinal arterial pulsation and 
oxygen saturations using an intra-luminal opto-eleĐtƌoŶiĐ pƌoďe͟. 
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As part of the application for ethics approval, the PPG processing system and 
both intraluminal and finger PPG probes were assessed and approved for use by the 
Clinical Physics and Infection Control department at Barts Health NHS Trust. 
Good quality red and infrared PPG signals were obtained intraoperatively from 
the duodenal mucosa of all 9 patients recruited to the clinical study following informed 
written consent. 
It is important to note that, due to the great proximity to the surgical site, 
intraoperative monitoring of duodenal SpO2 could not be done in a continuous way, plus 
during these measurements there was considerable movement artefact imposed on the 
signals induced by the surgical team. Therefore, to check the accuracy of duodenal PPG, 
offline analysis was conducted using a sample of the good quality PPG signals collected 
from each patient at periods of haemodynamic stability. These signals were larger in 
amplitude than the ones obtained with the finger PPG probe, but calculations of SpO2 
showed an underestimation of 2% when compared to the both the finger probe and the 
commercial device. Even though this is an uncalibrated system and thus prone to 
displaying such behaviours, further investigations were warranted. Analysis of the PPG 
waveform in the frequency domain has been previously described as a possible method 
of estimating arterial blood oxygen saturation. At the heart rate frequency the 
calculation of SpO2 yielded higher values, more in agreement with the finger PPG probe 
and the commercial device. Close inspection of the duodenal PPG waveform reveals a 
moderate modulation at the respiratory rate which could explain the difference in SpO2 
between the duodenum and the finger calculations using the traditional method. 
Previous research has demonstrated respiratory modulation of the venous 
compartment and the possibility of estimating venous blood oxygen saturation from 
PPG signals. Using the frequency domain algorithm at the respiratory rate, lower values 
of blood oxygen saturation were obtained for both the duodenum and the finger PPG 
signals; these were within the expected physiological range for venous blood. 
 During their routine surgical interventions, two of the patients recruited for this 
observational clinical study experienced an episode of hypotension. Neither the finger 
PPG probe nor the commercial pulse oximeter registered any noteworthy changes. In 
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contrast, the intraluminal PPG probe outputted a significant decrease in amplitude and 
SpO2 calculations unveiled an interesting situation to consider in each case. For the first 
patient, calculations at the cardiac frequency revealed a decrease of SpO2 of 10%, which 
was not seen in the second patient. However, both of them showed a further decrease 
10 to 20 minutes after the event, at a time when vital signs had returned to their normal 
limits. SpO2 values match the calculated values at respiratory rate for both the 
intraluminal and the finger PPG probes. This suggests the possibility of 
photoplethysmography identifying changes in tissue oxygenation and blood volume in 
the splanchnic circulation resulting from external and/or internal regulatory 
mechanisms. Further investigations need to be conducted to determine whether these 
haemodynamic changes may provide a warning sign for the development of ischaemia. 
As the intraluminal PPG probe was not affixed to the duodenal mucosa, with the 
intraoperative activity and movement, in some occasions it moved into the stomach. As 
part of the surgical procedure, all patients had a nasogastric tube inserted which caused 
decompression of the stomach. This enabled measurements to be taken from the gastric 
mucosa. Stomach PPG signals were of good quality with SpO2 values within the 
physiological range when using the frequency domain algorithm – time domain 
calculations showed an underestimation alike the duodenal measurements. Due to the 
reduced sample size, these results are not conclusive. But their trending shows 
similarities to the duodenum, making the stomach, when deflated, a potential PPG site. 
This is the first described study done in human patients of a minimally invasive 
photoplethysmographic estimation of blood oxygen saturation of the splanchnic 
circulation. Beyond accurately measuring SpO2 from the duodenum and the deflated 
stomach, the developed PPG system with existing intraluminal probe demonstrated the 
capability of identifying periods of compromised perfusion. It thus shows great promise 
as complementary monitoring for patients at risk of developing splanchnic ischaemia. 
Future work 
Due to the potentially significant clinical use for the technique described in this 
thesis, it may be important to consider the following lines of research: 
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 Recruiting more patients in order to confirm and solidify hypothesis that 
this technique may provide early detection of splanchnic hypoxia. Animal studies are 
already present in literature confirming its potential. 
 The probe described by Jacquet-Lagrèze and colleagues [88], which 
included an inflatable balloon to ensure contact of the sensor with the mucosal wall, 
could be considered. It however required regular deflation. From the study presented 
in this thesis, there seems to be a need for an instantaneous – even if not so much 
continuous – ďlood oǆǇgeŶ ĐalĐulatioŶ ǁhiĐh ǁouldŶ͛t ďe ǀiaďle if a ďallooŶ had to ďe 
inflated at regular times. Different technology of expanding tubular fabric, possibly 
inspired by blood vessel stents, could be the subject of research. 
 The gastric mucosa should be investigated further. 
Photoplethysmography has been avoided in the stomach, but the present study 
confirms that signals can be obtained from the gastric mucosa if the organ is deflated. 
Possibility of including a PPG sensor in the tip of nasogastric tube that causes deflation 
could be under consideration. 
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